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Introduction
This report provides an update on the latest New Zealand cancer survival statistics. 
What is cancer survival?
How is survival measured?
How is survival presented in this report?
The relative survival rate is presented in two ways.
1. Change over time: one-year and five-year relative survival
2. Overall 1994–2011 relative survival, presented as cumulative and interval-specific
See
*D45–D47 were only considered malignant from 2003 onwards
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Technical notes
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Survival' refers to the length of time lived after an initial diagnosis of cancer.  Survival is one of the key indicators of the impact of cancer on society. It is a 
valuable way of measuring the success of cancer control. A number of different statistical procedures can be used to derive survival figures.
Which cancers are included?
All adult cancers (C00–C96, D45–D47)*
Bladder (C67)
Brain (C71)
Breast – female (C50)
Cervix (C53)
Childhood cancers (C00–C96, D45–D47, ages 0–14)*
Colorectum and anus (C18–C21)
Head, neck and larynx (C00–C14, C32)
Hodgkin lymphoma (C81)
Kidney, ureter and urethra (C64–C66, C68)
Leukaemia (C91–C95)
Liver and intrahepatic bile ducts (C22)
Melanoma (C43)
Myeloma (C90)
Non-Hodgkin lymphoma (C82–C85, C96)
Oesophagus (C15)
Ovary (C56)
Pancreas (C25)
Prostate (C61)
Stomach (C16)
Testis (C62)
Thyroid (C73)
Trachea, bronchus and lung (C33–C34)
Uterus (C54–C55)
All survival estimates in this publication are relative survival ratios. Relative survival is the observed survival in the cancer patient group divided by the expected 
survival of a matched group in the general population. It is defined as a ratio, but expressed as a percentage. Relative survival is cancer survival in the absence of 
other causes of death. It represents the proportion of patients within a particular group alive after a certain number of years of follow-up, most commonly five 
years, and attributes all the ‘excess’ mortality of the group to the cancer in question. For example, a relative survival of 75% means that the cancer reduces the 
likelihood of surviving five years after diagnosis by 25%. A relative survival of 100% indicates that cancer patients experience mortality rates equivalent to those 
in a comparable group from the general population. If a relative survival rate exceeds 100%, this indicates that cancer patients have better observed survival than 
is expected for people in the general population.
Cumulative relative survival presents the relative survival of patients over a specified number of years.
Interval-specific relative survival presents the relative survival of patients for a year, given the patient has already survived the previous year. 
Patients diagnosed between 1994 and 2011 and followed up until the end of 2013 were included for both calculations.
Survival information is provided for 24 cancers. The brackets next to the cancer show the corresponding ICD code(s). These cancers do not include children in 
the analysis; 'Childhood cancers' presents survival for patients aged 0–14 years with any type of cancer.
Change over time shows one-year and five-year survival for cancer patients observed during two-year periods between 1998 and 2011. This information shows 
how the chances of one-year and five-year survival for cancer patients changed over that 14-year period. One-year survival data is a new addition to this 
publication.
Trends noted in change over time information may not necessarily be directly due to changes in survival ratios, but rather may be due to changes in diagnosis, 
treatment or early detection techniques, or may be artefacts of the data (eg, changing definitions, random variation).  This publication does not attempt to 
explain the underlying cause of any trends. Change over time information should be treated with caution when small numbers are involved.
example calculations
Technical notes
Data used in this report
Data exclusions
Cancer registrations excluded from analysis where: 

Statistical methods
2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011
2000 0–1 1–2 2–3 3–4 4–5 5–6 6–7 7–8 8–9 9–10 10–11 11–12
2001 0–1 1–2 2–3 3–4 4–5 5–6 6–7 7–8 8–9 9–10 10–11
2002 0–1 1–2 2–3 3–4 4–5 5–6 6–7 7–8 8–9 9–10
2003 0–1 1–2 2–3 3–4 4–5 5–6 6–7 7–8 8–9
2004 0–1 1–2 2–3 3–4 4–5 5–6 6–7 7–8
2005 0–1 1–2 2–3 3–4 4–5 5–6 6–7
2006 0–1 1–2 2–3 3–4 4–5 5–6
2007 0–1 1–2 2–3 3–4 4–5
2008 0–1 1–2 2–3 3–4
2009 0–1 1–2 2–3
2010 0–1 1–2
2011 0–1
─
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Year of follow-up
Note: The numbers represent the interval of survival that the years of diagnosis and follow-up contribute to eg, 2011 as year of diagnosis and 
2011 as year of follow-up= 0–1.
· the patient's date of registration was the same as the date of death
· the registration was a multiple cancer.
‘Cancer’ is defined as a range of diseases in which abnormal cells proliferate and grow in an uncontrolled manner. In this publication cancer is 
classified as those malignant cancers registered in the New Zealand Cancer Registry under the ICD codes C00–C96 and D45–D47. ICD codes 
D45–D47 (chronic myeloproliferative disorders and myelodysplastic syndromes) were only included from 2003 onwards.
This publication uses cancer incidence information from the New Zealand Cancer Registry and the mortality information from the New Zealand 
Mortality Collection held by the Ministry of Health.  Expected survival estimates for the general population were obtained from ethnic-specific 
(Māori/non-Māori) life tables developed by Statistics New Zealand. The Cancer Registry is population-based and has been in existence since 1948.  
Registration of cancer cases became compulsory, through legislation, in July 1994. The primary source of cancer incidence data is laboratory reports 
(along with hospital discharge reporting). Information also comes from death certificates, autopsy reports and the records of cancer treatment 
providers.
Information about the deaths of people registered with cancer was obtained through passive follow-up. The records of all people with cancer registered 
in the period 1 January 1994 to 31 December 2011 were linked with dates of death for the period 1 January 1994 to 31 December 2013. For the purpose 
of this analysis it was assumed that cancer patients for whom no death information was available were alive.
Cancer data pertains to patients aged 15 years and over; childhood cancers include patients aged 0–14 years and is not site specific. People who are 
diagnosed and subsequently die overseas (without the Ministry of Health knowing) are considered 'alive' in this data. 
It should be noted that numbers in the ‘All adult cancers’ group (which includes sites not reported on in this publication) will have varied over time 
due to changes in Cancer Registry registration rules.
The relative survival ratio is the observed survival in the cancer patient group divided by the expected survival of a matched group from the New Zealand 
population. Observed survival was drawn from data in the New Zealand Cancer Registry and the New Zealand Mortality Collection. Both are databases 
administered by the Ministry of Health. Expected survival was taken from life tables (tables of annual probabilities of death in the general population) of the New 
Zealand Māori and non-Māori population. The use of ethnic-specific life tables helps to smooth biases exhibited in the survival ratios of Māori and non-Māori. 
This information is then used to calculate cancer survival ratios using the Stata program and the Ederer II method (Ederer et al 1961).
The period method (Brenner and Gefeller 1996) was used to calculate five-year relative survival estimates over time. This method uses patients diagnosed in 
different years and takes their survival experience during a specific follow-up period. In this publication the follow-up periods were two-year periods from 
1998–1999 to 2010–2011. This method uses the survival experience of recently diagnosed patients.
The cohort method was used to calculate one-year relative survival over time and cumulative and interval-specific relative survival. This method uses patients 
diagnosed in a particular year and follows them for a certain number of years. This publication included patients diagnosed between 1994 and 2011 and followed 
until the end of 2013. 
One-year relative survival included patients diagnosed in the year prior to, and including, the follow-up period in question. Patients contributed to each year they 
survived. For example, only patients diagnosed in 2003 or earlier could contribute to the 10th year of survival; if a patient was diagnosed in 2012 they could only 
contribute to the first year of survival and a part of the second year.
The figure below illustrates the diagnosis and follow-up intervals used for five-year relative survival using the period analysis (shaded box) and cohort analysis 
(outlined box). 
Period method: Five-year survival is based on patients diagnosed in different years and their survival experience observed during the specific 
follow-up period (2010–2011).
Cohort method: Five-year survival is based on patients diagnosed in a specific period (eg, 2005–2006) who were followed up for five complete 
years.
Interpretation
For help interpreting cancer survival ratios, tables and graphs:
Key terms
Confidence intervals
Cumulative relative survival
Deprivation
Further information: 
Ethnicity
Expected survival
What do the graphs show? 
Cumulative relative survival is a measure of patient survival corrected for the effect of other independent causes of death.  It represents the proportion of patients 
within a particular group alive after a certain number of years of follow-up, and attributes all the ‘excess’ mortality of the group to the cancer in question.
Confidence intervals are a range of values used to describe the uncertainty around a single value (such as a survival ratio), in order to estimate where the true 
value lies. Confidence intervals describe how different the estimate could have been if chance had led to a different set of data. They are calculated with a stated 
probability, in this case 95% (indicating that there is a 95% chance that the true value lies within the confidence intervals).
If two confidence intervals do not overlap, then it is reasonable to assume that the difference is not due to chance (that is, is statistically significant). If two 
confidence intervals overlap, it is not possible to draw any conclusion about the significance of any difference between them. Confidence intervals in this 
publication have been calculated for survival ratios at the 95% level using the log cumulative hazard scale, as described in Dickman et al 2007.
Expected survival is the proportion of people in the general population alive after a certain period of time. Expected survival data is calculated from ethnic-
specific life tables for the New Zealand resident population, based on data from Statistics New Zealand.  These tables include information on the probability of 
death and life expectancy for both sexes and by single year of life.
The New Zealand Index of Deprivation is a measure of socioeconomic status calculated for discrete geographic areas. 
Note that the 2001 Index has been used in this publication.  Events coded to 1996 or 2006 domicile codes were mapped to 2001.
In this publication, the deprivation indices have been grouped into quintiles: quintiles 1–2 represent areas of the least deprivation and quintile 5 represents areas 
of the most deprivation.
The ethnicity data in this publication relates to ethnicity as recorded in the New Zealand Cancer Registry. Ethnicity data is required to be collected and classified 
according to Ministry of Health ethnicity data protocols for the health and disability sector (Ministry of Health 2004). Under the protocols, ethnicity is 
determined through self-identification or, when this is not possible, by appropriate proxy using a standard question format.  Individuals may select up to three 
ethnic groups they feel they belong to. The ethnicity data in this publication is based on prioritised ethnicity.  Under this system each individual is allocated to a 
single ethnic group according to the following prioritised list: Māori, Pacific peoples, Asian, other groups except New Zealand European, New Zealand European.  
Thus, any person who selects Māori as one of their three ethnicities will be recorded as Māori.
Ethnicity as recorded in the Cancer Registry is taken from hospital discharge information, the National Health Index and the Mortality Collection.  Therefore, 
the less contact a patient has with the hospital system, the less likely he or she is to have an accurate ethnicity recorded. Those registrations recorded with 
unspecified ethnicity have been included in the non-Māori group in this report.
New Zealand Socioeconomic Deprivation Indexes
· In grouping results by age, sex, extent of disease, ethnic group or deprivation, some of the numbers produced are very low. A single additional death may 
make a large difference to a survival ratio.
· The numbers of patients who survive more than a few years after diagnosis of some cancers (eg, pancreatic cancer) are low. In these cases survival ratios 
can vary considerably with the addition of one or two extra deaths to the data set.
· In the case of cancers that are more likely to affect older people (such as prostate cancer), the numbers of Māori with these cancers affecting older age 
groups will be relatively small because the Māori population has a younger age structure than the non-Māori population.
· Cumulative relative survival and interval-specific survival are presented by extent of disease, but in many cases extent of disease was not recorded. The 
percentage of cases without an extent of disease ranged from 5.9% of testicular cancer patients to 75.7% of bladder cancer patients. Information on the 
proportion of patients in each category can be found in 'Cases included in analysis, New Zealand, 1994–2011'.
Significance testing has not been applied to most of the data in this report (with the exception of the addition of confidence intervals); therefore most differences 
discussed in this report are not necessarily statistically significant. However, if the confidence intervals do not overlap for the two time periods or groups, then 
the differences can be said to be statistically significantly different.
· There were coding changes to ovarian cancer and leukaemia in 2003 and bladder cancer in 2005 that affect change over time analysis from 1998 to 2011. It 
is likely that the coding changes result in the decreased survival seen in the years subsequent to the coding change.
The following survival ratios should be interpreted with caution:
Extent of disease
International Statistical Classification of Diseases and Related Health Problems (ICD)
Interval-specific relative survival
Mortality
Mortality refers to the number of deaths recorded during a given period.
Observed survival
Patients withdrawn
Relative survival
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Interval-specific relative survival is calculated separately for each year of follow-up.  By following patients’ progress in this way, it is possible to see how the 
probability of survival varies over time. 
Observed survival is the proportion of patients alive after a certain amount of time after the diagnosis of cancer. Observed survival data was obtained from the 
New Zealand Cancer Registry and the New Zealand Mortality Collection, both of which are databases administered by the Ministry of Health. People who are 
diagnosed and subsequently die overseas without the Ministry of Health knowing are considered ‘alive’ in this data.
The extent of disease data used in this publication is that recorded according to the information that is available at registration, and is grouped into several broad 
categories:
• Localised – the tumour is confined to the organ of origin
• Regional – the tumour has invaded adjacent tissues or organs or involves regional lymph nodes
• Distant – the tumour has spread to distant organs or lymph nodes
• Not stated – the information is not sufficient to assign an extent of disease.
Extent of disease is determined using all diagnostic and therapeutic evidence available to the staff of the Cancer Registry, and may be modified within four 
months of diagnosis if more information comes to hand.
The Cancer Registry records extent of disease information where it is available.  Because pathology reports are the main source of data, this information is most 
complete for tumours for which the primary treatment is surgical (eg, breast and colorectal cancers).
ICD codes comprise a system of classification of diseases, including cancer, devised by the World Health Organization.  ICD codes in this publication are taken 
from the Australian Version of the International Classification of Diseases, 10th Revision.
Dickman P, Coviello E, Hills M. 2013. Estimating and Modelling Relative Survival. The Stata Journal  vv(ii): 1–25. URL: 
www.pauldickman.com/survival/strs.pdf
Relative survival is the observed survival in the cancer patient group divided by the expected survival of a comparable group from the general population. The 
patient group and general population group are matched, where applicable for sex, age, year and ethnic group. Relative survival reflects the excess mortality 
experienced by patients diagnosed with cancer.
A patient was withdrawn from analysis if the patient had not died and a complete year of follow-up was not possible. For example, if they were registered with 
cancer on 1 July 2011 and alive on 31 December 2013, only two complete years of outcome can be determined (2012 and 2013). Similarly, if a patient was 
registered on 1 December 2009, there would only be four years and one month of follow-up data and so this patient would be withdrawn during year five.
What do the graphs show?
One- and five-year relative survival
One-year relative survival
75.6 x 100
Five-year relative survival
55.4 x 100
41.6 x 100
Alive Died Withdrawn2 Observed Expected Relative
1 330831 87941 0 73.4 96.8 75.8
2 242890 27517 0 65.1 94.1 69.2
3 215373 16475 13864 60.0 91.5 65.6
4 185034 11476 13082 56.1 88.8 63.1
5 160476 8788 12255 52.9 86.2 61.4
6 139433 6835 11307 50.2 83.6 60.0
7 121291 5505 10331 47.8 81.1 59.0
8 105455 4697 9355 45.6 78.5 58.1
9 91403 3875 8773 43.6 75.8 57.4
10 78755 3319 8319 41.6 73.2 56.9
58.0 x 100
Alive Died Withdrawn2 Observed Expected Relative
1 30061 20834 0 30.7 96.4 31.8
2 9227 3874 0 58.0 96.9 59.9
3 5353 1328 355 74.3 97.0 76.6
4 3670 601 241 83.1 97.0 85.7
5 2828 299 227 89.0 96.9 91.8
6 2302 209 179 90.6 96.8 93.5
7 1914 134 145 92.7 96.7 95.9
8 1635 107 120 93.2 96.4 96.6
9 1408 62 101 95.4 96.1 99.3
10 1245 61 120 94.9 95.8 99.0
1Relative to a comparable group of people in the general population
2See 'Key terms' for an explanation of patients withdrawn
Years since 
diagnosis
Cumulative survival
How was 10-year cumulative relative survival calculated?
Patients diagnosed between 1994 and 2003 were included.
There were 78,755 patients alive at the start of the 10th year of follow-up. 
41.6% of patients diagnosed with cancer between 1994 and 2003 survived 10 years after diagnosis. 
73.2% were expected to survive 10 years based on survival of a comparable demographic.
63.3 %expected survival of comparable population 87.5
56.9 %
Cumulative relative survival: 1994–2011
Cumulative 
relative survival
 = observed survival of cancer patients  =  = 
expected survival of comparable population 73.2
Five-year 
relative survival
 = observed survival of cancer patients  =  = 
 =  = 78.0 %97.0
This graph shows five-year relative survival of adult cancer patients between 1998 and 2011. 
Survival for each two-year period is based on patients alive in the two-year periods and diagnosed 
in the previous 5 years.
How was this calculated for 2010–2011? 
Patients diagnosed between 2005 and 2011 and alive during 2010 or 2011 were included. Their 
survival in 2010–2011 (One, two, three, four, or five years survived) contributed to the calculation 
of five-year relative survival:
One-year 
relative survival
 = expected survival of comparable population
observed survival of cancer patients
Number of patients Cumulative survival
Interval-specific relative survival presents the probability of surviving a certain number of years based on the amount of time survived already.
Survival is calculated separately for each year of follow-up, which gives an idea of how survival probability changes with each further year survived. 
This publication included cancer patients diagnosed between 1994 and 2011 and followed up until 
31 December 2013 to calculate interval-specific relative survival. 
The table below shows interval-specific relative survival for lung cancer patients over 10 years of 
follow-up.
How was the second-year interval-specific relative survival calculated?
59.9% of lung cancer patients who survive their first year are expected to survive 
their second year of follow-up.
58.0% of patients who survived until the end of the first year after diagnosis also survived until the 
end of the second year. 96.9% were expected to survive the second year based on survival of a 
comparable demographic.
Interval-specific 
relative survival
 = observed survival of cancer patients  =  = 59.9 %
expected survival of comparable population 96.9
The table below shows CRS for all adult cancer patients over 10 years of follow-up.
Years since 
diagnosis
Interval-specific relative survival: 1994–2011
How was this calculated for 2010–2011?
These graphs show how relative survival changed between 1998 and 2011. They help to give an idea of the expected prognosis of recently diagnosed patients.
Cumulative relative survival (CRS) represents the proportion of cancer patients likely to survive after a certain number of years of follow-up. 
This publication included cancer patients diagnosed between 1994 and 2011 and followed up until 
31 December 2013 to calculate CRS. 
78.0% of cancer patients survive one year after diagnosis.1
75.6% of cancer patients diagnosed in 2010–2011 survived one year; 97.0% were expected to 
survive one year based on survival of a comparable demographic group.
56.9% of cancer patients survive 10 years after diagnosis.1
This graph shows one-year relative survival of adult cancer patients between 1998 and 2011. 
Survival for each two-year period includes patients diagnosed in this period and reflects their 
survival experience during the same two-year follow-up period.
63.3% of cancer patients survive five years after diagnosis.1
Number of patients
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Help using this file
Which sheet should I look at?
Overview Overview
For help interpreting these four survival rates, see: 
Five-year survivalOne-year survival
2. To see a comparison of the latest one- and five-year survival for the 
most commonly diagnosed cancers in New Zealand look at the 
'Overview'. Key facts accompany the figures.
1. To see a comparison of one-year, five-year and 10-year survival across 
all cancers look at the 'Overview' tab. Key facts accompany the figures.
3. To see how one- and five-year survival changed between 1998–1999 and 2010–2011 for each cancer: look at one- and five-year survival sheets. Select a cancer from 
the dropdown menu. Survival is presented by total New Zealand population, and broken down by sex, ethnic group, age and deprivation quintile. Key facts accompany 
the figures and tables.
What do the graphs show?
5. To see the number of cases included in analysis select the 'Cases' sheet.
Cases
Interval-specific survivalCumulative survival
4. To see one- to 10-year cumulative or interval-specific relative survival (1994–2011) for selected cancers: look at 'Cumulative Survival' and 'Interval-specific Survival' 
sheets. Select a cancer from the dropdown menu. Survival is presented by total New Zealand population, and broken down by sex, ethnic group, extent of disease and 
deprivation quintile. Key facts accompany the figures and tables.
How can I view a different cancer?
1. At the top of the sheet is a blue box next to 'Select a cancer'.
2. Click on the down arrow in the blue box. A list of cancers will appear.
3. Select the cancer you would like to see.
4. The graphs, tables and key facts will update based on your selected cancer.
Source: New Zealand Cancer Registry and New Zealand Mortality Collection
Notes:
Confidence intervals are 95%.
Cancer site data includes patients aged 15+ years only, while 'Childhood cancers' includes patients aged 0–14 years and ignores cancer site.
New Zealand cancer survival overview
Key facts
Relative survival for all cancers, 1994–2011
Cancer survival varies considerably between cancer sites. Five-year relative survival ranges from 95.9% for testicular cancer to 
just 6.8% for pancreatic cancer. 
How survival prospects change with time also depends on the cancer type. For example, one-year survival for leukaemia is 
68.7%, and five-year and 10-year decrease to 51.4% and 43.3% survival, respectively. However, one-year survival for myeloma is 
72.9%, which decreases to 38.4% for five-year survival and further to 23.7% for 10-year survival.
Which cancers have the highest survival?
Testicular, melanoma, female breast, prostate, thyroid cancer and Hodgkin lymphoma all have one-year relative survival of 90% 
or higher. These cancers also have a five-year survival of 80% or more and a 10-year survival of 75% or more. Testicular cancer, 
melanoma and female breast cancer patients have a one-year relative survival close to 100%, which means that patients initially 
experience mortality rates close to those experienced in the general population.
Which cancers have the lowest survival?
Pancreatic cancer has the lowest one-year survival of 18%. All other cancers have one-year survival above 30%. There are six 
cancers with five-year survival below 25%: stomach, brain, oesophageal, lung, liver and pancreatic cancer. Myeloma and ovarian 
cancer have five-year survival of around 40% and all other cancers have a five-year survival above 50%. 
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Survival (%) 1-year 5-year 10-year
Source: New Zealand Cancer Registry and New Zealand Mortality Collection
Notes:
Māori numbers for melanoma are very low, leading to the wide confidence intervals.
Confidence intervals are 95%.
One- and five-year relative survival for common cancers, by sex and ethnicity, 
2010–2011
These graphs show one- and five-year relative survival for 2010–2011 (the most up-to-date data available) for all adult cancers 
combined, and the five most common cancers diagnosed in New Zealand in 2011. These five accounted for 62% of all cancers 
diagnosed, yet survival varies considerably; five-year survival for colorectal, melanoma and lung cancer is 63%, 90% and 11%, 
respectively.
Non-Māori survival for both males and females is higher than for Māori males and females, respectively, for each of these 
cancers.
New Zealand cancer survival overview
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Source: New Zealand Cancer Registry and New Zealand Mortality Collection
Note: confidence intervals are 95%.
One- and five-year relative survival for common cancers, by extent of disease, 
2010–2011
New Zealand cancer survival overview
The extent to which a cancer has spread at the time of diagnosis can be an important determinant of survival. Extent of disease is 
categorised as localised, regional or distant spread, or not stated if this information is unattainable. 
Patients with localised cancers frequently show the best survival. Survival decreases with increased spread for all cancers shown 
below. 
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Cases included in analysis, New Zealand, 1994–2011
<15 15–44 45–54 55–64 65–74 75+ Total
Total population, by sex
All - 30027 41287 69177 91293 99047 330831
Male - 11025 16158 37212 55746 53269 173410
Female - 19002 25129 31965 35547 45778 157421
Māori population, by sex
All - 4501 5219 7004 6375 3177 26276
Male - 1615 1726 3251 3483 1632 11707
Female - 2886 3493 3753 2892 1545 14569
Non-Māori population, by sex
All - 25526 36068 62173 84918 95870 304555
Male - 9410 14432 33961 52263 51637 161703
Female - 16116 21636 28212 32655 44233 142852
Source: 
Number of cases by extent of disease and age group
<15 15–44 45–54 55–64 65–74 75+ Total
Localised - 14678 17243 23409 24198 19838 99366
Regional - 5273 8226 12258 14612 13840 54209
Distant - 2929 5384 10655 15418 18257 52643
Not stated - 7147 10434 22855 37065 47112 124613
Total - 30027 41287 69177 91293 99047 330831
Source: 
Age group (years)
Age group (years)
Number of cases, by ethnic group, sex and age group for cumulative and interval-
specific survival analysis
All adult cancers (C00–C96, D45–D47)
New Zealand Cancer Registry 
New Zealand Mortality Collection
New Zealand Cancer Registry 
New Zealand Mortality Collection
Cases included in analysis, New Zealand, 1994–2011
<15 15–44 45–54 55–64 65–74 75+ Total
Total population, by sex
All - 250 546 1296 2596 3829 8517
Male - 164 385 1003 2020 2670 6242
Female - 86 161 293 576 1159 2275
Māori population, by sex
All - 37 56 68 84 89 334
Male - 21 36 44 61 56 218
Female - 16 20 24 23 33 116
Non-Māori population, by sex
All - 213 490 1228 2512 3740 8183
Male - 143 349 959 1959 2614 6024
Female - 70 141 269 553 1126 2159
Source: 
Number of cases by extent of disease and age group
<15 15–44 45–54 55–64 65–74 75+ Total
Localised - 38 88 179 328 281 914
Regional - 21 48 124 224 233 650
Distant - 23 22 83 145 234 507
Not stated - 168 388 910 1899 3081 6446
Total - 250 546 1296 2596 3829 8517
Source: 
Age group (years)
Age group (years)
Number of cases, by ethnic group, sex and age group for cumulative and interval-
specific survival analysis
Bladder (C67)
New Zealand Cancer Registry 
New Zealand Mortality Collection
New Zealand Cancer Registry 
New Zealand Mortality Collection
Cases included in analysis, New Zealand, 1994–2011
<15 15–44 45–54 55–64 65–74 75+ Total
Total population, by sex
All - 916 675 892 943 817 4243
Male - 544 425 533 559 422 2483
Female - 372 250 359 384 395 1760
Māori population, by sex
All - 101 50 58 51 21 281
Male - 58 32 33 28 10 161
Female - 43 18 25 23 11 120
Non-Māori population, by sex
All - 815 625 834 892 796 3962
Male - 486 393 500 531 412 2322
Female - 329 232 334 361 384 1640
Source: 
Number of cases by extent of disease and age group
<15 15–44 45–54 55–64 65–74 75+ Total
Localised - 840 635 833 858 705 3871
Regional - 3 2 2 4 0 11
Distant - 11 3 7 3 10 34
Not stated - 62 35 50 78 102 327
Total - 916 675 892 943 817 4243
Source: 
Age group (years)
Age group (years)
Number of cases, by ethnic group, sex and age group for cumulative and interval-
specific survival analysis
Brain (C71)
New Zealand Cancer Registry 
New Zealand Mortality Collection
New Zealand Cancer Registry 
New Zealand Mortality Collection
Cases included in analysis, New Zealand, 1994–2011
<15 15–44 45–54 55–64 65–74 75+ Total
Total population, by sex
All - 6336 11249 10765 7972 8134 44456
Male - 0 0 0 0 0 0
Female - 6336 11249 10765 7972 8134 44456
Māori population, by sex
All - 1041 1532 1220 667 268 4728
Male - 0 0 0 0 0 0
Female - 1041 1532 1220 667 268 4728
Non-Māori population, by sex
All - 5295 9717 9545 7305 7866 39728
Male - 0 0 0 0 0 0
Female - 5295 9717 9545 7305 7866 39728
Source: 
Number of cases by extent of disease and age group
<15 15–44 45–54 55–64 65–74 75+ Total
Localised - 2613 5562 5975 4307 2641 21098
Regional - 2748 4069 3274 2344 2206 14641
Distant - 245 366 390 364 555 1920
Not stated - 730 1252 1126 957 2732 6797
Total - 6336 11249 10765 7972 8134 44456
Source: 
Age group (years)
Age group (years)
Number of cases, by ethnic group, sex and age group for cumulative and interval-
specific survival analysis
Breast – female (C50)
New Zealand Cancer Registry 
New Zealand Mortality Collection
New Zealand Cancer Registry 
New Zealand Mortality Collection
Cases included in analysis, New Zealand, 1994–2011
<15 15–44 45–54 55–64 65–74 75+ Total
Total population, by sex
All - 1492 666 468 362 304 3292
Male - 0 0 0 0 0 0
Female - 1492 666 468 362 304 3292
Māori population, by sex
All - 339 164 96 46 18 663
Male - 0 0 0 0 0 0
Female - 339 164 96 46 18 663
Non-Māori population, by sex
All - 1153 502 372 316 286 2629
Male - 0 0 0 0 0 0
Female - 1153 502 372 316 286 2629
Source: 
Number of cases by extent of disease and age group
<15 15–44 45–54 55–64 65–74 75+ Total
Localised - 938 274 148 70 15 1445
Regional - 159 87 70 48 29 393
Distant - 62 62 53 53 49 279
Not stated - 333 243 197 191 211 1175
Total - 1492 666 468 362 304 3292
Source: 
Age group (years)
Age group (years)
Number of cases, by ethnic group, sex and age group for cumulative and interval-
specific survival analysis
Cervix (C53)
New Zealand Cancer Registry 
New Zealand Mortality Collection
New Zealand Cancer Registry 
New Zealand Mortality Collection
Cases included in analysis, New Zealand, 1994–2011
<15 15–44 45–54 55–64 65–74 75+ Total
Total population, by sex
All 2336 0 0 0 0 0 2336
Male 1281 0 0 0 0 0 1281
Female 1055 0 0 0 0 0 1055
Māori population, by sex
All 508 0 0 0 0 0 508
Male 279 0 0 0 0 0 279
Female 229 0 0 0 0 0 229
Non-Māori population, by sex
All 1828 0 0 0 0 0 1828
Male 1002 0 0 0 0 0 1002
Female 826 0 0 0 0 0 826
Source: 
Number of cases by extent of disease and age group
<15 15–44 45–54 55–64 65–74 75+ Total
Localised 609 0 0 0 0 0 609
Regional 133 0 0 0 0 0 133
Distant 200 0 0 0 0 0 200
Not stated 1394 0 0 0 0 0 1394
Total 2336 0 0 0 0 0 2336
Source: 
Age group (years)
Age group (years)
Number of cases, by ethnic group, sex and age group for cumulative and interval-
specific survival analysis
Childhood cancers (C00–C96, D45–D47, ages 0–14)
New Zealand Cancer Registry 
New Zealand Mortality Collection
New Zealand Cancer Registry 
New Zealand Mortality Collection
Cases included in analysis, New Zealand, 1994–2011
<15 15–44 45–54 55–64 65–74 75+ Total
Total population, by sex
All - 1622 3963 9543 15521 18413 49062
Male - 738 2044 5203 8647 8308 24940
Female - 884 1919 4340 6874 10105 24122
Māori population, by sex
All - 185 340 583 619 331 2058
Male - 74 171 313 393 157 1108
Female - 111 169 270 226 174 950
Non-Māori population, by sex
All - 1437 3623 8960 14902 18082 47004
Male - 664 1873 4890 8254 8151 23832
Female - 773 1750 4070 6648 9931 23172
Source: 
Number of cases by extent of disease and age group
<15 15–44 45–54 55–64 65–74 75+ Total
Localised - 356 1015 2511 4500 5050 13432
Regional - 659 1508 4040 6560 7277 20044
Distant - 397 876 1911 2862 3035 9081
Not stated - 210 564 1081 1599 3051 6505
Total - 1622 3963 9543 15521 18413 49062
Source: 
Age group (years)
Age group (years)
Number of cases, by ethnic group, sex and age group for cumulative and interval-
specific survival analysis
Colorectum and anus (C18–C21)
New Zealand Cancer Registry 
New Zealand Mortality Collection
New Zealand Cancer Registry 
New Zealand Mortality Collection
Cases included in analysis, New Zealand, 1994–2011
<15 15–44 45–54 55–64 65–74 75+ Total
Total population, by sex
All - 705 1141 1769 1766 1645 7026
Male - 453 848 1351 1314 990 4956
Female - 252 293 418 452 655 2070
Māori population, by sex
All - 110 140 180 122 35 587
Male - 66 106 136 93 25 426
Female - 44 34 44 29 10 161
Non-Māori population, by sex
All - 595 1001 1589 1644 1610 6439
Male - 387 742 1215 1221 965 4530
Female - 208 259 374 423 645 1909
Source: 
Number of cases by extent of disease and age group
<15 15–44 45–54 55–64 65–74 75+ Total
Localised - 240 268 387 408 423 1726
Regional - 198 404 543 460 358 1963
Distant - 41 76 103 109 93 422
Not stated - 226 393 736 789 771 2915
Total - 705 1141 1769 1766 1645 7026
Source: 
Age group (years)
Age group (years)
Number of cases, by ethnic group, sex and age group for cumulative and interval-
specific survival analysis
Head, neck and larynx (C00–C14, C32)
New Zealand Cancer Registry 
New Zealand Mortality Collection
New Zealand Cancer Registry 
New Zealand Mortality Collection
Cases included in analysis, New Zealand, 1994–2011
<15 15–44 45–54 55–64 65–74 75+ Total
Total population, by sex
All - 802 167 161 150 122 1402
Male - 428 116 109 74 77 804
Female - 374 51 52 76 45 598
Māori population, by sex
All - 82 14 12 8 2 118
Male - 39 11 6 2 0 58
Female - 43 3 6 6 2 60
Non-Māori population, by sex
All - 720 153 149 142 120 1284
Male - 389 105 103 72 77 746
Female - 331 48 46 70 43 538
Source: 
Number of cases by extent of disease and age group
<15 15–44 45–54 55–64 65–74 75+ Total
Localised - 0 0 0 0 0 0
Regional - 0 0 0 0 0 0
Distant - 0 0 0 0 0 0
Not stated - 802 167 161 150 122 1402
Total - 802 167 161 150 122 1402
Source: 
Age group (years)
Age group (years)
Number of cases, by ethnic group, sex and age group for cumulative and interval-
specific survival analysis
Hodgkin lymphoma (C81)
New Zealand Cancer Registry 
New Zealand Mortality Collection
New Zealand Cancer Registry 
New Zealand Mortality Collection
Cases included in analysis, New Zealand, 1994–2011
<15 15–44 45–54 55–64 65–74 75+ Total
Total population, by sex
All - 522 1073 1687 2135 2079 7496
Male - 304 698 1141 1403 1221 4767
Female - 218 375 546 732 858 2729
Māori population, by sex
All - 96 141 171 116 62 586
Male - 58 95 120 72 31 376
Female - 38 46 51 44 31 210
Non-Māori population, by sex
All - 426 932 1516 2019 2017 6910
Male - 246 603 1021 1331 1190 4391
Female - 180 329 495 688 827 2519
Source: 
Number of cases by extent of disease and age group
<15 15–44 45–54 55–64 65–74 75+ Total
Localised - 316 599 831 894 573 3213
Regional - 67 187 293 411 311 1269
Distant - 91 196 365 499 532 1683
Not stated - 48 91 198 331 663 1331
Total - 522 1073 1687 2135 2079 7496
Source: 
Age group (years)
Age group (years)
Number of cases, by ethnic group, sex and age group for cumulative and interval-
specific survival analysis
Kidney (C64–C66, C68)
New Zealand Cancer Registry 
New Zealand Mortality Collection
New Zealand Cancer Registry 
New Zealand Mortality Collection
Cases included in analysis, New Zealand, 1994–2011
<15 15–44 45–54 55–64 65–74 75+ Total
Total population, by sex
All - 1099 1000 1654 2554 3492 9799
Male - 621 582 1022 1582 1856 5663
Female - 478 418 632 972 1636 4136
Māori population, by sex
All - 199 129 176 170 93 767
Male - 106 75 95 102 59 437
Female - 93 54 81 68 34 330
Non-Māori population, by sex
All - 900 871 1478 2384 3399 9032
Male - 515 507 927 1480 1797 5226
Female - 385 364 551 904 1602 3806
Source: 
Number of cases by extent of disease and age group
<15 15–44 45–54 55–64 65–74 75+ Total
Localised - 0 0 0 0 0 0
Regional - 0 0 0 0 0 0
Distant - 0 0 0 0 0 0
Not stated - 1099 1000 1654 2554 3492 9799
Total - 1099 1000 1654 2554 3492 9799
Source: 
Age group (years)
Age group (years)
Number of cases, by ethnic group, sex and age group for cumulative and interval-
specific survival analysis
Leukaemia (C91–C95)
New Zealand Cancer Registry 
New Zealand Mortality Collection
New Zealand Cancer Registry 
New Zealand Mortality Collection
Cases included in analysis, New Zealand, 1994–2011
<15 15–44 45–54 55–64 65–74 75+ Total
Total population, by sex
All - 213 498 752 861 871 3195
Male - 155 402 573 585 477 2192
Female - 58 96 179 276 394 1003
Māori population, by sex
All - 79 181 211 120 55 646
Male - 61 155 171 90 36 513
Female - 18 26 40 30 19 133
Non-Māori population, by sex
All - 134 317 541 741 816 2549
Male - 94 247 402 495 441 1679
Female - 40 70 139 246 375 870
Source: 
Number of cases by extent of disease and age group
<15 15–44 45–54 55–64 65–74 75+ Total
Localised - 30 68 76 68 32 274
Regional - 10 17 27 22 15 91
Distant - 53 108 157 204 169 691
Not stated - 120 305 492 567 655 2139
Total - 213 498 752 861 871 3195
Source: 
Age group (years)
Age group (years)
Number of cases, by ethnic group, sex and age group for cumulative and interval-
specific survival analysis
Liver (C22)
New Zealand Cancer Registry 
New Zealand Mortality Collection
New Zealand Cancer Registry 
New Zealand Mortality Collection
Cases included in analysis, New Zealand, 1994–2011
<15 15–44 45–54 55–64 65–74 75+ Total
Total population, by sex
All - 628 2472 6527 10335 10099 30061
Male - 249 1199 3604 6260 6114 17426
Female - 379 1273 2923 4075 3985 12635
Māori population, by sex
All - 169 775 1716 1604 684 4948
Male - 69 331 838 790 321 2349
Female - 100 444 878 814 363 2599
Non-Māori population, by sex
All - 459 1697 4811 8731 9415 25113
Male - 180 868 2766 5470 5793 15077
Female - 279 829 2045 3261 3622 10036
Source: 
Number of cases by extent of disease and age group
<15 15–44 45–54 55–64 65–74 75+ Total
Localised - 71 171 507 748 338 1835
Regional - 86 350 757 1013 592 2798
Distant - 297 1194 2918 4029 3557 11995
Not stated - 174 757 2345 4545 5612 13433
Total - 628 2472 6527 10335 10099 30061
Source: 
Age group (years)
Age group (years)
Number of cases, by ethnic group, sex and age group for cumulative and interval-
specific survival analysis
Lung (C33–C34)
New Zealand Cancer Registry 
New Zealand Mortality Collection
New Zealand Cancer Registry 
New Zealand Mortality Collection
Cases included in analysis, New Zealand, 1994–2011
<15 15–44 45–54 55–64 65–74 75+ Total
Total population, by sex
All - 6468 6212 7342 7959 8745 36726
Male - 2580 2982 4127 4719 4853 19261
Female - 3888 3230 3215 3240 3892 17465
Māori population, by sex
All - 151 92 72 70 67 452
Male - 50 29 34 42 29 184
Female - 101 63 38 28 38 268
Non-Māori population, by sex
All - 6317 6120 7270 7889 8678 36274
Male - 2530 2953 4093 4677 4824 19077
Female - 3787 3167 3177 3212 3854 17197
Source: 
Number of cases by extent of disease and age group
<15 15–44 45–54 55–64 65–74 75+ Total
Localised - 5737 5500 6311 6688 6860 31096
Regional - 242 220 362 485 909 2218
Distant - 200 233 343 433 502 1711
Not stated - 289 259 326 353 474 1701
Total - 6468 6212 7342 7959 8745 36726
Source: 
Age group (years)
Age group (years)
Number of cases, by ethnic group, sex and age group for cumulative and interval-
specific survival analysis
Melanoma (C43)
New Zealand Cancer Registry 
New Zealand Mortality Collection
New Zealand Cancer Registry 
New Zealand Mortality Collection
Cases included in analysis, New Zealand, 1994–2011
<15 15–44 45–54 55–64 65–74 75+ Total
Total population, by sex
All - 140 461 837 1279 1684 4401
Male - 92 272 485 753 869 2471
Female - 48 189 352 526 815 1930
Māori population, by sex
All - 32 73 97 123 60 385
Male - 19 39 47 65 35 205
Female - 13 34 50 58 25 180
Non-Māori population, by sex
All - 108 388 740 1156 1624 4016
Male - 73 233 438 688 834 2266
Female - 35 155 302 468 790 1750
Source: 
Number of cases by extent of disease and age group
<15 15–44 45–54 55–64 65–74 75+ Total
Localised - 0 0 0 0 0 0
Regional - 0 0 0 0 0 0
Distant - 0 0 0 0 0 0
Not stated - 140 461 837 1279 1684 4401
Total - 140 461 837 1279 1684 4401
Source: 
Age group (years)
Age group (years)
Number of cases, by ethnic group, sex and age group for cumulative and interval-
specific survival analysis
Myeloma (C90)
New Zealand Cancer Registry 
New Zealand Mortality Collection
New Zealand Cancer Registry 
New Zealand Mortality Collection
Cases included in analysis, New Zealand, 1994–2011
<15 15–44 45–54 55–64 65–74 75+ Total
Total population, by sex
All - 1247 1515 2347 2966 3318 11393
Male - 741 876 1292 1602 1589 6100
Female - 506 639 1055 1364 1729 5293
Māori population, by sex
All - 172 130 186 157 100 745
Male - 101 74 101 78 50 404
Female - 71 56 85 79 50 341
Non-Māori population, by sex
All - 1075 1385 2161 2809 3218 10648
Male - 640 802 1191 1524 1539 5696
Female - 435 583 970 1285 1679 4952
Source: 
Number of cases by extent of disease and age group
<15 15–44 45–54 55–64 65–74 75+ Total
Localised - 0 0 0 0 0 0
Regional - 0 0 0 0 0 0
Distant - 0 0 0 0 0 0
Not stated - 1247 1515 2347 2966 3318 11393
Total - 1247 1515 2347 2966 3318 11393
Source: 
Age group (years)
Age group (years)
Number of cases, by ethnic group, sex and age group for cumulative and interval-
specific survival analysis
Non-Hodgkin lymphoma (C82–C85, C96)
New Zealand Cancer Registry 
New Zealand Mortality Collection
New Zealand Cancer Registry 
New Zealand Mortality Collection
Cases included in analysis, New Zealand, 1994–2011
<15 15–44 45–54 55–64 65–74 75+ Total
Total population, by sex
All - 94 274 786 1243 1793 4190
Male - 67 211 593 899 1000 2770
Female - 27 63 193 344 793 1420
Māori population, by sex
All - 26 41 90 110 63 330
Male - 20 32 65 83 38 238
Female - 6 9 25 27 25 92
Non-Māori population, by sex
All - 68 233 696 1133 1730 3860
Male - 47 179 528 816 962 2532
Female - 21 54 168 317 768 1328
Source: 
Number of cases by extent of disease and age group
<15 15–44 45–54 55–64 65–74 75+ Total
Localised - 3 23 66 84 60 236
Regional - 12 53 126 153 79 423
Distant - 42 86 221 303 286 938
Not stated - 37 112 373 703 1368 2593
Total - 94 274 786 1243 1793 4190
Source: 
Age group (years)
Age group (years)
Number of cases, by ethnic group, sex and age group for cumulative and interval-
specific survival analysis
Oesophagus (C15)
New Zealand Cancer Registry 
New Zealand Mortality Collection
New Zealand Cancer Registry 
New Zealand Mortality Collection
Cases included in analysis, New Zealand, 1994–2011
<15 15–44 45–54 55–64 65–74 75+ Total
Total population, by sex
All - 739 884 1138 1091 1232 5084
Male - 0 0 0 0 0 0
Female - 739 884 1138 1091 1232 5084
Māori population, by sex
All - 146 124 117 58 30 475
Male - 0 0 0 0 0 0
Female - 146 124 117 58 30 475
Non-Māori population, by sex
All - 593 760 1021 1033 1202 4609
Male - 0 0 0 0 0 0
Female - 593 760 1021 1033 1202 4609
Source: 
Number of cases by extent of disease and age group
<15 15–44 45–54 55–64 65–74 75+ Total
Localised - 360 276 245 164 117 1162
Regional - 79 133 136 130 137 615
Distant - 235 413 702 733 805 2888
Not stated - 65 62 55 64 173 419
Total - 739 884 1138 1091 1232 5084
Source: 
Age group (years)
Age group (years)
Number of cases, by ethnic group, sex and age group for cumulative and interval-
specific survival analysis
Ovary (C56)
New Zealand Cancer Registry 
New Zealand Mortality Collection
New Zealand Cancer Registry 
New Zealand Mortality Collection
Cases included in analysis, New Zealand, 1994–2011
<15 15–44 45–54 55–64 65–74 75+ Total
Total population, by sex
All - 191 503 1132 1888 2686 6400
Male - 105 284 655 994 1132 3170
Female - 86 219 477 894 1554 3230
Māori population, by sex
All - 50 100 158 190 114 612
Male - 22 50 86 91 46 295
Female - 28 50 72 99 68 317
Non-Māori population, by sex
All - 141 403 974 1698 2572 5788
Male - 83 234 569 903 1086 2875
Female - 58 169 405 795 1486 2913
Source: 
Number of cases by extent of disease and age group
<15 15–44 45–54 55–64 65–74 75+ Total
Localised - 12 19 38 58 43 170
Regional - 32 72 157 197 86 544
Distant - 115 289 610 967 1111 3092
Not stated - 32 123 327 666 1446 2594
Total - 191 503 1132 1888 2686 6400
Source: 
Age group (years)
Age group (years)
Number of cases, by ethnic group, sex and age group for cumulative and interval-
specific survival analysis
Pancreas (C25)
New Zealand Cancer Registry 
New Zealand Mortality Collection
New Zealand Cancer Registry 
New Zealand Mortality Collection
Cases included in analysis, New Zealand, 1994–2011
<15 15–44 45–54 55–64 65–74 75+ Total
Total population, by sex
All - 122 2513 11961 19052 14803 48451
Male - 122 2513 11961 19052 14803 48451
Female - 0 0 0 0 0 0
Māori population, by sex
All - 10 126 680 1036 456 2308
Male - 10 126 680 1036 456 2308
Female - 0 0 0 0 0 0
Non-Māori population, by sex
All - 112 2387 11281 18016 14347 46143
Male - 112 2387 11281 18016 14347 46143
Female - 0 0 0 0 0 0
Source: 
Number of cases by extent of disease and age group
<15 15–44 45–54 55–64 65–74 75+ Total
Localised - 46 759 2883 2787 763 7238
Regional - 6 211 1058 1132 271 2678
Distant - 6 67 324 887 1745 3029
Not stated - 64 1476 7696 14246 12024 35506
Total - 122 2513 11961 19052 14803 48451
Source: 
Age group (years)
Age group (years)
Number of cases, by ethnic group, sex and age group for cumulative and interval-
specific survival analysis
Prostate (C61)
New Zealand Cancer Registry 
New Zealand Mortality Collection
New Zealand Cancer Registry 
New Zealand Mortality Collection
Cases included in analysis, New Zealand, 1994–2011
<15 15–44 45–54 55–64 65–74 75+ Total
Total population, by sex
All - 478 684 1176 1872 2524 6734
Male - 266 400 825 1261 1457 4209
Female - 212 284 351 611 1067 2525
Māori population, by sex
All - 223 208 236 277 154 1098
Male - 105 114 146 154 85 604
Female - 118 94 90 123 69 494
Non-Māori population, by sex
All - 255 476 940 1595 2370 5636
Male - 161 286 679 1107 1372 3605
Female - 94 190 261 488 998 2031
Source: 
Number of cases by extent of disease and age group
<15 15–44 45–54 55–64 65–74 75+ Total
Localised - 55 90 140 240 227 752
Regional - 121 186 349 489 445 1590
Distant - 212 244 382 572 539 1949
Not stated - 90 164 305 571 1313 2443
Total - 478 684 1176 1872 2524 6734
Source: 
Age group (years)
Age group (years)
Number of cases, by ethnic group, sex and age group for cumulative and interval-
specific survival analysis
Stomach (C16)
New Zealand Cancer Registry 
New Zealand Mortality Collection
New Zealand Cancer Registry 
New Zealand Mortality Collection
Cases included in analysis, New Zealand, 1994–2011
<15 15–44 45–54 55–64 65–74 75+ Total
Total population, by sex
All - 2008 378 120 40 16 2562
Male - 2008 378 120 40 16 2562
Female - 0 0 0 0 0 0
Māori population, by sex
All - 486 33 5 2 2 528
Male - 486 33 5 2 2 528
Female - 0 0 0 0 0 0
Non-Māori population, by sex
All - 1522 345 115 38 14 2034
Male - 1522 345 115 38 14 2034
Female - 0 0 0 0 0 0
Source: 
Number of cases by extent of disease and age group
<15 15–44 45–54 55–64 65–74 75+ Total
Localised - 1445 285 82 27 7 1846
Regional - 231 47 16 6 4 304
Distant - 215 25 15 4 3 262
Not stated - 117 21 7 3 2 150
Total - 2008 378 120 40 16 2562
Source: 
Age group (years)
Age group (years)
Number of cases, by ethnic group, sex and age group for cumulative and interval-
specific survival analysis
Testis (C62)
New Zealand Cancer Registry 
New Zealand Mortality Collection
New Zealand Cancer Registry 
New Zealand Mortality Collection
Cases included in analysis, New Zealand, 1994–2011
<15 15–44 45–54 55–64 65–74 75+ Total
Total population, by sex
All - 1253 729 561 392 274 3209
Male - 253 192 174 137 80 836
Female - 1000 537 387 255 194 2373
Māori population, by sex
All - 227 114 77 54 15 487
Male - 36 26 23 24 5 114
Female - 191 88 54 30 10 373
Non-Māori population, by sex
All - 1026 615 484 338 259 2722
Male - 217 166 151 113 75 722
Female - 809 449 333 225 184 2000
Source: 
Number of cases by extent of disease and age group
<15 15–44 45–54 55–64 65–74 75+ Total
Localised - 786 449 313 212 102 1862
Regional - 317 163 142 85 65 772
Distant - 29 37 43 50 40 199
Not stated - 121 80 63 45 67 376
Total - 1253 729 561 392 274 3209
Source: 
Age group (years)
Age group (years)
Number of cases, by ethnic group, sex and age group for cumulative and interval-
specific survival analysis
Thyroid (C73)
New Zealand Cancer Registry 
New Zealand Mortality Collection
New Zealand Cancer Registry 
New Zealand Mortality Collection
Cases included in analysis, New Zealand, 1994–2011
<15 15–44 45–54 55–64 65–74 75+ Total
Total population, by sex
All - 431 1055 1871 1578 1216 6151
Male - 0 0 0 0 0 0
Female - 431 1055 1871 1578 1216 6151
Māori population, by sex
All - 97 197 224 144 63 725
Male - 0 0 0 0 0 0
Female - 97 197 224 144 63 725
Non-Māori population, by sex
All - 334 858 1647 1434 1153 5426
Male - 0 0 0 0 0 0
Female - 334 858 1647 1434 1153 5426
Source: 
Number of cases by extent of disease and age group
<15 15–44 45–54 55–64 65–74 75+ Total
Localised - 255 695 1227 980 546 3703
Regional - 61 175 348 282 245 1111
Distant - 35 84 147 158 126 550
Not stated - 80 101 149 158 299 787
Total - 431 1055 1871 1578 1216 6151
Source: 
Age group (years)
Age group (years)
Number of cases, by ethnic group, sex and age group for cumulative and interval-
specific survival analysis
Uterus (C54–C55)
New Zealand Cancer Registry 
New Zealand Mortality Collection
New Zealand Cancer Registry 
New Zealand Mortality Collection
All adult cancers (C00–C96, D45–D47)
Survival for total population
Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 74.9 76.1 76.1 76.5 77.1 77.6 78.0
Male 73.4 75.1 74.8 75.5 75.6 77.0 76.9
Female 76.5 77.2 77.4 77.6 78.6 78.3 79.2
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 65.0 65.4 65.0 66.2 67.7 66.5 68.6
Male 59.5 59.9 58.6 60.6 60.8 60.4 62.5
Female 69.8 69.7 70.4 70.6 73.0 71.1 73.0
Non-Māori population, by sex
All 75.6 77.0 77.0 77.4 77.9 78.7 78.9
Male 74.3 76.1 76.0 76.6 76.8 78.3 78.0
Female 77.1 77.9 78.1 78.4 79.2 79.1 79.9
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 89.7 90.4 91.1 90.4 91.6 91.4 92.7
45–54 84.4 85.2 85.5 86.1 87.7 87.4 87.8
55–64 77.8 81.1 81.4 81.7 82.6 83.7 84.4
65–74 72.7 75.1 74.0 76.8 76.4 77.4 77.7
75+ 65.7 64.3 64.5 63.8 64.1 64.3 64.3
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 78.0 78.9 80.1 80.5 81.3 82.5 81.9
3 76.4 77.2 77.0 76.8 77.0 77.2 77.7
4 72.9 74.0 73.7 74.5 74.6 75.6 75.4
5 69.8 72.2 70.4 71.8 72.6 71.1 73.3
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  In 2010–11 78% of patients diagnosed with cancer survived one year relative to 
background mortality.
•  Survival improved steadily over time.
•  In 2010–11 male survival was 76.9% and female survival was 79.2% relative to 
background mortality.
•  Survival improved over time for both ethnic groups, particularly for non-Māori 
males.
•  One-year survival for non-Māori remained approximately 10% higher than for 
Māori.
•  Survival improved over time for all age groups, except for those aged 75+ years.
•  Survival improved over time for each deprivation quintile, but remained better for 
those residing in less deprived quintiles.
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Bladder (C67)
Survival for total population
Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 85.1 84.9 82.9 77.0 69.0 69.0 73.2
Male 86.7 86.2 85.0 80.7 70.4 73.4 76.1
Female 80.5 81.5 76.8 65.9 64.7 59.4 65.4
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 90.4 69.7 76.4 60.4 61.2 55.1 78.2
Male 89.9 84.9 80.8 78.1 56.0 60.3 78.7
Female 91.5 30.9 67.8 27.5 72.9 48.7 77.6
Non-Māori population, by sex
All 85.0 85.4 83.1 77.9 69.4 69.8 72.8
Male 86.7 86.3 85.2 80.8 71.1 73.9 75.9
Female 80.1 83.2 77.2 68.8 64.2 60.2 64.0
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 96.0 100.1 87.6 86.3 64.4 69.3 58.5
45–54 100.4 95.6 95.1 79.9 86.5 88.4 94.9
55–64 89.0 89.9 92.5 85.6 76.6 77.0 76.3
65–74 88.0 88.8 85.5 81.4 76.8 76.0 75.0
75+ 77.3 77.5 75.3 70.4 60.7 60.2 69.4
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 85.2 88.1 85.0 81.0 69.9 73.5 73.9
3 90.1 88.9 83.9 76.8 72.0 68.6 68.5
4 81.9 80.5 79.8 76.6 62.7 65.7 76.8
5 82.7 79.2 81.0 70.1 72.8 62.3 72.4
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  From 2005 a coding change resulted in superficial transitional cell carcinoma of 
the bladder being excluded from bladder cancer registrations.
•  Between 2006 and 2011 one-year survival improved from 69% to 73.2%. 
•  In 2010–11 male survival was 76.1% and female survival was 65.4%, relative to 
background mortality.
•  Survival for non-Māori improved slightly whereas survival for Māori was more 
variable, probably due to smaller patient numbers.
•  Survival improved for those aged 45–54 and 75+ years, and declined in all other 
age groups.
•  Survival varied within deprivation quintiles over time. Survival improved the most 
for those residing in deprivation quintile 4.
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Brain (C71)
Survival for total population
Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 36.8 34.6 34.4 36.5 43.7 43.9 49.8
Male 38.2 38.9 32.0 35.9 41.4 46.1 49.0
Female 34.9 28.0 38.0 37.3 46.7 40.8 51.1
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 53.5 46.3 28.0 42.8 40.7 49.2 42.0
Male 46.2 59.4 19.5 51.0 36.2 35.9 40.2
Female 68.0 30.6 37.4 36.1 47.3 63.3 46.6
Non-Māori population, by sex
All 35.8 34.0 35.0 36.0 44.0 43.5 50.4
Male 37.6 37.9 32.9 35.1 41.8 46.8 49.7
Female 33.2 27.8 38.0 37.5 46.7 39.0 51.4
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 79.9 77.0 75.3 76.0 85.5 80.8 83.2
45–54 60.2 47.2 42.8 50.1 56.0 60.7 74.3
55–64 25.6 29.4 31.1 29.6 42.1 38.2 56.4
65–74 10.2 11.1 15.2 14.7 22.7 29.2 31.9
75+ 6.4 4.4 3.3 9.4 9.9 9.4 13.9
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 34.6 35.6 36.3 37.3 49.2 49.6 53.3
3 31.6 29.1 30.6 31.0 45.6 36.2 46.7
4 37.6 36.6 32.6 37.6 41.6 42.1 45.5
5 45.1 34.9 37.3 37.5 35.8 39.5 50.9
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  Between 1998 and 2011 one-year relative survival showed an increased trend.
•  Survival was comparable in males and females.
•  Survival for non-Māori improved from 35.8% to 50.4%. Low numbers of Māori 
patients limit meaningful comparison between the two ethnic groups.
•  Survival was better for younger people than for older people. Over time, survival 
improved within each age group.
•  Over time, survival improved for all deprivation quintiles. There were no real 
differences in survival between deprivation quintiles.
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Breast – female (C50)
Survival for total population
Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 95.7 96.0 96.7 96.2 97.4 96.7 97.1
Male - - - - - - -
Female 95.7 96.0 96.7 96.2 97.4 96.7 97.1
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 94.2 94.9 95.2 93.9 96.3 95.4 97.0
Male - - - - - - -
Female 94.2 94.9 95.2 93.9 96.3 95.4 97.0
Non-Māori population, by sex
All 95.9 96.1 96.9 96.5 97.5 96.8 97.1
Male - - - - - - -
Female 95.9 96.1 96.9 96.5 97.5 96.8 97.1
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 96.7 96.9 97.5 97.6 97.6 97.7 97.9
45–54 97.8 97.8 97.6 97.5 98.6 98.3 98.6
55–64 97.0 98.1 97.6 97.6 98.2 97.2 98.7
65–74 96.3 94.1 96.8 97.2 97.3 96.9 97.1
75+ 89.9 90.8 93.2 89.9 93.9 92.2 91.6
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 96.7 96.4 97.4 96.6 97.8 97.2 97.6
3 95.2 96.4 96.5 96.5 97.8 97.4 97.0
4 95.8 95.3 95.9 96.6 96.6 96.4 96.7
5 94.6 95.4 96.3 94.7 96.9 95.0 96.6
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  One-year survival improved slightly between 1998 and 2011.
•  Māori and non-Māori women had comparable survival.
•  One-year survival by age group did not change over time; women in the 75+ years 
age group continued to have worse survival than younger women.
•  One-year survival was not influenced by deprivation level.
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Cervix (C53)
Survival for total population
Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 88.7 88.6 87.9 85.8 86.5 88.5 86.9
Male - - - - - - -
Female 88.7 88.6 87.9 85.8 86.5 88.5 86.9
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 79.5 87.5 86.1 83.7 86.3 86.1 85.4
Male - - - - - - -
Female 79.5 87.5 86.1 83.7 86.3 86.1 85.4
Non-Māori population, by sex
All 90.8 88.9 88.3 86.3 86.6 89.2 87.3
Male - - - - - - -
Female 90.8 88.9 88.3 86.3 86.6 89.2 87.3
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 93.2 97.0 96.6 93.6 94.6 95.3 93.7
45–54 88.4 87.6 84.4 87.4 92.2 89.6 91.8
55–64 82.1 84.2 86.0 87.6 81.8 83.1 78.9
65–74 99.3 79.6 71.5 79.4 65.2 83.1 72.1
75+ 68.7 54.0 69.0 60.6 68.9 65.1 68.2
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 90.6 90.0 91.5 89.5 93.0 91.3 91.1
3 87.7 84.5 92.3 88.2 87.3 95.1 89.1
4 88.0 90.9 86.2 78.5 82.7 89.5 88.8
5 87.8 87.5 81.7 84.8 82.0 82.0 80.7
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  One-year survival changed little between 1998 and 2011.
•  One-year survival for Māori women increased from 79.5% to 85.4% over time; in 
non-Māori women there was a slight downward trend, from 90.8% to 87.3%.
•  Survival varied within age groups, and overall one-year survival was better for 
younger people.
•  One-year survival generally improved over time for deprivation quintiles 1−4, but 
decreased for deprivation quintile 5.
•  Cervical screening may affect survival. Screening finds cervical tumours at the pre-
cancerous stage (not included in this data), potentially resulting in a decrease in the 
number of actual cancers registered, but an increase in the proportion of registered 
cancers at an aggressive or advanced stage, increasing the likelihood of death.
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Childhood cancers (C00–C96, D45–D47, ages 0–14)
Survival for total population
Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 89.7 88.1 89.5 90.4 88.8 89.6 90.4
Male 93.1 89.3 88.5 91.0 87.6 89.4 89.8
Female 85.1 86.5 90.7 89.9 90.1 89.9 91.5
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 94.3 81.4 91.8 87.9 82.6 89.3 85.1
Male 92.5 86.6 90.4 95.5 83.4 84.3 89.0
Female 96.2 74.1 94.2 79.0 81.6 96.4 79.3
Non-Māori population, by sex
All 88.5 90.0 89.0 90.9 90.9 89.7 92.0
Male 93.2 90.1 87.9 89.8 89.0 91.2 90.0
Female 81.8 89.8 90.1 91.8 92.9 87.8 95.1
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 - - - - - - -
45–54 - - - - - - -
55–64 - - - - - - -
65–74 - - - - - - -
75+ - - - - - - -
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 92.3 87.7 90.8 94.9 87.0 97.3 92.2
3 96.2 86.5 91.4 89.8 89.9 85.6 94.3
4 86.1 91.5 83.4 88.8 90.8 83.8 90.1
5 82.9 87.1 90.7 87.8 88.5 88.5 87.2
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  One-year survival for children with cancer was relatively constant over time.
•  Male survival varied slightly over time, and female survival showed an increased 
trend.
•  Māori children had worse one-year survival than non-Māori children between 
2004 and 2011.
•  Survival varied for children living in deprivation quintiles 1−4, but improved 
overall for those living in deprivation quintile 5.
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Colorectum and anus (C18–C21)
Survival for total population
Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 78.4 78.5 79.9 79.9 79.6 79.7 80.9
Male 78.3 78.0 81.1 80.4 79.7 80.5 82.1
Female 78.5 78.9 78.8 79.4 79.6 78.8 79.6
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 72.3 76.6 69.1 72.4 77.0 75.3 74.9
Male 70.3 73.3 66.7 67.3 74.8 71.3 72.6
Female 74.8 80.3 72.2 78.0 79.3 80.4 77.2
Non-Māori population, by sex
All 78.6 78.5 80.4 80.2 79.8 79.9 81.2
Male 78.7 78.2 81.8 81.0 79.9 81.1 82.6
Female 78.6 78.8 79.0 79.5 79.6 78.8 79.7
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 83.6 80.3 83.5 85.7 86.9 87.4 89.6
45–54 82.6 85.4 84.7 85.1 86.5 85.6 85.1
55–64 82.3 83.9 84.4 85.9 86.8 83.7 86.7
65–74 77.9 80.5 80.4 82.2 82.2 81.9 83.6
75+ 74.6 71.8 75.5 73.3 72.1 74.1 74.7
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 78.9 79.8 82.7 83.3 82.7 83.5 84.2
3 81.4 80.0 81.5 77.9 78.9 79.8 79.4
4 76.7 75.9 78.6 78.5 79.9 78.1 78.7
5 75.6 77.4 74.6 77.8 74.1 74.1 78.3
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  One-year survival improved slightly over time.
•  Both male and female one-year survival improved slightly over time.
•  Māori continued to have lower one-year survival than non-Māori, although 
survival improved in both ethnic groups.
•  One-year survival improved over time in most age groups, but remained lower in 
older people.
•  One-year survival fluctuated over time within deprivation quintiles. Patients in 
quintiles 1−2 had slightly better survival than those residing in quintiles 3−5.
One-year relative survival, New Zealand, 1998–1999 to 2010–2011
0
10
20
30
40
50
60
70
80
90
100
Māori Non–Māori 
1-year relative survival (%) 
0
10
20
30
40
50
60
70
80
90
100
Male Female
1-year relative survival (%) 
0
10
20
30
40
50
60
70
80
90
100
1−2 3 4 5
1-year relative survival (%) 
0
10
20
30
40
50
60
70
80
90
100
15–44 45–54 55–64 65–74 75+
1-year relative survival (%) 
0
10
20
30
40
50
60
70
80
90
100
1998–1999 2004–2005 2010–2011 
1-year relative survival (%) 
Head, neck and larynx (C00–C14, C32)
Survival for total population
Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 84.8 81.4 80.0 83.1 82.0 83.6 86.3
Male 83.1 81.0 80.3 84.6 82.8 83.4 87.4
Female 88.8 82.6 79.3 79.6 80.1 84.0 83.4
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 83.2 80.1 80.8 83.9 80.8 82.4 78.3
Male 76.1 77.5 80.3 82.5 80.1 78.1 78.1
Female 97.5 87.0 83.0 87.8 82.8 90.3 78.7
Non-Māori population, by sex
All 84.9 81.5 79.9 83.0 82.1 83.7 86.9
Male 83.7 81.2 80.3 84.8 83.1 83.9 88.2
Female 87.8 82.2 79.1 78.6 79.9 83.2 83.7
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 94.9 95.1 93.0 97.6 94.6 92.7 94.3
45–54 93.3 88.9 88.6 91.8 92.8 89.0 91.5
55–64 86.7 82.5 85.0 82.7 88.8 88.4 91.3
65–74 79.7 80.0 75.2 79.5 74.0 79.6 85.1
75+ 78.1 69.9 66.5 71.9 68.2 73.5 73.6
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 86.0 83.7 82.3 88.1 85.4 88.9 89.6
3 87.6 74.7 76.9 82.7 77.4 81.9 80.4
4 83.8 83.3 80.9 79.3 78.9 82.3 86.8
5 80.6 82.1 78.7 81.9 84.5 79.3 85.3
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  One-year survival fluctuated slightly between 1998 and 2011, but was the highest 
in the 2010–11 period.
•  Over time survival for non-Māori was slightly better than for Māori.
•  There were no clear trends observed for survival by age group.
•  Over time there was a general improvement in survival for patients in all 
deprivation quintiles except quintile 3.
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Hodgkin lymphoma (C81)
Survival for total population
Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 91.6 90.9 92.1 90.1 90.7 93.0 92.7
Male 91.1 93.9 91.2 90.1 88.1 92.8 91.9
Female 92.2 88.1 93.2 90.1 94.4 93.2 93.7
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 102.7 93.6 94.1 90.9 100.6 86.0 100.7
Male 100.2 86.1 100.5 89.7 100.3 87.8 100.8
Female 104.6 100.1 86.7 91.9 101.0 83.7 100.6
Non-Māori population, by sex
All 90.9 90.6 91.8 90.0 89.8 93.5 91.9
Male 90.7 94.7 90.3 90.2 87.1 93.2 91.3
Female 91.2 86.8 93.9 89.8 93.7 93.9 92.7
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 100.1 99.0 99.0 97.0 97.8 99.2 98.3
45–54 95.0 94.7 95.0 100.3 100.2 93.6 100.3
55–64 75.7 91.1 95.0 84.6 80.7 85.5 96.8
65–74 82.2 67.9 83.0 79.2 77.7 84.1 94.9
75+ 47.9 36.0 49.8 64.4 59.6 64.4 46.2
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 94.3 97.6 91.7 88.9 93.7 91.0 93.0
3 77.5 83.3 100.9 94.9 86.9 93.8 92.9
4 97.6 90.8 83.4 90.8 90.9 96.1 87.9
5 94.0 83.4 90.9 87.1 90.1 92.3 97.3
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  One-year survival changed little between 1998 and 2011.
•  Females had slightly better survival than males.
•  Survival for Māori over time was generally better than for non-Māori, although 
comparison should be made with caution given the low number of Māori patients.
•  Survival fluctuated over time in all age groups except 15−44 years. Survival was 
better for younger people than for older people.
•  There were no clear trends observed for survival by age group.
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Kidney (C64–C66, C68)
Survival for total population
Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 73.8 72.5 69.9 75.7 77.5 80.3 75.4
Male 76.2 69.4 69.5 78.0 78.9 80.5 74.3
Female 69.5 77.7 70.5 72.0 74.7 80.0 77.5
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 74.5 78.3 63.5 75.4 73.7 67.1 68.1
Male 82.4 73.1 63.4 77.2 73.5 62.2 67.4
Female 60.6 87.0 63.7 72.3 74.2 73.6 69.6
Non-Māori population, by sex
All 73.7 72.0 70.4 75.7 77.9 81.4 76.2
Male 75.8 69.0 69.9 78.1 79.5 81.8 75.1
Female 70.2 76.9 71.0 72.0 74.7 80.7 78.2
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 83.8 83.4 79.7 91.7 93.0 88.0 92.1
45–54 78.8 85.6 76.4 82.2 89.7 87.0 85.7
55–64 78.1 72.6 80.1 81.2 82.6 85.0 83.0
65–74 75.0 75.1 68.8 75.0 76.4 82.2 72.5
75+ 63.5 59.4 55.0 64.0 62.9 68.8 61.2
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 77.1 71.3 73.3 75.7 77.7 85.0 79.9
3 76.2 74.2 71.6 74.5 79.0 79.7 75.7
4 73.5 70.6 67.4 75.1 76.7 78.7 72.3
5 65.5 74.6 63.9 77.7 76.8 73.6 69.5
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  One-year survival fluctuated slightly between 1998 and 2011 for all patients.
•  Survival for non-Māori generally improved over time, but survival for Māori was 
more varied.
•  Survival was generally better for younger people than for older people with kidney 
cancer.
•  There was no clear relationship between survival and deprivation level.
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Leukaemia (C91–C95)
Survival for total population
Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 66.9 71.9 75.7 71.5 63.7 70.6 69.2
Male 65.1 73.6 77.0 75.4 65.4 70.6 68.4
Female 69.6 69.4 73.9 66.2 61.4 70.6 70.4
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 67.7 75.1 71.0 69.7 64.3 74.1 64.6
Male 68.7 71.6 77.3 71.9 62.8 72.8 63.8
Female 66.1 80.3 61.9 67.4 66.3 76.3 65.6
Non-Māori population, by sex
All 66.8 71.6 76.0 71.7 63.6 70.2 69.7
Male 64.8 73.8 77.0 75.7 65.6 70.3 68.9
Female 69.8 68.5 74.7 66.1 61.0 70.1 71.0
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 74.2 81.8 89.4 79.6 81.4 84.0 87.8
45–54 77.6 84.2 86.9 82.7 79.1 83.3 84.5
55–64 75.4 79.1 83.3 80.5 76.2 83.2 77.5
65–74 65.4 70.2 76.2 74.4 60.4 65.8 68.8
75+ 59.1 61.3 63.5 60.1 48.6 58.5 50.1
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 66.7 73.2 78.0 73.3 65.0 77.4 77.7
3 67.6 74.7 78.2 71.7 61.6 68.8 65.5
4 67.2 71.4 71.3 72.5 64.6 67.1 63.6
5 65.2 67.3 74.4 67.9 63.6 65.1 63.1
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  A coding change in 2003 resulted in some leukaemias being coded outside of 
C91–C95.
•  There were no clear trends observed for survival by sex or ethnic group.
•  Survival varied in most age groups over time and was better for younger people 
than for older people.
•  There was no clear trend over time for survival by deprivation quintile.
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Liver (C22)
Survival for total population
Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 22.1 27.5 29.4 33.3 33.4 35.6 38.5
Male 23.6 28.2 28.7 34.5 36.2 40.0 41.0
Female 17.8 26.3 30.9 30.4 27.4 26.0 31.9
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 20.0 26.0 27.5 30.7 33.8 28.3 33.1
Male 18.3 28.1 24.0 29.7 32.1 26.4 35.0
Female 34.7 17.0 39.7 34.6 39.9 36.3 26.7
Non-Māori population, by sex
All 22.6 28.0 30.0 33.7 33.2 37.3 39.7
Male 25.4 28.3 30.5 35.5 37.7 43.9 42.4
Female 16.2 27.5 29.0 29.9 25.0 24.6 32.8
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 22.8 40.8 29.2 43.6 40.7 31.6 59.2
45–54 45.7 30.2 35.9 39.4 34.4 38.5 48.6
55–64 19.4 27.2 40.0 36.1 48.1 47.9 43.0
65–74 21.6 29.3 25.4 36.4 29.2 35.9 44.2
75+ 12.9 18.1 18.2 22.4 24.2 23.4 21.2
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 21.1 24.9 26.0 28.0 29.5 38.5 43.1
3 24.2 41.4 35.5 36.5 35.6 36.4 30.5
4 23.8 17.8 28.7 31.0 33.6 40.0 33.8
5 21.1 28.3 29.8 38.0 35.0 28.3 41.7
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  One-year survival steadily improved between 1998 and 2011.
•  Male survival nearly doubled between 1998 and 2011 and was higher than female 
survival over time.
•  Survival was better for non-Māori than for Māori over time, but increased for both 
ethnic groups.
 
•  Overall survival improved for all age groups over time.
•  Survival improved over time in most deprivation quintiles. No real differences in 
survival were seen between deprivation quintiles.
One-year relative survival, New Zealand, 1998–1999 to 2010–2011
0
10
20
30
40
50
60
70
80
90
100
Māori Non–Māori 
1-year relative survival (%) 
0
10
20
30
40
50
60
70
80
90
100
Male Female
1-year relative survival (%) 
0
10
20
30
40
50
60
70
80
90
100
1−2 3 4 5
1-year relative survival (%) 
0
10
20
30
40
50
60
70
80
90
100
15–44 45–54 55–64 65–74 75+
1-year relative survival (%) 
0
10
20
30
40
50
60
70
80
90
100
1998–1999 2004–2005 2010–2011 
1-year relative survival (%) 
Lung (C33–C34)
Survival for total population
Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 31.4 31.4 30.2 31.9 31.9 33.3 34.3
Male 30.4 30.0 28.6 28.8 28.9 31.0 31.2
Female 32.9 33.3 32.3 36.2 35.6 35.9 37.7
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 30.1 27.8 27.7 30.4 28.0 30.0 33.5
Male 29.1 25.7 23.2 24.2 24.3 27.8 27.9
Female 31.2 29.7 31.5 35.9 31.2 31.7 37.7
Non-Māori population, by sex
All 31.6 32.1 30.7 32.2 32.8 34.1 34.4
Male 30.6 30.6 29.4 29.5 29.7 31.6 31.8
Female 33.3 34.2 32.5 36.3 36.9 37.2 37.7
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 40.9 48.5 45.3 50.1 50.1 56.3 57.5
45–54 36.5 37.5 40.6 36.0 40.4 39.8 44.4
55–64 32.4 36.6 35.4 37.6 34.6 38.1 40.0
65–74 31.7 31.3 28.3 32.5 33.8 34.4 36.2
75+ 28.1 25.1 24.6 24.9 25.0 26.7 25.4
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 33.2 27.8 32.1 37.0 35.9 36.6 34.5
3 31.5 36.0 33.5 29.1 34.7 32.1 33.0
4 29.9 32.2 28.2 30.5 28.6 33.2 34.5
5 30.6 30.7 27.5 30.5 29.0 31.4 34.4
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  Survival improved marginally between 1998 and 2011.
•  Survival for females was slightly better than for males and improved marginally 
over time. Male survival changed little over time.
•  Survival for non-Māori was slightly better over time than for Māori.
•  Survival improved over time for most age groups. Survival was better for younger 
people than for older people.
•  Very small differences in survival were seen between deprivation quintiles.
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Melanoma (C43)
Survival for total population
Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 97.1 96.5 96.9 96.8 96.6 97.0 96.3
Male 96.4 95.5 95.7 95.4 96.0 95.7 94.8
Female 97.8 97.6 98.2 98.4 97.4 98.5 98.2
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 97.8 94.9 93.0 90.1 93.5 88.8 91.2
Male 99.4 88.4 82.6 75.6 99.9 86.9 88.2
Female 95.8 96.9 99.0 102.4 90.1 90.6 94.2
Non-Māori population, by sex
All 97.1 96.5 97.0 96.9 96.7 97.1 96.4
Male 96.4 95.5 95.9 95.6 96.0 95.8 94.9
Female 97.9 97.6 98.2 98.3 97.5 98.6 98.2
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 97.6 98.9 99.0 97.8 97.6 96.7 98.1
45–54 97.6 97.2 98.1 98.8 97.6 98.5 97.2
55–64 97.2 96.5 97.1 96.9 97.6 96.9 96.8
65–74 96.4 95.2 95.4 96.3 97.1 97.3 95.9
75+ 96.8 94.7 95.3 94.7 94.3 96.0 94.9
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 97.4 97.3 98.0 97.7 97.1 97.8 97.1
3 97.6 97.4 97.0 96.3 97.0 96.3 96.1
4 96.2 94.8 96.6 97.1 95.8 97.8 96.0
5 96.8 95.4 94.8 94.3 96.0 94.6 94.8
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  One-year survival for melanoma was consistently high between 1998 and 2011.
•  Survival for females was slightly higher than for males.
•  Survival for Māori showed a downward trend between 1998 and 2011. Survival was 
stable for non-Māori. Māori numbers for melanoma are very low compared to non-
Māori numbers.
•  Survival was slightly better for younger people than for older people.
•  No real changes in survival by deprivation quintile were seen over time. Survival 
was marginally better for patients residing in less deprived areas.
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Myeloma (C90)
Survival for total population
Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 70.5 71.8 73.5 76.5 76.8 77.8 77.3
Male 70.7 72.4 73.3 75.9 76.1 79.6 77.5
Female 70.1 71.0 73.7 77.2 77.8 75.5 77.0
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 67.3 76.2 62.5 65.3 76.2 86.5 80.8
Male 70.6 77.0 78.4 54.9 71.6 86.4 72.9
Female 62.5 75.1 49.2 73.2 78.5 86.6 91.5
Non-Māori population, by sex
All 70.7 71.4 74.3 77.5 76.9 76.8 76.9
Male 70.8 72.0 73.0 77.3 76.3 78.9 78.1
Female 70.7 70.7 76.0 77.7 77.7 74.2 75.1
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 84.8 91.8 93.0 84.8 92.4 100.1 100.1
45–54 81.4 89.4 91.2 88.3 88.4 86.7 92.9
55–64 77.8 88.5 83.3 82.8 84.5 90.9 91.1
65–74 73.5 77.2 72.1 84.8 79.9 77.6 80.7
75+ 61.6 53.5 63.3 61.8 61.9 64.7 60.8
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 72.4 75.8 76.2 79.3 77.1 78.6 81.4
3 64.0 74.1 73.0 76.9 75.1 78.4 77.6
4 67.0 65.7 70.2 75.1 75.5 76.4 71.8
5 77.7 68.2 73.6 72.2 77.9 77.1 74.1
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  Survival steadily improved between 1998 and 2011.
•  Male and female survival was comparable, and survival improved for both sexes 
over time.
•  Survival for non-Māori generally improved over time and was more stable than 
survival for Māori.
•  Survival was better for younger people with myeloma than for older people.
•  There was no clear trend in survival by deprivation quintile.
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Non-Hodgkin lymphoma (C82–C85, C96)
Survival for total population
Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 72.3 73.9 73.9 77.1 76.5 79.8 81.1
Male 72.9 73.7 75.1 77.9 77.0 80.8 81.6
Female 71.5 74.2 72.8 76.2 76.0 78.5 80.4
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 67.7 74.2 63.6 56.4 68.6 72.6 76.0
Male 68.9 72.3 65.0 49.2 68.7 74.0 78.1
Female 66.4 76.6 62.7 66.8 68.5 70.6 73.3
Non-Māori population, by sex
All 72.5 73.9 74.8 78.3 77.1 80.4 81.5
Male 73.2 73.8 75.8 79.7 77.5 81.4 81.9
Female 71.8 74.0 73.7 76.6 76.5 79.1 81.0
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 81.0 84.7 85.6 86.8 88.6 93.1 89.8
45–54 82.8 83.8 85.6 86.2 87.3 92.0 90.2
55–64 81.9 82.7 80.8 86.9 87.3 86.4 87.9
65–74 72.4 76.5 71.8 78.9 77.9 79.3 87.2
75+ 56.3 56.9 59.9 60.1 55.7 63.7 64.2
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 72.0 75.3 74.3 78.8 81.4 83.1 81.2
3 74.0 72.2 76.4 79.1 80.4 77.2 82.7
4 74.9 73.8 73.2 76.7 67.9 77.6 81.1
5 66.4 73.4 71.4 72.5 73.3 77.9 78.3
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  Survival steadily improved between 1998 and 2011.
•  Survival was comparable for males and females and improved over time for both 
sexes.
•  Survival for non-Māori steadily improved over time and was better than for Māori.
•  Survival showed an upward trend over time in most age groups. Survival in the 75+ 
years age group was consistently lower than in other age groups over time.
•  There was no real difference in survival between deprivation quintiles.
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Oesophagus (C15)
Survival for total population
Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 29.7 30.2 35.0 37.1 35.8 37.0 39.1
Male 30.1 29.3 34.8 35.1 35.9 36.2 40.8
Female 28.8 32.0 35.5 41.6 35.4 38.7 35.4
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 12.6 14.5 26.1 30.5 38.7 18.0 41.7
Male 4.8 9.2 24.6 35.9 26.9 17.6 39.2
Female 27.4 34.6 31.0 17.4 79.8 18.8 46.6
Non-Māori population, by sex
All 31.3 31.3 35.9 37.7 35.5 38.6 38.8
Male 32.6 31.0 36.0 35.1 36.7 37.8 40.9
Female 29.0 31.9 35.8 43.8 33.5 40.1 34.0
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 50.1 16.7 45.5 45.5 50.1 63.8 62.0
45–54 40.2 43.5 53.0 40.1 53.7 44.9 51.6
55–64 38.8 46.6 46.3 48.5 47.1 46.2 50.4
65–74 27.9 34.9 35.0 41.3 38.7 36.7 38.3
75+ 24.1 17.9 26.2 27.6 25.8 29.8 30.3
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 35.9 32.3 36.1 34.3 36.8 44.0 43.6
3 25.3 21.1 38.4 37.2 34.4 43.4 37.6
4 31.4 30.4 30.6 44.1 36.2 30.0 35.6
5 23.7 36.4 35.4 31.6 32.9 28.4 38.3
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  Survival generally improved between 1998 and 2011.
•  Male and female survival was comparable.
•  Survival improved for both Māori and non-Māori over time, except for one low 
survival value for Māori during the 2008–09 period.
•  Survival generally improved over time for all age groups. Survival was better for 
younger people than for older people.
•  No real differences in survival were seen between deprivation groups.
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Ovary (C56)
Survival for total population
Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 72.9 73.3 71.6 66.0 65.5 68.2 70.7
Male - - - - - - -
Female 72.9 73.3 71.6 66.0 65.5 68.2 70.7
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 77.7 74.9 70.0 64.6 73.4 72.2 72.4
Male - - - - - - -
Female 77.7 74.9 70.0 64.6 73.4 72.2 72.4
Non-Māori population, by sex
All 72.4 73.2 71.8 66.1 64.6 67.8 70.4
Male - - - - - - -
Female 72.4 73.2 71.8 66.1 64.6 67.8 70.4
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 89.1 91.7 91.7 83.1 89.2 85.4 89.5
45–54 87.1 89.3 84.1 92.3 81.5 89.7 81.5
55–64 75.0 76.1 82.0 71.1 79.6 79.6 86.6
65–74 68.4 66.8 71.6 67.4 64.3 62.9 70.2
75+ 46.9 44.0 36.7 40.4 30.8 35.7 38.2
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 76.0 75.7 74.3 70.3 66.0 73.7 74.8
3 74.0 66.8 70.4 68.6 68.5 65.3 67.4
4 70.6 75.1 70.4 61.2 66.7 64.9 67.3
5 69.0 72.5 70.1 61.2 59.5 64.1 69.5
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  Ovarian cancers of borderline malignancy were excluded from registration from 1 
January 2003.
•  Survival improved between 2006 and 2011.
•  Māori women had better survival than non-Māori women between 2006 and 2011.
•  Survival varied in all age groups over time. Younger women with ovarian cancer 
continued to have better survival than older women.
•  There was little difference in survival between deprivation quintiles.
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Pancreas (C25)
Survival for total population
Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 16.9 17.7 18.1 17.7 18.9 16.6 21.2
Male 20.0 20.0 17.5 19.0 20.7 17.3 18.2
Female 13.5 15.3 18.7 16.4 17.2 16.0 24.3
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 28.4 9.1 16.6 21.5 18.8 17.6 24.0
Male 29.3 8.7 17.1 18.6 24.7 16.4 20.4
Female 27.1 9.5 16.0 23.8 13.6 18.5 27.6
Non-Māori population, by sex
All 15.6 18.5 18.2 17.2 18.9 16.5 20.9
Male 18.8 21.0 17.5 19.1 20.3 17.4 18.0
Female 12.3 16.0 18.9 15.4 17.5 15.6 24.0
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 58.0 42.9 58.9 48.2 50.1 40.1 47.1
45–54 22.3 23.7 26.1 19.0 19.3 31.1 33.0
55–64 20.4 19.5 22.1 25.0 25.2 27.7 26.7
65–74 14.5 16.1 18.7 18.6 20.0 14.0 21.3
75+ 12.6 14.5 11.5 10.3 12.9 8.8 15.2
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 14.2 16.8 24.6 19.7 22.0 19.1 23.6
3 24.4 18.4 13.9 18.5 20.1 15.8 18.6
4 14.8 16.4 18.8 14.9 15.9 15.2 20.8
5 13.9 18.7 10.1 17.0 15.7 15.3 19.1
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  One-year survival for pancreatic cancer remained low between 1998 and 2011. In 
2010–11 survival was the highest since 1998–99.
•  There was no consistent difference between male and female survival over time.
•  Survival for non-Māori was relatively stable over time, while survival for Māori was 
more varied.
•  Survival was consistently better for younger people over time.
•  There was no clear trend in survival by deprivation quintile.
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Prostate (C61)
Survival for total population
Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 93.3 95.8 95.5 95.8 96.3 96.5 96.9
Male 93.3 95.8 95.5 95.8 96.3 96.5 96.9
Female - - - - - - -
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 91.5 93.9 95.2 92.0 92.5 91.8 92.9
Male 91.5 93.9 95.2 92.0 92.5 91.8 92.9
Female - - - - - - -
Non-Māori population, by sex
All 93.4 95.9 95.5 96.0 96.5 96.7 97.1
Male 93.4 95.9 95.5 96.0 96.5 96.7 97.1
Female - - - - - - -
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 91.8 100.2 100.2 93.5 100.2 100.2 100.2
45–54 96.0 99.1 99.8 99.7 99.3 98.8 99.7
55–64 97.9 99.1 99.3 99.0 99.4 99.2 99.5
65–74 95.4 97.6 97.8 98.2 97.8 98.4 98.8
75+ 88.1 90.2 88.2 88.3 90.2 88.5 88.5
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 94.5 96.8 96.6 96.9 97.3 98.2 98.1
3 93.5 95.7 96.6 96.0 97.0 96.7 97.0
4 92.6 95.5 93.7 95.0 95.0 94.7 94.3
5 90.6 94.1 93.9 94.1 95.1 94.2 97.1
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  One-year survival for prostate cancer was consistently high over time.
•  One-year survival was 96.9% in the 2010–11 period for men with prostate cancer. 
This was the highest survival since 1998–99.
•  Survival was slightly better for non-Māori men than for Māori men. Survival for 
both ethnic groups generally improved over time.
•  Survival was better for younger men than for older men.
•  Deprivation had little effect on survival.
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Stomach (C16)
Survival for total population
Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 41.7 39.3 43.6 43.3 44.1 46.5 50.5
Male 42.8 38.5 42.5 45.8 44.1 45.9 52.1
Female 39.7 40.5 45.4 39.8 44.2 47.8 47.8
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 29.2 32.2 48.0 44.1 38.5 45.8 54.5
Male 34.2 30.7 40.3 45.2 35.0 43.1 53.1
Female 22.0 33.7 58.8 42.9 42.5 48.9 55.8
Non-Māori population, by sex
All 43.6 40.5 42.7 43.1 45.5 46.7 49.6
Male 44.1 39.6 42.9 45.9 45.9 46.4 51.9
Female 42.7 42.1 42.2 39.0 44.8 47.4 44.8
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 50.1 44.0 52.5 47.8 55.3 49.1 55.3
45–54 46.0 53.8 52.1 50.2 48.2 53.4 53.2
55–64 49.5 46.9 54.0 46.6 46.9 56.3 59.7
65–74 44.4 44.8 49.1 45.4 46.7 48.6 48.2
75+ 33.1 27.4 29.7 37.1 36.3 37.1 44.5
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 45.1 39.2 45.7 49.1 48.6 47.8 53.1
3 46.8 40.4 45.0 44.2 39.2 41.4 49.6
4 36.4 39.4 39.8 39.5 49.8 50.1 43.1
5 39.0 36.7 42.8 38.6 37.3 46.0 54.1
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  Survival showed an upward trend between 1998 and 2011.
•  Survival for males and females was comparable over time.
•  Between 1998 and 2001 Māori survival was lower than non-Māori survival. After 
this there was no consistent difference.
•  Survival varied over time for all age groups. Survival was lower for the 75+ years 
age group compared to other age groups.
•  There was no clear difference in survival between deprivation quintiles.
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Testis (C62)
Survival for total population
Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 99.1 96.6 97.0 97.2 97.7 97.4 98.7
Male 99.1 96.6 97.0 97.2 97.7 97.4 98.7
Female - - - - - - -
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 96.9 98.2 92.6 96.3 95.3 97.2 97.3
Male 96.9 98.2 92.6 96.3 95.3 97.2 97.3
Female - - - - - - -
Non-Māori population, by sex
All 99.8 96.3 98.2 97.4 98.5 97.5 99.0
Male 99.8 96.3 98.2 97.4 98.5 97.5 99.0
Female - - - - - - -
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 99.2 97.9 97.6 97.4 97.2 98.4 98.9
45–54 100.4 91.9 98.0 97.9 98.4 96.7 98.7
55–64 100.9 91.8 95.0 86.3 100.8 90.6 93.0
65–74 102.5 101.6 85.4 103.5 102.2 102.2 101.9
75+ 56.8 0.0 0.0 114.1 104.3 71.8 105.0
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 100.3 97.0 98.4 96.7 97.3 97.6 100.2
3 100.2 98.6 98.8 99.1 97.2 96.4 97.3
4 97.2 95.6 94.3 96.0 98.7 98.9 98.9
5 98.5 94.7 95.8 97.5 97.8 96.5 97.0
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  Survival fluctuated between 96% and 99% between 1998 and 2011. Testicular 
cancer continued to have the highest survival of all cancers presented in this 
publication.
•  Survival for non-Māori survival was marginally higher than for Māori, except 
during 2000–01. Survival for both ethnic groups was greater than 92% between 
1998 and 2011.
•  Low numbers of patients aged above 55 years prohibits meaningful comparison of 
age data over time and survival should be treated with caution for these age groups.
•  Deprivation had little effect on survival.
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Thyroid (C73)
Survival for total population
Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 94.2 94.6 92.7 93.9 93.4 95.7 95.5
Male 89.0 93.3 87.3 91.9 91.8 92.8 94.5
Female 95.5 95.0 94.6 94.7 94.0 96.6 95.8
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 94.5 99.1 91.0 94.0 89.3 99.6 97.4
Male 93.9 102.4 79.7 89.0 79.3 96.8 96.8
Female 94.7 98.2 94.5 95.7 92.9 100.7 97.6
Non-Māori population, by sex
All 94.2 93.9 93.1 93.9 94.1 94.9 95.1
Male 87.9 92.1 88.8 92.4 94.1 92.0 94.1
Female 95.6 94.5 94.6 94.5 94.1 95.9 95.5
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 99.4 99.3 98.4 99.4 99.0 98.9 100.1
45–54 98.5 98.7 95.5 97.8 98.4 99.4 96.1
55–64 86.2 91.1 93.2 92.7 93.9 95.4 94.4
65–74 83.9 96.8 84.3 84.7 84.2 91.1 92.3
75+ 79.0 66.0 71.5 72.6 65.3 78.7 77.3
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 93.7 94.0 97.0 94.5 95.7 96.8 95.7
3 95.1 96.9 93.1 95.3 89.9 94.1 95.1
4 91.8 90.7 86.4 88.2 90.0 97.3 94.0
5 96.3 95.9 92.9 96.4 95.9 94.8 96.6
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  Survival exceeded 92% for each observation period between 1998 and 2011.
•  Survival for females was better than for males.
•  Survival for Māori was more varied than for non-Māori over time.
•  Survival was better for younger patients than for older patients with thyroid 
cancer.
•  Survival was similar across deprivation quintiles.
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Uterus (C54–C55)
Survival for total population
Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 86.5 87.1 88.3 89.1 89.6 92.3 89.9
Male - - - - - - -
Female 86.5 87.1 88.3 89.1 89.6 92.3 89.9
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 79.3 77.4 88.2 84.6 94.5 82.2 83.4
Male - - - - - - -
Female 79.3 77.4 88.2 84.6 94.5 82.2 83.4
Non-Māori population, by sex
All 87.3 88.2 88.4 89.7 88.9 93.8 90.9
Male - - - - - - -
Female 87.3 88.2 88.4 89.7 88.9 93.8 90.9
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 89.0 91.0 97.5 92.2 88.1 96.0 94.8
45–54 90.7 91.0 94.5 93.2 94.3 94.2 95.8
55–64 90.2 90.3 88.2 92.5 95.9 95.1 93.1
65–74 86.4 88.0 92.2 91.2 84.8 90.5 88.7
75+ 78.2 75.9 73.8 77.1 81.8 84.7 76.9
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 92.7 90.2 89.8 90.0 90.6 91.7 90.9
3 83.6 85.3 88.0 88.2 92.2 94.5 96.2
4 86.3 88.9 91.4 88.8 88.5 93.3 86.4
5 81.8 82.9 83.4 89.0 87.4 90.4 86.7
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  Survival showed a slight upward trend between 1998 and 2011.
•  Non-Māori women generally had better survival than Māori women over time.
•  Survival fluctuated in each age group over time. Survival for those aged 75+ years 
continued to be lower than for all other age groups.
•  Women in deprivation quintile 5 had lower survival than women in deprivation 
quintiles 1−4. Survival improved the most over time for women in quintile 3. 
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Survival for total population
Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 57.7 60.0 60.4 61.1 61.0 62.0 63.3
Male 56.6 58.3 58.8 60.3 59.8 60.5 62.4
Female 58.8 62.0 62.1 62.1 62.3 63.5 64.3
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 43.6 45.7 46.9 46.1 48.7 46.6 49.3
Male 40.2 38.4 39.7 41.2 42.9 38.6 42.5
Female 46.5 51.5 52.9 50.1 53.3 52.6 54.1
Non-Māori population, by sex
All 58.8 61.2 61.5 62.4 62.1 63.5 64.7
Male 57.8 59.6 60.1 61.7 61.1 62.3 64.0
Female 59.9 63.0 62.9 63.3 63.2 64.8 65.5
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 77.0 79.4 80.2 78.2 80.1 80.5 81.5
45–54 68.1 70.6 72.1 72.1 73.8 75.5 76.8
55–64 60.0 64.7 66.8 67.3 68.1 68.9 70.5
65–74 55.1 58.2 58.4 61.3 59.8 61.0 63.6
75+ 47.0 46.6 44.9 45.6 44.3 45.1 45.2
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 62.0 64.3 65.7 66.6 67.1 68.8 69.4
3 60.2 60.5 61.9 61.5 61.3 60.4 62.7
4 54.3 57.3 56.6 58.3 57.2 59.3 59.9
5 50.9 54.7 53.1 54.2 54.5 54.6 55.9
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  Five-year survival improved steadily over time from 57.7% in 1998–99.
•  Both male and female survival improved over time.
•  Five-year survival for non-Māori was approximately 1.3 times the Māori five-year 
survival.
•  Five-year survival improved over time in all age groups except the 75+ years age 
group. Survival in the 55−64 year age group improved the most over time.
•  Between 1998 and 2011 5−year survival improved consistently in deprivation 
quintiles 1−2. Survival was better in patients residing in less deprived areas.
Five-year relative survival, New Zealand, 1998–1999 to 2010–2011
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Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 71.1 70.6 67.0 63.3 51.7 47.2 49.3
Male 73.6 72.3 69.3 64.9 53.0 49.7 52.5
Female 64.1 65.9 60.6 57.9 47.6 41.8 41.2
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 70.8 57.0 51.0 54.4 30.0 46.7 59.4
Male 80.3 61.1 52.1 67.5 27.4 50.8 58.3
Female 51.7 44.4 50.6 28.1 28.1 33.1 63.0
Non-Māori population, by sex
All 71.2 71.0 67.5 63.9 52.8 47.2 48.9
Male 73.5 72.6 69.8 65.0 54.3 49.7 52.3
Female 64.5 66.5 61.1 59.9 48.1 41.8 39.7
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 84.1 100.8 85.2 80.5 52.8 67.7 29.9
45–54 91.4 89.8 87.2 73.9 61.2 73.9 79.2
55–64 75.7 79.6 76.9 75.6 69.7 53.2 54.7
65–74 77.4 74.4 68.6 68.0 55.5 51.2 61.7
75+ 57.5 57.1 57.5 52.3 41.8 39.5 37.1
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 72.3 75.0 68.6 65.3 57.6 51.9 50.7
3 74.8 74.5 72.4 66.9 54.4 46.9 47.4
4 67.4 61.4 63.7 61.6 46.8 45.2 48.8
5 67.4 66.9 61.3 57.7 43.1 40.0 47.0
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  From 2005 a coding change resulted in superficial transitional cell carcinoma of 
the bladder being excluded from bladder cancer registrations.
•  There was no obvious trend for survival between 2006 and 2011.
•  Survival declined over time for women, and remained lower than for males.
•  Survival for Māori improved between 2006 and 2011; there was no clear trend for 
non-Māori survival.
•  There were no clear trends observed for survival by age group.
•  Survival trended downwards for deprivation quintiles 1−2. There was no apparent 
trend for survival for other deprivation quintiles.
Five-year relative survival, New Zealand, 1998–1999 to 2010–2011
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Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 18.8 16.7 17.6 15.9 16.8 22.9 18.8
Male 20.1 19.4 15.4 14.3 13.8 22.1 18.9
Female 16.8 12.9 21.9 18.2 21.9 23.3 18.7
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 38.9 38.3 13.6 21.2 12.9 24.7 15.1
Male 23.2 34.8 15.6 22.4 10.2 18.5 19.9
Female - 39.2 10.2 24.2 12.8 31.7 12.4
Non-Māori population, by sex
All 17.9 15.6 17.7 15.5 17.2 22.8 19.2
Male 19.8 18.7 15.3 14.0 14.0 22.4 19.0
Female 14.9 11.4 22.2 17.9 22.5 22.6 19.4
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 53.8 52.5 47.3 49.4 43.2 59.2 43.6
45–54 18.5 22.6 21.0 13.2 21.2 28.2 39.1
55–64 8.5 7.4 9.4 9.8 12.4 18.3 10.8
65–74 6.9 4.9 5.9 5.1 7.0 8.0 6.3
75+ 4.8 1.0 1.9 1.9 1.6 1.1 3.1
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 19.5 15.0 16.1 16.6 15.4 26.0 22.2
3 16.9 13.7 16.6 15.8 15.8 20.8 16.7
4 15.5 18.8 16.1 13.2 18.9 20.7 9.8
5 24.0 19.5 22.5 18.2 15.0 18.6 30.3
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  Five-year survival remained low between 1998 and 2011.
•  Male and female survival were similar and both fluctuated over time.
•  Survival for Māori varied more over time than non-Māori survival.
•  Survival was better for younger people with brain cancer than for older people, but 
without any clear trends within each age group over time.
•  There was no clear trend for survival by deprivation quintile over time.
Five-year relative survival, New Zealand, 1998–1999 to 2010–2011
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Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 79.3 83.1 83.2 83.5 84.9 85.6 87.3
Male - - - - - - -
Female 79.3 83.1 83.2 83.5 84.9 85.6 87.3
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 71.1 79.6 76.9 74.4 78.2 84.5 84.1
Male - - - - - - -
Female 71.1 79.6 76.9 74.4 78.2 84.5 84.1
Non-Māori population, by sex
All 80.1 83.5 83.9 84.5 85.6 85.7 87.7
Male - - - - - - -
Female 80.1 83.5 83.9 84.5 85.6 85.7 87.7
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 75.6 79.9 80.7 80.3 81.8 84.8 84.7
45–54 82.1 87.3 85.2 85.5 87.6 89.9 90.7
55–64 83.4 85.4 87.4 89.2 88.3 88.1 90.4
65–74 78.7 83.9 84.0 84.9 84.5 87.1 88.2
75+ 75.4 76.0 75.0 72.5 78.6 72.8 78.6
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 83.2 83.9 85.7 85.1 88.0 88.0 89.6
3 77.5 82.0 84.0 85.1 84.3 84.5 86.3
4 77.8 82.2 80.2 81.8 82.9 84.1 87.4
5 75.8 83.8 80.7 80.2 81.6 83.4 83.5
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  Five-year survival increased steadily over time from 79.3% to 87.3% between 1998 
and 2011.
•  Survival for non-Māori women was slightly better than for Māori women. 
•  There was an upward trend in survival for all age groups over time except for 
women aged 75+ years.
•  Women residing in the least deprived areas continued to have the best survival. 
Five-year relative survival, New Zealand, 1998–1999 to 2010–2011
Breast – female (C50)
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Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 70.6 76.4 73.2 72.1 68.6 72.8 73.7
Male - - - - - - -
Female 70.6 76.4 73.2 72.1 68.6 72.8 73.7
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 63.8 69.9 68.2 70.1 59.1 71.6 68.2
Male - - - - - - -
Female 63.8 69.9 68.2 70.1 59.1 71.6 68.2
Non-Māori population, by sex
All 72.4 78.0 74.4 72.5 70.9 73.1 75.0
Male - - - - - - -
Female 72.4 78.0 74.4 72.5 70.9 73.1 75.0
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 84.8 92.2 86.0 83.7 86.0 92.2 83.1
45–54 70.5 74.1 73.0 74.9 72.8 74.7 82.9
55–64 56.0 65.4 79.3 72.5 59.7 63.4 65.1
65–74 56.7 50.5 50.3 48.8 59.0 38.7 44.4
75+ 45.8 46.3 25.2 20.4 19.8 23.3 32.8
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 76.8 82.7 79.8 77.7 83.7 75.6 84.8
3 73.3 69.7 78.1 71.0 67.5 77.6 80.8
4 64.8 81.7 69.6 63.9 61.5 77.3 71.5
5 68.6 69.9 64.5 71.8 60.1 64.0 62.1
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  Five-year survival fluctuated around 72% between 1998 and 2011.
•  There was no apparent trend in survival by ethnic group. Non-Māori women 
continued to have better survival than Māori women over time.
•  Survival was substantially better for younger women with cervical cancer than for 
older women, but without any clear trends within each age group over time.
•  Survival was better for women residing in the least deprived areas, but there was 
no clear trend for survival within deprivation quintiles over time.
•  Cervical screening may affect survival. Screening finds cervical tumours at the pre-
cancerous stage (not included in this data), potentially resulting in a decrease in the 
number of actual cancers registered, but an increase in the proportion of registered 
cancers at an aggressive or advanced stage, increasing the likelihood of death.
Five-year relative survival, New Zealand, 1998–1999 to 2010–2011
Cervix (C53)
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Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 71.6 76.7 80.9 81.9 77.4 79.7 84.5
Male 71.8 77.7 80.3 87.5 75.2 82.0 84.1
Female 71.1 75.4 81.7 76.2 79.5 77.0 85.4
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 64.4 68.9 80.4 78.8 66.8 77.3 82.6
Male 48.7 76.4 85.1 88.5 63.1 82.9 81.2
Female 79.1 63.3 73.5 64.3 69.5 71.3 84.4
Non-Māori population, by sex
All 73.5 78.8 80.9 82.6 80.0 80.3 84.9
Male 77.5 78.0 79.0 87.0 78.6 81.6 85.0
Female 68.2 79.8 83.2 78.5 81.4 78.3 84.9
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 - - - - - - -
45–54 - - - - - - -
55–64 - - - - - - -
65–74 - - - - - - -
75+ - - - - - - -
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 69.0 77.0 79.7 86.3 84.3 85.5 85.7
3 88.8 74.5 87.7 76.9 75.1 76.7 89.4
4 61.5 77.7 77.2 74.4 73.1 79.2 78.1
5 66.9 77.5 78.9 86.9 73.6 75.6 84.6
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  Five-year survival for children with cancer improved between 1998 and 2011.
•  Male and female survival were comparable and showed a general upward trend 
over time.
•  Māori children had worse survival than non-Māori children over time.
•  Survival improved for children living in deprivation quintiles 1−2.
•  A large proportion of childhood cancers were blood cancers. From 2003 some 
leukaemias were instead registered as chronic myeloproliferative disorders and 
myelodysplastic syndromes (D45−D47). This may account for the decrease in 
survival in 2006.
Five-year relative survival, New Zealand, 1998–1999 to 2010–2011
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Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 57.6 60.2 60.5 59.4 59.6 60.3 63.3
Male 56.7 59.0 59.3 59.3 59.1 58.4 62.6
Female 58.6 61.4 61.5 59.5 60.1 62.2 64.0
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 40.1 45.2 46.8 46.8 54.7 43.5 53.9
Male 44.3 47.3 37.9 47.5 47.1 36.8 46.4
Female 35.0 42.3 59.5 45.4 65.4 51.7 62.2
Non-Māori population, by sex
All 58.2 60.7 61.0 60.0 59.8 61.2 63.8
Male 57.1 59.4 60.4 59.9 59.6 59.6 63.5
Female 59.3 62.0 61.6 60.1 60.0 62.7 64.1
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 57.9 64.6 63.4 62.5 62.9 63.3 70.8
45–54 62.0 63.9 64.8 59.1 65.3 60.5 67.6
55–64 60.3 63.4 63.1 66.0 63.3 62.2 64.8
65–74 57.4 60.1 61.5 60.5 61.0 62.9 66.8
75+ 55.1 57.7 57.0 55.0 55.4 57.7 58.4
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 60.5 63.7 63.2 62.3 62.5 66.1 69.2
3 58.6 61.5 63.4 59.3 60.2 58.5 62.1
4 53.0 55.9 57.7 58.1 58.4 59.3 60.3
5 55.4 55.9 54.3 55.1 54.8 52.7 55.9
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  Five-year survival changed little between 1998 and 2011.
•  Survival for females was better than for males over time.
•  Māori patients had lower survival than non-Māori patients. Survival improved 
slightly over time for non-Māori.
•  Survival was marginally better in younger people with colorectal cancer than in 
older people over time.
•  Survival improved over time for patients residing in deprivation quintile 4 but 
there were no clear trends within other deprivation quintiles.
Five-year relative survival, New Zealand, 1998–1999 to 2010–2011
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Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 64.2 60.8 58.9 65.0 61.0 63.4 67.5
Male 64.5 57.7 57.9 63.7 60.6 60.5 67.8
Female 63.2 68.7 61.3 67.8 61.4 70.7 66.6
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 61.7 50.1 47.7 53.7 66.3 47.9 56.2
Male 64.9 40.0 50.1 49.2 63.3 41.5 45.3
Female 51.4 66.6 52.1 62.0 75.4 63.1 88.0
Non-Māori population, by sex
All 64.3 61.7 59.8 66.2 60.5 65.2 68.6
Male 64.5 59.1 58.4 65.3 60.4 62.6 70.1
Female 63.7 68.2 62.9 67.9 60.3 71.5 64.8
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 80.0 89.9 83.2 81.5 86.1 77.4 79.2
45–54 78.3 64.2 66.6 77.0 74.0 78.1 75.3
55–64 63.2 63.9 62.4 62.5 67.3 65.5 69.5
65–74 59.4 56.4 49.7 57.0 52.0 55.4 59.8
75+ 55.5 47.0 48.2 56.5 40.4 50.2 59.4
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 68.3 56.7 61.8 69.8 65.7 73.1 72.5
3 67.6 55.5 60.1 67.8 57.9 61.9 64.2
4 59.5 72.2 57.0 63.7 57.2 57.6 70.0
5 58.9 59.8 54.2 57.6 62.9 58.2 60.5
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  Five-year survival fluctuated between 1998 and 2011 and was highest in the 
2010–11 period.
•  Survival was generally better for females than for males over time.
•  Survival for Māori was lower and more varied than non-Māori survival over time.
•  Survival was better for younger people than for older people, but there was no 
clear trend within age groups over time.
•  Survival was generally better for patients residing in less deprived areas, but there 
was no clear trend for survival within deprivation quintiles over time.
Five-year relative survival, New Zealand, 1998–1999 to 2010–2011
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Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 83.0 85.8 83.3 83.0 80.8 79.5 84.5
Male 82.6 90.1 79.8 83.5 78.9 79.4 85.7
Female 84.6 80.7 87.0 81.7 83.0 79.9 83.0
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 83.2 85.4 87.6 83.1 95.8 70.4 93.3
Male 85.1 87.0 102.6 78.3 89.2 73.9 84.9
Female 70.6 85.5 74.1 89.3 103.5 67.9 102.2
Non-Māori population, by sex
All 83.2 85.8 83.0 83.0 79.2 80.4 83.7
Male 82.8 90.4 77.8 83.7 78.3 79.8 85.6
Female 85.2 80.1 88.8 80.8 80.2 81.4 81.1
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 92.4 96.4 94.7 91.6 93.9 91.0 95.9
45–54 94.0 95.8 67.6 101.7 90.6 88.3 93.9
55–64 65.9 82.1 81.6 73.8 71.3 77.1 62.5
65–74 53.6 76.5 74.1 57.2 41.1 46.2 77.3
75+ 11.6 1.6 43.8 15.3 49.3 31.7 33.7
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 89.4 93.0 80.9 86.8 80.1 84.3 85.3
3 72.9 61.9 87.6 82.5 75.6 71.4 74.8
4 88.8 89.7 88.1 86.5 82.4 82.3 81.7
5 74.2 90.8 77.3 71.6 84.4 79.8 98.9
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  Five-year survival was relatively constant between 1998 and 2011.
•  Survival for males and females was comparable over time.
•  Survival for Māori was more variable than for non-Māori over time.
•  Survival was better for younger people with Hodgkin lymphoma than for older 
people, but without any clear trends within each age group over time.
•  There was no clear relationship between survival and deprivation level.
Five-year relative survival, New Zealand, 1998–1999 to 2010–2011
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Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 55.4 57.4 53.6 57.4 60.8 61.2 58.8
Male 55.2 57.9 55.1 57.6 60.2 61.0 57.8
Female 55.0 56.6 51.3 57.1 61.9 61.7 60.8
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 32.4 72.6 49.4 46.9 50.4 50.2 45.8
Male 30.2 66.5 55.3 47.5 46.5 45.8 45.0
Female 33.5 86.3 39.7 44.3 57.6 57.0 45.8
Non-Māori population, by sex
All 57.0 56.4 54.0 58.3 61.6 62.2 60.2
Male 56.8 57.2 55.1 58.3 61.3 62.3 59.0
Female 56.8 55.1 52.3 58.2 62.2 62.2 62.4
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 66.3 73.4 61.4 81.3 78.9 74.3 88.8
45–54 65.9 69.2 65.6 65.3 69.4 75.6 75.4
55–64 53.4 61.3 64.1 61.9 68.4 66.1 66.1
65–74 60.8 59.5 51.0 56.7 59.2 58.2 52.9
75+ 42.1 41.4 38.4 42.8 44.6 48.3 41.3
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 61.0 57.9 57.2 60.4 65.4 64.5 66.1
3 64.6 62.3 51.3 52.7 56.8 58.5 60.2
4 50.3 57.0 52.8 57.1 61.1 59.3 59.0
5 43.3 49.9 49.1 55.8 56.4 59.8 45.1
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  Five-year survival fluctuated between 1998 and 2011 for all patients.
•  Māori survival was lower than non-Māori survival between 1998 and 2011, except 
for the period 2000–01.
•  Survival was better for younger people with kidney cancer than for older people.
•  Survival was generally better for patients residing in less deprived areas, but there 
was no clear trend for survival within deprivation quintiles over time.
Five-year relative survival, New Zealand, 1998–1999 to 2010–2011
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Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 40.2 48.4 55.3 56.5 49.7 53.5 51.5
Male 37.0 48.4 56.8 58.7 51.0 52.6 50.5
Female 44.8 48.4 53.3 53.5 48.0 54.7 53.0
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 41.2 38.5 55.9 48.7 50.1 51.8 43.5
Male 46.9 38.4 59.1 42.7 42.1 46.1 43.8
Female 39.5 38.0 49.9 56.7 61.9 57.4 42.5
Non-Māori population, by sex
All 40.2 49.1 55.2 57.1 49.7 53.5 52.4
Male 36.6 49.2 56.6 60.0 51.8 53.1 51.2
Female 45.3 49.0 53.3 53.2 46.8 54.3 54.2
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 56.4 59.1 74.9 66.7 69.3 70.1 74.6
45–54 54.4 60.0 71.9 67.6 73.1 66.3 70.6
55–64 52.0 56.4 60.2 68.2 67.4 71.0 69.4
65–74 38.9 46.0 57.3 61.0 45.2 48.3 47.5
75+ 23.9 37.8 39.3 39.3 31.7 36.5 28.1
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 38.8 47.2 57.2 58.4 55.5 61.8 55.6
3 45.9 52.8 58.5 57.6 43.3 48.7 51.1
4 40.7 45.3 54.2 58.0 48.3 53.1 48.3
5 34.7 46.7 49.3 50.0 49.2 45.3 46.1
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  A coding change in 2003 resulted in some leukaemias being coded outside of 
C91–C95.
•  There was no clear trend in five-year survival by sex.
•  Survival for Māori varied more over time than for non-Māori and was generally 
lower.
•  Survival showed an upward trend for patients aged 15−44 and 55−64 years and 
was better for younger people with leukaemia than for older people.
•  Survival was slightly better for patients residing in less deprived areas but there 
was no clear trend for survival within deprivation quintiles over time.
Five-year relative survival, New Zealand, 1998–1999 to 2010–2011
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Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 10.3 8.3 8.9 11.4 11.8 15.3 14.7
Male 10.6 7.1 7.4 10.1 11.1 15.9 14.9
Female 9.4 11.7 12.7 14.2 13.0 12.9 14.1
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 5.6 3.8 5.5 16.8 14.8 14.4 9.8
Male 4.5 2.8 4.1 10.6 12.5 15.5 9.7
Female - 6.7 14.6 49.8 24.3 10.1 9.9
Non-Māori population, by sex
All 11.8 9.9 10.0 10.0 11.4 15.4 15.7
Male 13.3 8.6 8.9 9.7 11.4 16.1 16.0
Female 9.1 12.2 12.4 9.9 11.6 13.1 14.6
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 18.4 8.7 22.7 28.9 26.1 17.8 40.6
45–54 9.5 13.8 14.9 18.3 17.6 21.9 15.2
55–64 9.7 10.4 14.9 14.3 14.9 24.7 23.0
65–74 12.4 8.6 3.9 7.3 9.6 13.4 16.6
75+ 5.8 2.0 2.6 3.2 4.7 6.0 4.5
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 14.3 11.9 7.3 6.4 7.9 16.2 12.7
3 13.1 11.0 18.4 13.5 10.2 9.1 10.1
4 5.6 5.1 5.1 14.2 12.9 18.2 16.1
5 9.9 7.5 7.9 12.4 14.7 12.1 18.0
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  Five-year survival remained low between 1998 and 2011.
•  Both males and females had poor survival over time.
•  Survival for non-Māori improved slightly over time, but survival for Māori 
fluctuated over time.
•  Survival was better for younger people with liver cancer than for older people: 
survival was less than 6% for the 75+ years age group. 
•  There was a slight improvement in survival over time for people residing in 
deprivation quintiles 4 and 5.
Five-year relative survival, New Zealand, 1998–1999 to 2010–2011
Liver (C22)
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Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 10.1 10.3 9.0 9.0 9.8 9.4 11.0
Male 10.0 9.9 7.6 7.5 9.5 7.9 9.5
Female 10.2 10.7 11.1 11.1 10.3 11.2 12.7
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 6.6 6.6 7.1 5.9 6.9 5.9 6.5
Male 6.8 6.7 3.5 4.8 7.9 4.8 6.2
Female 6.3 6.6 11.7 7.0 6.5 7.0 6.7
Non-Māori population, by sex
All 10.7 11.0 9.3 9.5 10.4 10.2 11.9
Male 10.4 10.5 8.2 7.8 9.7 8.4 10.1
Female 11.2 11.9 11.0 12.2 11.2 12.5 14.2
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 24.1 26.8 20.8 21.4 27.5 28.0 27.4
45–54 16.1 10.8 16.2 15.4 13.0 14.8 16.7
55–64 12.6 12.6 14.6 12.1 11.0 12.1 14.4
65–74 9.1 11.3 8.8 7.9 11.9 10.8 11.9
75+ 6.7 6.5 3.7 5.7 5.3 4.2 6.0
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 11.0 13.2 10.0 12.3 12.5 12.0 13.0
3 11.0 12.1 9.5 5.9 10.2 9.2 10.1
4 9.2 8.4 7.8 9.7 8.5 8.6 10.5
5 8.4 7.5 8.1 7.7 8.0 7.7 9.7
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  Five-year survival was low between 1998 and 2011, ranging from 9.0% to 11.0%.
•  Survival for females was slightly better than for males, but both males and females 
had poor survival over time.
•  Survival for non-Māori was slightly better than for Māori over time.
•  Survival for young people (15−44 years) with lung cancer was 3.6–6.7 times the 
survival for older people (75+ years). 
•  Survival was generally better for patients residing in less deprived areas, but 
survival was low in all deprivation quintiles.
Five-year relative survival, New Zealand, 1998–1999 to 2010–2011
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Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 91.0 88.3 88.5 89.5 88.9 88.3 89.6
Male 88.0 84.7 85.6 86.3 85.7 83.7 86.9
Female 94.1 92.0 91.5 92.9 92.4 93.5 92.7
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 102.3 91.5 80.8 75.3 77.1 83.0 73.1
Male 93.1 82.1 53.7 41.4 72.1 83.7 61.0
Female 108.1 93.2 93.0 95.7 80.7 82.3 84.6
Non-Māori population, by sex
All 90.9 88.2 88.6 89.7 89.1 88.3 89.8
Male 88.0 84.6 85.8 86.7 85.9 83.7 87.2
Female 93.9 92.0 91.5 92.9 92.5 93.6 92.8
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 94.1 95.0 95.0 91.6 95.8 91.6 93.9
45–54 91.2 91.7 92.2 94.2 93.6 93.7 93.1
55–64 90.6 89.2 89.4 90.8 92.3 89.5 90.8
65–74 89.0 85.0 87.5 89.7 87.8 89.2 91.3
75+ 90.2 80.6 77.8 82.3 76.6 79.5 82.0
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 91.4 88.7 90.7 92.5 92.1 90.1 92.2
3 92.4 88.0 88.9 89.8 89.9 86.4 90.0
4 89.5 88.8 87.5 88.8 84.1 88.0 88.2
5 90.8 86.8 83.7 82.1 85.7 86.3 82.8
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  Five-year survival for melanoma was consistently high between 1998 and 2011.
•  Female survival was consistently better than male survival over time.
•  Māori survival generally declined between 1998 and 2011, although Māori 
numbers for melanoma are low compared to non-Māori. There was no real change in 
non-Māori survival. 
•  Survival was slightly better for younger people with melanoma than for older 
people, but without any clear trends within each age group over time.
•  Survival was generally better for patients residing in less deprived areas, but there 
was no clear trend for survival within deprivation quintiles over time.
Five-year relative survival, New Zealand, 1998–1999 to 2010–2011
Melanoma (C43)
0
10
20
30
40
50
60
70
80
90
100
1998–1999 2004–2005 2010–2011 
5-year relative survival (%) 
0
10
20
30
40
50
60
70
80
90
100
Māori Non–Māori 
5-year relative survival (%) 
0
10
20
30
40
50
60
70
80
90
100
Male Female
5-year relative survival (%) 
0
10
20
30
40
50
60
70
80
90
100
1−2 3 4 5
5-year relative survival (%) 
0
10
20
30
40
50
60
70
80
90
100
15–44 45–54 55–64 65–74 75+
5-year relative survival (%) 
Survival for total population
Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 27.8 32.9 35.8 38.1 37.5 45.3 45.2
Male 27.6 35.0 35.1 38.7 40.4 47.5 46.1
Female 27.7 31.0 36.9 37.5 34.1 42.4 44.2
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 20.5 23.5 44.0 41.9 22.3 58.4 38.6
Male 26.9 12.8 54.9 41.5 25.5 41.4 30.9
Female 20.7 44.4 30.9 40.8 14.6 65.6 43.2
Non-Māori population, by sex
All 28.6 33.8 35.1 37.7 38.7 44.3 46.0
Male 28.6 37.4 33.7 38.2 40.4 47.0 47.5
Female 28.5 30.1 37.2 37.3 36.6 40.6 44.0
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 50.8 58.3 72.2 77.8 75.4 68.2 89.6
45–54 49.7 61.9 67.6 67.8 55.6 66.7 70.3
55–64 39.7 45.7 40.5 51.3 56.6 61.5 55.3
65–74 22.3 32.3 34.0 33.9 37.2 45.3 54.1
75+ 18.6 19.4 21.6 19.2 17.4 22.7 18.8
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 25.3 34.4 36.3 41.3 40.5 38.6 50.6
3 27.7 34.9 35.8 31.2 43.2 55.5 39.2
4 31.1 31.7 31.3 38.1 29.7 43.9 38.5
5 22.7 26.0 37.4 36.7 34.4 47.8 47.9
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  Five-year survival improved between 1998 and 2011.
•  Survival for males was generally slightly better than female survival over time. 
Survival in both sexes showed a general upward trend.
•  Survival for non-Māori steadily increased over time. Māori survival was more 
variable.
•  Survival was better in 2010–11 compared to 1998–99 for all age groups and 
increased over time in patients aged 65−74 years. In other age groups there was no 
apparent trend in survival over time.
•  Survival improved for all deprivation quintiles in recent years.
Five-year relative survival, New Zealand, 1998–1999 to 2010–2011
Myeloma (C90)
0
10
20
30
40
50
60
70
80
90
100
1998–1999 2004–2005 2010–2011 
5-year relative survival (%) 
0
10
20
30
40
50
60
70
80
90
100
Māori Non–Māori 
5-year relative survival (%) 
0
10
20
30
40
50
60
70
80
90
100
Male Female
5-year relative survival (%) 
0
10
20
30
40
50
60
70
80
90
100
1−2 3 4 5
5-year relative survival (%) 
0
10
20
30
40
50
60
70
80
90
100
15–44 45–54 55–64 65–74 75+
5-year relative survival (%) 
Survival for total population
Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 49.2 54.9 55.5 57.8 58.8 64.2 67.8
Male 50.9 50.6 57.5 57.0 58.1 64.2 69.0
Female 47.2 60.0 53.4 58.5 59.2 64.3 66.4
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 58.5 45.0 46.3 45.1 52.7 51.6 61.3
Male 58.9 43.2 48.6 34.5 54.0 59.1 57.7
Female 58.7 45.3 43.7 55.4 53.6 43.7 65.5
Non-Māori population, by sex
All 48.7 55.6 56.2 58.6 59.2 65.1 68.2
Male 50.5 51.1 58.1 58.5 58.5 64.6 69.7
Female 46.7 60.9 54.3 58.5 59.6 65.6 66.4
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 67.0 70.8 75.4 74.9 78.6 81.7 88.8
45–54 65.8 74.7 68.2 73.1 72.4 77.7 84.9
55–64 52.0 66.9 62.6 65.1 66.9 75.4 76.9
65–74 43.2 50.1 50.5 57.5 59.0 62.0 70.2
75+ 33.8 34.2 39.6 37.9 34.5 43.1 42.5
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 42.9 61.1 57.4 59.4 62.5 67.0 70.0
3 55.6 51.2 58.2 63.7 64.2 63.0 70.9
4 56.5 49.9 51.7 54.8 52.7 64.9 64.2
5 43.5 51.6 54.6 52.2 53.2 58.4 62.6
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  Five-year survival improved steadily from 49.2% to 67.8% between 1998 and 2011.
•  Male and female survival were comparable. Survival improved over time for both 
sexes.
•  Māori survival was consistently lower than non-Māori survival, except during 
1998–99. Non-Māori survival increased steadily over time.
•  There was a general upward trend in survival over time in all age groups. Survival 
was better for younger people than for older people.
•  Survival generally improved for each deprivation quintile over time; little 
difference was apparent between deprivation quintiles.
Five-year relative survival, New Zealand, 1998–1999 to 2010–2011
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Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 14.0 10.0 13.3 10.4 10.4 11.2 11.1
Male 12.4 8.1 12.8 9.7 9.3 10.4 11.2
Female 17.1 13.7 14.2 11.4 12.3 12.5 10.7
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 11.5 0.6 11.6 3.7 4.0 5.0 5.4
Male 7.0 0.0 - - 2.9 4.3 7.6
Female - 7.4 25.9 7.9 7.7 6.0 0.3
Non-Māori population, by sex
All 14.2 11.0 13.7 11.0 10.7 11.9 11.6
Male 12.7 9.4 13.6 10.6 9.8 11.1 11.4
Female 17.0 13.9 13.7 12.0 12.2 13.2 11.4
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 39.6 34.6 43.3 2.5 5.5 37.3 21.0
45–54 25.1 18.8 19.1 12.0 22.5 35.0 25.2
55–64 22.9 14.7 28.6 14.2 17.5 16.8 13.7
65–74 9.6 10.6 11.6 16.8 11.7 12.1 14.7
75+ 11.1 5.3 6.2 2.9 4.1 3.4 4.5
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 17.3 9.8 16.9 9.3 7.5 10.2 12.9
3 14.5 7.5 10.2 7.1 8.6 10.1 10.1
4 7.7 9.0 14.4 11.2 15.2 9.2 9.3
5 16.3 11.6 9.6 11.1 10.8 9.7 11.7
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  There was no improvement in survival between 1998 and 2011.
•  Survival for females declined over time, but survival for both sexes was low 
between 1998 and 2011.
•  Māori survival was more varied than non-Māori survival.
•  Survival was better for younger people with oesophageal cancer than for older 
people, but without any clear trends within each age group over time.
•  No real differences in survival were seen between deprivation groups, and survival 
was variable across time in all quintiles.
Five-year relative survival, New Zealand, 1998–1999 to 2010–2011
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Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 43.3 45.7 49.4 41.0 34.9 37.0 38.8
Male - - - - - - -
Female 43.3 45.7 49.4 41.0 34.9 37.0 38.8
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 58.7 67.4 52.8 41.8 35.8 31.9 35.2
Male - - - - - - -
Female 58.7 67.4 52.8 41.8 35.8 31.9 35.2
Non-Māori population, by sex
All 41.8 43.4 49.0 40.6 34.7 37.6 39.1
Male - - - - - - -
Female 41.8 43.4 49.0 40.6 34.7 37.6 39.1
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 73.4 76.3 91.2 66.9 76.3 59.5 76.3
45–54 59.0 57.7 63.5 61.1 51.2 57.6 47.6
55–64 37.3 46.4 41.9 42.2 39.7 44.5 44.4
65–74 31.7 23.6 34.6 37.8 26.8 26.4 35.1
75+ 22.9 24.2 20.0 15.1 10.6 13.0 12.2
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 48.7 47.9 51.8 44.6 37.9 45.9 41.4
3 39.3 41.5 46.6 39.2 34.4 27.8 32.6
4 41.5 41.0 46.6 36.2 33.8 32.9 34.2
5 40.8 50.3 50.1 41.6 27.5 33.7 44.1
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  From 2003 a coding change resulted in ovarian cancers of borderline malignancy 
being excluded from registration. 
•  Survival fluctuated between 2004 and 2011.
•  Non-Māori and Māori women had similar survival between 2004 and 2011. There 
was no clear trend in survival in either ethnic group.
•  Survival was better for younger women with ovarian cancer than for older women, 
but without any clear trends within each age group over time.
•  There was little difference in survival between deprivation quintiles and no 
apparent trend in survival over time.
Five-year relative survival, New Zealand, 1998–1999 to 2010–2011
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Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 5.0 5.0 5.2 3.8 4.4 5.2 4.6
Male 5.8 6.0 5.8 3.1 4.7 5.0 5.2
Female 4.2 4.2 4.5 4.1 4.1 5.5 4.0
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 6.5 9.9 9.5 2.5 7.0 7.5 3.2
Male 12.2 11.8 11.9 2.5 12.4 5.5 4.1
Female 3.3 8.1 7.3 2.3 3.9 10.1 2.1
Non-Māori population, by sex
All 4.8 4.4 4.8 3.8 4.3 4.9 4.7
Male 5.3 5.1 5.4 3.2 4.2 4.7 5.1
Female 4.3 3.8 4.1 4.1 4.3 5.1 4.3
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 35.4 16.8 13.5 20.3 11.7 22.8 16.8
45–54 13.2 14.1 8.6 6.9 5.7 6.3 18.7
55–64 8.9 7.8 6.3 5.8 7.0 14.9 4.9
65–74 2.5 4.0 7.0 4.9 5.2 4.5 5.2
75+ 2.6 2.7 3.2 1.0 2.6 1.5 1.8
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 4.6 6.5 8.0 3.6 6.1 6.9 5.7
3 7.5 4.0 2.2 3.0 2.6 2.5 3.5
4 5.6 2.2 3.8 4.5 4.2 4.2 5.1
5 1.9 7.4 5.8 2.7 3.6 6.6 2.5
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  Five-year survival for pancreatic cancer did not improve between 1998 and 2011.
•  Male and female survival were comparable and did not improve over time.
•  Non-Māori survival was low and did not change over time. Māori survival was 
more variable but remained low.
•  There was no apparent trend in survival by age group over time.
•  There was no apparent trend in survival by deprivation quintile over time.
Five-year relative survival, New Zealand, 1998–1999 to 2010–2011
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Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 81.9 83.8 85.0 89.1 88.9 88.7 91.1
Male 81.9 83.8 85.0 89.1 88.9 88.7 91.1
Female - - - - - - -
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 80.0 72.9 82.5 82.2 81.6 73.5 85.3
Male 80.0 72.9 82.5 82.2 81.6 73.5 85.3
Female - - - - - - -
Non-Māori population, by sex
All 81.9 84.3 85.1 89.5 89.3 89.5 91.4
Male 81.9 84.3 85.1 89.5 89.3 89.5 91.4
Female - - - - - - -
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 64.9 92.4 91.9 95.5 101.0 101.0 96.1
45–54 88.3 84.1 95.1 97.4 96.1 94.2 98.2
55–64 88.9 91.1 93.3 94.7 94.2 95.1 96.2
65–74 85.6 88.5 90.7 93.8 93.4 91.6 96.1
75+ 73.1 72.5 69.2 74.7 74.9 74.2 73.2
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 84.6 88.0 88.6 92.6 92.7 93.1 94.9
3 87.0 82.6 86.6 90.6 90.6 87.6 91.1
4 78.2 82.9 81.8 85.8 84.7 86.2 86.3
5 73.0 77.5 79.0 83.7 83.8 83.3 88.0
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  Five-year survival for prostate cancer improved between 1998 and 2011.
•  Survival in the 2010–11 period was the highest since 1998–99.
•  Māori men had lower and more varied survival than non-Māori men over time.
•  There was an increased trend in survival for men aged 55−74 years over time. 
Survival continued to be substantially lower for men aged 75+ years.
•  Survival was generally better for patients residing in less deprived areas. There 
was an upward trend in survival over time in most deprivation quintiles.
Five-year relative survival, New Zealand, 1998–1999 to 2010–2011
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Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 19.2 19.2 20.0 22.8 21.7 25.1 24.6
Male 19.7 19.3 18.5 23.0 22.4 25.3 24.0
Female 18.2 18.6 22.6 22.6 20.7 24.6 25.6
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 14.9 18.4 28.3 23.3 19.2 21.2 32.1
Male 14.4 19.2 22.7 20.2 17.4 22.7 29.8
Female 15.8 16.9 38.4 26.8 20.7 19.6 34.1
Non-Māori population, by sex
All 20.0 19.2 19.0 22.6 22.3 26.0 22.9
Male 20.7 19.2 18.0 23.5 23.3 25.8 22.8
Female 18.6 18.9 20.5 21.5 20.7 26.2 23.0
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 23.4 27.0 30.5 37.5 27.5 37.6 29.4
45–54 22.2 28.0 33.0 32.3 25.5 34.6 32.9
55–64 22.9 19.6 24.1 17.9 23.7 29.2 29.5
65–74 23.5 24.5 23.5 27.1 21.4 24.6 23.8
75+ 12.0 11.5 11.1 17.1 17.9 17.9 19.1
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 20.6 18.0 18.9 29.1 26.7 25.6 27.6
3 17.1 22.3 23.0 22.1 17.6 27.4 17.6
4 15.5 13.9 18.6 18.1 23.8 25.0 20.9
5 19.2 22.1 20.5 19.7 17.6 21.3 28.3
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  Five-year survival improved for stomach cancer slightly between 1998 and 2011.
•  Survival for males and females was comparable over time. There was a general 
upward trend in survival for women.
•  There was no apparent trend in survival by ethnic group. Survival for non-Māori 
changed little over time.
•  Survival was better for younger people with stomach cancer than for older people, 
but without any clear trends within each age group over time.
•  Survival varied over time within deprivation quintiles. There was no clear trend for 
survival within deprivation quintiles over time.
Five-year relative survival, New Zealand, 1998–1999 to 2010–2011
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Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 95.6 92.9 94.7 96.2 97.2 96.1 96.1
Male 95.6 92.9 94.7 96.2 97.2 96.1 96.1
Female - - - - - - -
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 87.3 89.2 89.8 89.1 94.1 94.9 94.0
Male 87.3 89.2 89.8 89.1 94.1 94.9 94.0
Female - - - - - - -
Non-Māori population, by sex
All 97.7 94.1 95.9 97.9 98.1 96.3 96.7
Male 97.7 94.1 95.9 97.9 98.1 96.3 96.7
Female - - - - - - -
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 96.3 93.5 95.6 95.8 96.8 97.5 97.6
45–54 87.4 91.8 93.5 99.6 99.4 95.7 95.5
55–64 99.8 93.7 97.9 93.1 96.2 93.4 85.8
65–74 118.0 76.7 53.2 95.2 101.2 99.1 92.0
75+ 73.3 3.0 0.0 - - - 5.7
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 98.6 97.7 96.5 98.0 98.1 96.4 99.5
3 94.4 88.7 94.2 96.6 98.8 93.0 96.1
4 93.5 89.9 95.9 90.8 95.6 99.8 95.4
5 93.9 92.5 90.5 98.5 96.1 94.8 92.3
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  Five-year survival for testicular cancer remained high between 1998 and 2011. 
Testicular cancer had the highest five-year survival of all cancers analysed.
•  Survival for non-Māori men was slightly better than for Māori survival over time. 
Since 2006 survival for Māori has increased, lessening the gap between the two 
groups.
•  Low numbers of patients aged above 55 years prohibits meaningful comparison 
over time and between age groups.
•  Survival was slightly better for patients residing in less deprived areas but there 
was no clear trend for survival within deprivation quintiles over time.
Five-year relative survival, New Zealand, 1998–1999 to 2010–2011
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Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 89.3 93.5 91.9 88.1 91.6 92.0 92.1
Male 83.4 90.6 85.1 83.4 90.4 85.7 89.2
Female 91.5 94.5 93.9 89.9 92.2 94.0 93.1
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 88.1 96.2 90.7 78.4 90.5 93.9 92.3
Male 34.6 93.9 73.2 63.8 85.5 89.7 85.8
Female 93.9 97.6 96.4 83.6 92.2 95.4 94.2
Non-Māori population, by sex
All 89.4 93.1 92.0 89.8 91.7 91.7 92.0
Male 84.7 90.7 87.2 87.1 91.1 85.2 89.7
Female 90.9 93.9 93.5 90.9 92.1 93.7 92.7
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 97.4 98.1 98.7 99.8 99.0 98.2 98.2
45–54 94.6 96.7 98.8 89.9 95.6 101.5 93.7
55–64 75.2 85.8 95.5 77.2 98.9 86.8 90.3
65–74 89.9 92.6 67.1 73.3 79.8 73.7 84.9
75+ 53.3 75.3 72.3 75.3 52.8 63.6 69.3
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 88.7 96.7 95.1 91.6 94.6 94.7 94.5
3 89.5 89.2 90.8 85.2 89.5 89.4 89.8
4 84.7 86.3 85.8 85.7 85.3 93.9 94.8
5 93.1 97.4 94.0 87.4 93.8 89.3 87.7
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  Five-year survival for thyroid cancer ranged from 88.1% to 93.5% between 1998 
and 2011.
•  Survival for females was better than for males over time.
•  Survival for non-Māori was relatively constant over time. Survival for Māori was 
more varied.
•  Survival was better for younger people with thyroid cancer than for older people, 
but without any clear trends within each age group over time.
•  There was no clear trend in survival by deprivation quintile over time. Survival was 
similar across deprivation quintiles.
Five-year relative survival, New Zealand, 1998–1999 to 2010–2011
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Survival, by sex
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by sex
All 73.3 72.6 75.1 79.0 75.0 79.2 78.4
Male - - - - - - -
Female 73.3 72.6 75.1 79.0 75.0 79.2 78.4
Survival, by ethnic group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Māori population, by sex
All 65.0 63.2 71.1 67.5 76.6 72.1 69.7
Male - - - - - - -
Female 65.0 63.2 71.1 67.5 76.6 72.1 69.7
Non-Māori population, by sex
All 74.1 73.7 75.7 80.7 74.8 79.9 79.9
Male - - - - - - -
Female 74.1 73.7 75.7 80.7 74.8 79.9 79.9
Survival, by age group
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by age group (years)
15–44 92.4 85.2 85.5 87.2 87.9 78.4 93.3
45–54 79.4 84.3 81.1 85.0 80.7 89.2 87.6
55–64 79.3 73.9 82.1 83.0 86.7 85.6 83.1
65–74 66.5 74.3 75.6 77.8 65.3 75.6 72.8
75+ 64.4 54.0 53.0 64.2 61.7 61.7 59.6
Survival, by deprivation quintile
1998–99 2000–01 2002–03 2004–05 2006–07 2008–09 2010–11
Total population, by deprivation quintile
1−2 83.7 73.7 83.7 80.0 77.3 81.2 80.2
3 71.7 75.7 74.5 83.4 76.2 79.6 85.1
4 71.2 72.3 66.2 79.2 72.3 83.5 70.1
5 64.1 68.4 71.8 74.0 73.8 73.0 79.3
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: New Zealand Cancer Registry 
New Zealand Mortality Collection
Note: The bars represent two-year periods. The lightest bar (left) is 1998–1999 and the darkest bar (right) is 2010–2011.
Key facts
•  Five-year survival for uterine cancer generally improved between 1998 and 2011.
•  Survival for non-Māori women was better than for Māori women over time, except 
for the 2006–07 period.
•  Survival was better for younger women with uterine cancer than for older women, 
but without any clear trends within each age group over time.
•  Survival was generally better for women residing in less deprived areas. Survival 
improved over time for women residing in deprivation quintile 5.
Five-year relative survival, New Zealand, 1998–1999 to 2010–2011
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Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 75.8 69.2 65.6 63.1 61.4 60.0 59.0 58.1 57.4 56.9
Male 74.7 67.8 64.3 62.0 60.2 58.8 57.7 56.9 56.3 55.7
Female 77.1 70.6 66.9 64.4 62.6 61.4 60.4 59.5 58.7 58.1
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 65.8 57.2 52.7 50.1 47.9 46.4 45.3 44.1 43.4 42.7
Male 59.6 50.5 46.1 43.6 41.9 40.4 39.6 38.7 38.4 37.9
Female 70.7 62.4 57.9 55.1 52.7 51.0 49.7 48.3 47.4 46.5
Non-Māori population, by sex
All 76.7 70.2 66.7 64.3 62.5 61.2 60.2 59.3 58.7 58.1
Male 75.7 69.1 65.6 63.3 61.5 60.1 59.1 58.2 57.6 57.0
Female 77.8 71.5 67.8 65.4 63.6 62.4 61.4 60.6 59.8 59.3
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 96.1 93.9 92.3 91.0 90.0 89.1 88.4 87.8 87.3 87.0
Regional 87.2 78.3 72.6 68.2 65.2 63.0 61.4 59.9 58.7 57.6
Distant 28.0 18.1 14.1 12.3 11.1 10.5 10.2 10.1 9.9 9.9
Not stated 74.6 66.7 62.4 59.7 57.5 55.9 54.5 53.3 52.5 51.6
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 79.7 73.8 70.6 68.4 66.7 65.5 64.7 64.1 63.4 63.0
3 76.2 69.5 65.8 63.4 61.6 60.3 59.2 58.1 57.5 56.9
4 73.7 66.6 62.7 60.2 58.3 57.0 55.7 54.6 53.9 53.2
5 71.0 63.6 59.4 56.8 54.7 53.2 52.1 51.1 50.4 49.7
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
All adult cancers (C00–C96, D45–D47)
New Zealand Cancer Registry 
New Zealand Mortality Collection
Key facts
•  Five-year and 10-year cumulative relative survival (CRS) for adults with 
cancer was 61.4% and 56.9%, respectively.
•  Male adults had slightly lower CRS than female adults.
•  Māori adults had lower CRS than non-Māori adults.
•  Patients with regional or distant spread of disease had lower CRS than 
those with localised spread.
•  CRS was better for patients residing in less deprived areas.
Cumulative relative survival, New Zealand, 1994–2011
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Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 80.0 71.8 67.7 65.0 62.9 61.4 60.1 59.1 58.4 58.2
Male 82.4 74.3 70.2 67.3 65.0 63.5 62.2 60.7 59.9 59.5
Female 73.3 64.9 60.9 58.9 57.2 55.6 54.5 54.8 54.4 54.6
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 72.7 63.8 61.4 58.7 56.4 57.0 56.4 55.8 53.2 54.1
Male 78.2 68.7 65.5 63.3 60.4 60.4 61.1 60.5 56.2 57.9
Female 62.6 54.7 53.7 50.1 49.2 50.9 47.3 46.8 48.2 47.5
Non-Māori population, by sex
All 80.3 72.1 67.9 65.3 63.2 61.6 60.3 59.3 58.7 58.4
Male 82.6 74.5 70.3 67.5 65.2 63.7 62.2 60.7 60.0 59.6
Female 73.9 65.5 61.3 59.3 57.6 55.9 54.9 55.2 54.8 55.0
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 92.3 85.9 81.7 79.8 78.6 77.4 76.7 75.0 73.0 73.9
Regional 66.7 48.3 40.9 36.2 35.1 32.2 31.7 28.1 28.4 28.0
Distant 17.8 7.5 6.3 5.9 4.9 4.4 3.5 3.3 3.4 3.6
Not stated 84.5 77.2 73.3 70.5 68.1 66.5 65.0 64.3 63.7 63.3
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 82.1 74.2 70.0 67.9 65.7 64.2 62.5 61.8 61.5 61.5
3 81.3 73.0 70.1 67.0 65.1 63.7 62.5 61.3 60.6 60.7
4 78.1 69.4 65.0 62.2 60.1 58.5 57.5 56.4 55.9 55.4
5 76.5 68.1 63.2 60.2 57.8 55.8 54.6 53.4 51.7 51.0
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Bladder (C67)
New Zealand Cancer Registry 
New Zealand Mortality Collection
Key facts
•  Five-year and 10-year cumulative relative survival (CRS) for bladder 
cancer patients was 62.9% and 58.2%, respectively.
•  Males had higher CRS than females.
•  Māori had lower CRS than non-Māori.
•  Extent of disease information was not stated for three-quarters of 
patients. Where this information was provided, patients with regional or 
distant spread of disease had lower CRS than those with localised spread.
•  Survival was better for patients residing in less deprived areas.
Cumulative relative survival, New Zealand, 1994–2011
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Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 39.6 26.3 22.6 20.4 18.9 17.6 16.5 16.0 15.4 14.8
Male 40.5 26.0 22.3 19.9 18.3 16.9 15.7 15.5 15.0 14.5
Female 38.4 26.7 23.0 21.2 19.7 18.6 17.6 16.7 16.1 15.3
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 41.8 27.1 22.4 21.3 21.0 19.4 18.5 17.1 15.0 13.9
Male 41.4 27.0 21.1 19.8 19.2 16.3 15.5 14.8 13.9 13.0
Female 42.5 27.3 24.0 23.2 23.3 23.4 22.4 20.1 16.1 14.7
Non-Māori population, by sex
All 39.5 26.3 22.6 20.3 18.7 17.5 16.3 15.9 15.5 14.9
Male 40.5 26.0 22.4 19.9 18.2 16.9 15.8 15.5 15.0 14.6
Female 38.1 26.7 22.9 21.0 19.4 18.2 17.2 16.4 16.1 15.4
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 40.6 26.7 22.8 20.5 19.0 17.6 16.5 15.9 15.2 14.6
Regional 18.4 9.2 9.2 9.2 9.2 9.2 9.2 9.2 9.2 9.3
Distant 27.1 21.1 15.1 12.1 9.1 6.1 6.1 6.2 6.3 6.4
Not stated 30.7 23.1 21.5 20.5 19.5 18.5 18.2 18.3 18.8 18.5
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 42.9 27.4 22.4 20.4 19.0 18.1 17.2 17.0 16.5 15.7
3 35.5 23.3 19.2 18.1 17.1 15.9 14.6 14.0 13.9 13.1
4 37.8 24.6 21.9 19.4 17.3 16.1 15.5 15.2 14.2 13.9
5 39.1 28.6 26.2 23.0 21.3 19.3 17.3 16.1 15.3 14.9
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Brain (C71)
New Zealand Cancer Registry 
New Zealand Mortality Collection
Key facts
•  Five-year and 10-year cumulative relative survival (CRS) for patients 
with brain cancer were low: 18.9% and 14.8%, respectively.
•  CRS for males and females was similar.
•  Māori and non-Māori CRS were comparable. Non-Māori women had 
slightly lower CRS than Māori women up to eight years after diagnosis, 
although Māori patient numbers were low and so comparison should be 
treated with caution.
•  Low numbers of patients with metastatic disease resulted in variable 
CRS for patients with regional and distant extent of disease.
•  There was no apparent trend in CRS by deprivation quintile over time.
Cumulative relative survival, New Zealand, 1994–2011
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Survival (%) 
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Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 96.1 92.5 89.1 86.4 84.0 82.3 81.0 79.6 78.2 77.0
Male - - - - - - - - - -
Female 96.1 92.5 89.1 86.4 84.0 82.3 81.0 79.6 78.2 77.0
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 95.3 90.8 86.5 83.0 79.4 76.7 74.4 71.5 69.6 67.2
Male - - - - - - - - - -
Female 95.3 90.8 86.5 83.0 79.4 76.7 74.4 71.5 69.6 67.2
Non-Māori population, by sex
All 96.2 92.6 89.4 86.8 84.5 83.0 81.7 80.5 79.2 78.1
Male - - - - - - - - - -
Female 96.2 92.6 89.4 86.8 84.5 83.0 81.7 80.5 79.2 78.1
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 100.3 99.6 98.5 97.6 96.8 96.1 95.7 94.9 94.0 93.5
Regional 97.7 92.3 87.6 83.3 79.2 76.4 73.8 71.6 69.5 67.4
Distant 51.8 37.1 27.2 21.2 17.6 15.7 14.8 14.1 12.8 13.0
Not stated 92.2 85.6 79.9 75.7 72.3 70.5 68.7 67.6 66.3 65.0
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 96.9 93.8 91.2 88.5 86.4 84.9 84.0 82.9 81.6 80.8
3 96.2 92.3 89.1 86.0 83.6 81.8 80.3 78.5 77.2 76.0
4 95.7 91.9 88.1 85.5 82.7 81.2 79.5 78.1 76.8 75.6
5 95.3 90.8 86.4 83.6 81.0 79.2 77.5 76.0 74.2 72.5
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Breast – female (C50)
New Zealand Cancer Registry 
New Zealand Mortality Collection
Key facts
•  Five-year and 10-year cumulative relative survival (CRS) for women with 
breast cancer were 84.0% and 77.0%, respectively.
•  Māori women had lower CRS than non-Māori women. This disparity 
increased over time after diagnosis.
•  Patients with regional or distant spread of disease had substantially 
lower CRS than those with localised spread.
•  Survival was slightly better for women residing in less deprived areas.
Cumulative relative survival, New Zealand, 1994–2011
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Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 87.4 79.6 76.0 73.3 71.8 70.9 70.0 69.5 68.6 68.3
Male - - - - - - - - - -
Female 87.4 79.6 76.0 73.3 71.8 70.9 70.0 69.5 68.6 68.3
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 83.9 75.0 71.2 68.0 65.5 64.5 63.1 62.7 62.8 63.3
Male - - - - - - - - - -
Female 83.9 75.0 71.2 68.0 65.5 64.5 63.1 62.7 62.8 63.3
Non-Māori population, by sex
All 88.3 80.7 77.2 74.7 73.3 72.5 71.7 71.2 70.1 69.6
Male - - - - - - - - - -
Female 88.3 80.7 77.2 74.7 73.3 72.5 71.7 71.2 70.1 69.6
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 100.0 99.4 98.8 98.5 98.3 97.8 97.3 97.2 97.1 97.2
Regional 90.4 81.0 76.6 69.8 67.6 65.4 63.7 62.3 60.4 59.2
Distant 35.8 22.2 17.5 15.2 13.0 11.5 11.6 10.9 11.0 11.1
Not stated 83.0 67.8 61.0 56.5 53.5 52.6 51.0 50.2 48.3 47.6
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 90.5 84.3 81.8 80.5 78.7 78.2 77.1 76.7 75.7 75.5
3 87.5 78.2 75.4 72.7 71.4 70.7 69.7 68.9 68.3 68.3
4 87.0 78.3 73.7 70.8 69.8 69.1 68.6 68.2 67.2 66.5
5 84.6 76.6 72.2 68.2 66.2 64.7 63.5 63.1 62.4 62.3
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Cervix (C53)
New Zealand Cancer Registry 
New Zealand Mortality Collection
Key facts
•  Five-year and 10-year cumulative relative survival (CRS) for women with 
cervical cancer were 71.8% and 68.3%, respectively.
•  Māori women had lower CRS than non-Māori women.
•  Patients with distant spread of disease had substantially lower CRS than 
those with localised or regional spread.
•  Survival was better for patients residing in less deprived areas.
•  Cervical screening may affect survival. Screening finds cervical tumours 
at the pre-cancerous stage (not included in this data), potentially resulting 
in a larger proportion of registered cervical cancers at an aggressive or 
advanced stage, increasing the likelihood of death.
Cumulative relative survival, New Zealand, 1994–2011
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Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 89.4 84.1 80.8 79.4 78.4 77.6 77.2 76.6 76.6 76.6
Male 89.5 84.0 81.1 80.0 79.2 78.2 77.7 77.1 77.0 76.9
Female 89.3 84.2 80.6 78.6 77.4 76.9 76.5 76.1 76.1 76.2
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 85.7 79.5 75.4 73.7 73.1 72.3 72.1 70.9 70.9 71.0
Male 86.1 77.9 74.6 73.5 73.5 72.1 71.7 70.0 70.1 70.1
Female 85.3 81.4 76.4 74.0 72.6 72.6 72.6 72.0 72.0 72.0
Non-Māori population, by sex
All 90.4 85.4 82.3 81.0 79.9 79.1 78.6 78.2 78.2 78.1
Male 90.5 85.7 82.8 81.9 80.8 79.9 79.4 79.0 78.9 78.8
Female 90.4 84.9 81.7 79.9 78.8 78.1 77.6 77.3 77.3 77.3
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 87.1 82.1 78.9 78.1 77.6 76.5 75.9 75.5 75.5 75.6
Regional 91.8 85.0 80.3 78.6 77.7 77.7 77.8 77.8 77.8 77.9
Distant 72.1 59.6 53.4 50.1 48.3 47.1 47.1 47.1 47.1 47.1
Not stated 92.7 88.4 85.7 84.2 83.1 82.5 82.0 81.2 81.2 81.0
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 91.7 86.7 83.2 81.9 81.4 80.6 80.1 79.9 79.9 79.9
3 90.3 83.9 81.9 80.5 79.5 78.7 78.2 77.2 77.2 76.9
4 87.8 83.0 79.7 77.5 75.5 74.4 74.2 73.9 73.9 74.0
5 87.2 81.6 77.8 76.6 75.8 75.3 75.1 74.1 73.9 73.9
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Childhood cancers (C00–C96, D45–D47, ages 0–14)
New Zealand Cancer Registry 
New Zealand Mortality Collection
Key facts
•  Five-year and 10-year cumulative relative survival (CRS) for children 
with cancer were 78.4% and 76.6%, respectively.
•  Male and female children had similar CRS.
•  Māori children had lower CRS than non-Māori children.
•  Children with distant spread of cancer had lower CRS than those with 
localised or regional spread.
•  Survival was slightly better for children residing in less deprived areas.
Cumulative relative survival, New Zealand, 1994–2011
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Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 79.0 70.7 65.8 62.5 60.4 59.1 58.1 57.3 56.8 56.4
Male 79.3 70.9 65.6 61.8 59.4 57.8 56.8 56.0 55.4 55.1
Female 78.7 70.5 65.9 63.2 61.4 60.3 59.5 58.6 58.1 57.7
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 73.7 64.0 55.8 51.8 48.6 47.5 46.3 45.9 45.5 45.7
Male 71.1 60.8 52.6 48.1 44.7 43.0 41.4 41.3 41.6 42.0
Female 76.7 67.8 59.4 56.0 53.2 52.8 51.9 51.3 50.0 49.9
Non-Māori population, by sex
All 79.2 71.0 66.2 63.0 60.9 59.6 58.7 57.8 57.3 56.9
Male 79.7 71.3 66.2 62.5 60.1 58.4 57.5 56.7 56.1 55.8
Female 78.8 70.6 66.2 63.5 61.7 60.7 59.8 58.9 58.4 58.1
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 96.7 95.4 93.8 92.4 91.1 90.3 89.4 88.4 87.8 87.3
Regional 88.8 80.2 73.8 69.2 66.3 64.2 63.0 61.9 61.1 60.5
Distant 37.2 21.0 15.0 12.5 11.1 10.3 10.0 9.9 9.8 9.9
Not stated 70.3 59.8 53.7 50.0 47.7 46.6 45.8 45.3 45.1 45.1
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 81.3 73.6 68.9 66.2 64.4 62.9 62.2 61.7 61.1 61.0
3 79.1 70.9 66.0 62.7 60.4 59.4 58.3 57.3 56.8 56.6
4 77.6 69.1 63.9 60.2 58.0 56.4 55.3 54.2 53.9 53.3
5 75.9 66.6 61.3 57.5 55.1 53.8 52.9 52.1 51.3 50.6
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Colorectum and anus (C18–C21)
New Zealand Cancer Registry 
New Zealand Mortality Collection
Key facts
•  Five-year and 10-year cumulative relative survival (CRS) for adults with 
colorectal cancer were 60.4% and 56.4%, respectively.
•  Female and male CRS were comparable until four years after diagnosis, 
after which females had slightly higher CRS than males. 
•  Māori had lower CRS than non-Māori.
•  Patients with regional or distant spread of disease had substantially 
lower CRS than those with localised spread.
•  Survival was better for patients residing in less deprived areas.
Cumulative relative survival, New Zealand, 1994–2011
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Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 82.8 73.5 69.2 66.2 63.9 61.8 60.5 58.6 57.0 55.6
Male 82.8 72.8 68.3 65.0 62.7 60.4 59.1 57.3 55.5 54.1
Female 82.7 75.2 71.4 69.1 66.8 65.2 63.6 61.7 60.7 59.2
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 81.6 69.5 63.9 59.7 55.9 54.4 51.6 48.9 45.6 45.5
Male 79.0 64.7 59.2 54.2 50.6 48.5 45.5 44.0 40.0 40.6
Female 88.5 82.2 76.2 73.9 69.5 69.8 67.9 61.9 60.3 58.3
Non-Māori population, by sex
All 82.9 73.9 69.7 66.8 64.7 62.5 61.3 59.5 58.1 56.6
Male 83.1 73.6 69.2 66.1 63.9 61.5 60.4 58.6 57.0 55.4
Female 82.2 74.7 71.0 68.7 66.6 64.8 63.3 61.7 60.7 59.2
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 96.6 91.4 88.4 86.8 84.7 83.2 82.4 79.6 78.1 77.4
Regional 80.6 68.0 61.8 57.6 54.8 52.9 51.2 50.2 48.4 47.1
Distant 57.4 45.7 41.6 38.7 36.4 35.6 35.0 34.8 32.5 32.1
Not stated 79.8 70.8 67.0 63.9 61.8 59.1 57.5 55.5 54.1 52.0
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 85.2 77.8 73.8 70.8 67.6 66.0 65.6 64.3 62.5 61.8
3 80.7 72.4 67.7 65.2 63.4 61.6 60.1 57.6 55.3 53.5
4 82.2 70.9 66.4 63.9 62.8 60.8 58.6 56.8 56.4 54.3
5 81.6 71.3 67.1 63.2 60.3 57.0 55.4 53.4 51.9 50.6
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Head, neck and larynx (C00–C14, C32)
New Zealand Cancer Registry 
New Zealand Mortality Collection
Key facts
•  Five-year and 10-year cumulative relative survival (CRS) for patients 
with cancers of the head, neck and larynx were 63.9% and 55.6%, 
respectively.
•  Males had lower CRS than females.
•  Māori patients had lower CRS than non-Māori patients.
•  Patients with regional or distant spread of disease had lower CRS than 
those with localised spread.
•  Survival was better for patients residing in less deprived areas.
Cumulative relative survival, New Zealand, 1994–2011
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Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 91.7 88.4 86.4 84.1 82.7 81.5 80.4 78.9 78.0 76.9
Male 91.6 89.0 87.0 84.9 83.0 81.7 80.1 78.0 76.6 75.0
Female 91.8 87.7 85.7 82.9 82.2 81.2 80.8 80.0 79.8 79.3
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 95.7 91.3 89.1 86.6 85.0 80.8 80.0 77.7 78.2 76.7
Male 95.5 92.7 89.7 86.5 82.8 76.6 74.6 69.5 70.0 66.8
Female 95.9 90.0 88.5 86.9 87.2 85.3 85.7 86.1 86.6 87.0
Non-Māori population, by sex
All 91.3 88.2 86.2 83.8 82.5 81.5 80.4 79.0 78.0 76.9
Male 91.2 88.7 86.8 84.8 83.0 82.1 80.5 78.7 77.1 75.7
Female 91.4 87.5 85.3 82.5 81.7 80.7 80.2 79.4 79.1 78.4
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised - - - - - - - - - -
Regional - - - - - - - - - -
Distant - - - - - - - - - -
Not stated 91.7 88.4 86.4 84.1 82.7 81.5 80.4 78.9 78.0 76.9
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 92.8 89.4 88.1 87.0 85.8 85.2 84.3 82.5 81.9 80.5
3 90.7 86.5 83.8 80.1 77.6 76.2 75.0 73.6 73.3 73.0
4 91.3 89.3 87.6 85.0 85.2 83.3 82.3 80.5 79.1 77.4
5 90.7 87.3 84.8 81.7 79.6 78.0 76.8 75.9 74.1 73.2
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Hodgkin lymphoma (C81)
New Zealand Cancer Registry 
New Zealand Mortality Collection
Key facts
•  Five-year and 10-year cumulative relative survival (CRS) for adults with 
cancer were 82.7% and 76.9%, respectively.
•  Males had slightly lower CRS than females in later years of follow-up.
•  Māori had similar CRS to non-Māori.
•  Extent of disease information is not available for Hodgkin lymphoma 
patients.
•  Over time CRS was better for patients residing in less deprived areas. 
Cumulative relative survival, New Zealand, 1994–2011
Years since diagnosis
Years since diagnosis
Years since diagnosis
Years since diagnosis
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5 6 7 8 9 10
Years since diagnosis 
Male
Female
Survival (%) 
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5 6 7 8 9 10
Years since diagnosis 
Māori
Non-Māori
Survival (%) 
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5 6 7 8 9 10
Years since diagnosis 
Localised
Regional
Distant
Survival (%) 
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5 6 7 8 9 10
Years since diagnosis 
1−2  
3
4
5
Survival (%) 
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5 6 7 8 9 10
Years since diagnosis 
Survival (%) 
Survival for total population
Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 74.1 67.0 63.6 61.1 58.8 57.2 56.1 54.9 53.9 53.0
Male 74.3 66.9 63.6 60.9 58.9 57.2 56.1 54.7 53.8 52.9
Female 73.6 67.1 63.8 61.4 58.7 57.2 56.1 55.2 54.0 53.3
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 70.6 62.8 58.4 53.7 51.3 48.9 48.6 46.6 45.6 45.8
Male 69.5 61.2 57.0 51.8 50.8 48.7 49.7 45.8 44.9 44.6
Female 72.8 65.8 60.9 57.0 52.2 49.4 46.8 47.8 46.6 47.8
Non-Māori population, by sex
All 74.4 67.3 64.1 61.7 59.5 57.9 56.7 55.6 54.6 53.7
Male 74.7 67.4 64.1 61.7 59.6 58.0 56.7 55.5 54.6 53.6
Female 73.7 67.2 64.0 61.8 59.3 57.8 56.8 55.8 54.6 53.7
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 97.7 94.7 92.5 90.6 88.7 86.6 86.3 85.0 83.7 82.7
Regional 85.2 74.5 69.0 64.3 62.1 59.4 56.1 54.6 53.2 51.1
Distant 24.8 13.9 11.0 9.2 7.5 7.4 7.1 7.0 6.6 6.8
Not stated 67.7 58.9 54.2 50.7 46.5 44.8 41.8 39.5 38.6 37.9
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 76.6 69.4 66.5 64.6 63.0 61.3 60.3 59.6 59.1 57.9
3 74.2 66.6 63.5 60.9 58.4 56.9 55.9 54.2 52.4 52.1
4 72.6 65.8 61.7 59.5 57.3 55.2 53.9 52.1 51.4 49.8
5 71.0 64.4 60.7 56.5 53.4 52.2 50.8 50.0 48.4 48.2
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Kidney (C64–C66, C68)
New Zealand Cancer Registry 
New Zealand Mortality Collection
Key facts
•  Five-year and 10-year cumulative relative survival (CRS) for patients 
with kidney, ureter and urethral cancer were 58.8% and 53.0%, 
respectively.
•  Male and female CRS were almost identical.
•  Māori had lower CRS than non-Māori. 
•  Patients with distant spread of disease had substantially lower CRS than 
those with localised or regional spread.
•  Survival was better for patients residing in less deprived areas. The 
difference between CRS for patients in the least and most deprived 
quintiles increased in later years of follow-up.
Cumulative relative survival, New Zealand, 1994–2011
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Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 68.7 62.0 57.5 54.0 51.4 49.2 47.4 45.8 44.5 43.3
Male 69.6 62.7 58.0 54.3 51.2 48.8 47.2 45.6 44.3 42.9
Female 67.5 61.0 56.9 53.6 51.5 49.8 47.8 46.1 44.7 43.9
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 68.9 60.4 55.0 50.9 47.5 46.2 45.1 43.6 42.7 43.6
Male 69.2 60.6 55.4 50.3 46.4 46.0 46.0 44.3 43.2 44.1
Female 68.5 60.1 54.6 51.8 48.9 46.5 44.2 42.8 42.2 43.0
Non-Māori population, by sex
All 68.7 62.1 57.7 54.3 51.7 49.5 47.6 46.0 44.7 43.3
Male 69.6 62.8 58.2 54.6 51.7 49.0 47.3 45.7 44.4 42.8
Female 67.4 61.1 57.1 53.8 51.8 50.1 48.1 46.4 45.0 44.0
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised - - - - - - - - - -
Regional - - - - - - - - - -
Distant - - - - - - - - - -
Not stated - - - - - - - - - -
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 71.7 64.7 60.3 57.3 54.6 52.6 51.2 49.7 48.6 47.8
3 68.2 61.7 56.8 53.0 50.4 48.5 46.4 45.4 44.2 42.9
4 66.7 60.6 57.2 53.2 50.5 47.9 46.6 44.5 42.6 40.9
5 65.9 58.6 53.4 50.0 47.4 45.2 42.3 40.2 39.0 37.7
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Leukaemia (C91–C95)
New Zealand Cancer Registry 
New Zealand Mortality Collection
Key facts
•  Five-year and 10-year cumulative relative survival (CRS) for adults with 
cancer were 51.4% and 43.3%, respectively.
•  Male and female CRS were nearly identical.
•  Māori had slightly lower CRS than non-Māori between two and nine 
years' follow-up.
•  Extent of disease information is not available for leukaemia patients.
•  Survival was better for patients residing in less deprived areas.
Cumulative relative survival, New Zealand, 1994–2011
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Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 31.6 22.2 17.6 15.9 14.8 14.2 13.7 13.5 13.6 13.8
Male 33.6 23.8 18.3 16.5 15.1 14.9 14.4 14.5 14.7 15.1
Female 27.3 18.7 15.8 14.5 14.0 12.8 12.2 11.6 11.4 11.2
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 27.5 19.3 15.1 14.5 13.1 11.8 11.0 10.2 10.1 9.9
Male 26.8 18.2 13.7 13.3 11.9 11.3 10.5 9.9 10.1 10.4
Female 30.1 23.5 20.5 19.0 17.5 13.9 13.1 12.0 10.5 9.0
Non-Māori population, by sex
All 32.7 23.0 18.2 16.2 15.2 14.9 14.4 14.4 14.5 14.8
Male 35.7 25.6 19.7 17.4 16.1 16.1 15.6 15.9 16.1 16.6
Female 26.8 18.0 15.1 13.8 13.4 12.7 12.2 11.6 11.6 11.7
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 79.9 70.9 61.3 58.8 54.9 52.2 49.8 46.5 46.3 47.5
Regional 53.6 31.8 23.7 21.1 19.6 17.7 18.1 18.7 19.4 20.2
Distant 12.8 6.8 5.6 4.9 4.6 4.6 4.3 4.5 4.4 4.7
Not stated 30.5 20.5 15.5 13.6 12.6 12.3 11.8 11.9 12.1 12.1
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 32.4 22.8 18.1 16.1 14.6 13.5 13.3 13.1 13.5 13.9
3 32.8 21.4 17.6 15.6 14.5 14.5 13.9 13.0 12.4 12.7
4 29.5 21.8 16.3 15.0 14.0 13.6 12.2 12.5 12.3 11.6
5 31.4 21.9 17.1 15.4 14.6 14.3 14.0 13.9 14.3 14.7
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Liver (C22)
New Zealand Cancer Registry 
New Zealand Mortality Collection
Key facts
•  Five-year and 10-year cumulative relative survival (CRS) for liver cancer 
patients were low at 14.8% and 13.8%, respectively.
•  Females had slightly lower CRS than males.
•  Māori had slightly lower CRS than non-Māori.
•  Extent of disease information was not stated for two-thirds of patients. 
Where stated, CRS was lower for patients with distant spread.
•  There was no apparent trend in survival by deprivation.
Cumulative relative survival, New Zealand, 1994–2011
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Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 31.8 19.1 14.6 12.5 11.5 10.7 10.3 10.0 9.9 9.8
Male 29.8 17.3 13.3 11.4 10.6 9.8 9.5 9.3 9.4 9.3
Female 34.7 21.5 16.4 14.0 12.7 12.0 11.4 10.9 10.6 10.5
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 29.7 15.4 10.7 8.7 7.8 7.2 6.8 6.5 6.4 6.3
Male 26.3 13.1 9.0 7.4 6.7 6.4 6.0 5.8 5.9 5.7
Female 32.8 17.4 12.2 9.9 8.8 7.9 7.5 7.1 6.7 6.9
Non-Māori population, by sex
All 32.3 19.8 15.4 13.3 12.2 11.4 11.0 10.6 10.6 10.5
Male 30.3 17.9 13.9 12.0 11.2 10.4 10.0 9.9 9.9 9.8
Female 35.2 22.6 17.5 15.1 13.7 13.0 12.4 11.8 11.5 11.4
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 85.3 76.1 70.4 65.7 63.2 59.6 57.4 54.7 54.2 53.0
Regional 53.1 35.4 28.0 23.4 20.7 19.7 18.4 17.2 16.5 15.8
Distant 12.5 6.0 4.4 3.9 3.7 3.5 3.5 3.6 3.7 3.8
Not stated 37.4 19.4 13.2 10.5 9.3 8.5 8.1 7.9 7.8 7.8
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 33.8 21.3 16.7 14.6 13.5 12.9 12.5 11.9 11.8 11.8
3 32.3 19.0 14.3 12.1 11.2 10.2 9.7 9.2 9.0 8.9
4 30.7 17.9 13.8 11.7 10.8 10.1 9.5 9.2 9.2 8.9
5 30.2 17.5 13.1 11.0 9.8 9.1 8.7 8.6 8.5 8.4
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Lung (C33–C34)
New Zealand Cancer Registry 
New Zealand Mortality Collection
Key facts
•  Five-year and 10-year cumulative relative survival (CRS) for lung cancer 
patients were 11.5% and 9.8%, respectively.
•  Females had slightly higher CRS than males. 
•  Māori had slightly lower CRS than non-Māori patients.
•  Extent of disease was known in approximately half of patients. CRS was 
very low in patients with distant spread of disease.
•  CRS was slightly better in patients residing in less deprived quintiles.
Cumulative relative survival, New Zealand, 1994–2011
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Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 96.9 94.3 92.4 90.8 89.7 88.6 87.9 87.4 87.1 86.9
Male 95.8 92.4 90.0 88.0 86.6 85.1 84.0 83.6 83.4 83.2
Female 98.0 96.4 94.9 93.8 93.0 92.4 92.0 91.5 91.0 90.9
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 93.2 88.4 85.8 84.2 83.5 83.1 82.7 83.3 84.2 83.0
Male 89.5 82.8 77.4 74.6 73.0 72.4 70.5 70.6 71.7 71.0
Female 95.7 92.2 91.2 90.4 90.2 89.9 90.3 91.2 92.1 90.5
Non-Māori population, by sex
All 96.9 94.4 92.5 90.9 89.7 88.7 88.0 87.5 87.2 87.0
Male 95.9 92.5 90.2 88.1 86.7 85.2 84.2 83.8 83.6 83.3
Female 98.1 96.5 94.9 93.9 93.0 92.4 92.0 91.5 91.0 90.9
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 99.9 98.7 97.4 96.2 95.3 94.3 93.7 93.2 93.0 92.8
Regional 89.1 75.5 67.2 59.9 56.2 53.8 51.9 51.2 49.8 49.2
Distant 54.3 41.6 35.5 32.7 30.2 29.1 29.1 29.0 28.7 28.1
Not stated 94.9 91.2 88.0 87.3 86.3 86.1 84.4 83.3 82.9 82.5
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 97.5 95.6 94.1 92.6 91.7 90.9 90.5 90.4 90.1 89.9
3 96.9 94.4 92.4 90.9 89.7 88.6 88.2 87.5 87.2 87.1
4 96.6 93.6 91.2 89.7 88.4 87.2 85.9 85.1 84.6 84.9
5 95.5 92.0 89.3 87.2 85.9 84.7 83.4 82.8 82.5 81.9
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Melanoma (C43)
New Zealand Cancer Registry 
New Zealand Mortality Collection
Key facts
•  Five-year and 10-year cumulative relative survival (CRS) for patients 
with melanoma cancer were 89.7% and 86.9%, respectively.
•  Males had slightly lower CRS than females.
•  Māori had lower CRS than non-Māori patients.
•  Melanoma was localised in nearly 85% of patients. However, CRS was 
substantially lower in patients with regional or distant spread of disease.
•  Survival was better for patients residing in less deprived areas. The 
difference between CRS for patients in the least and most deprived 
quintiles increased in later years of follow-up.
Cumulative relative survival, New Zealand, 1994–2011
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Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 72.9 59.9 50.4 44.5 38.4 33.7 30.3 27.4 25.1 23.7
Male 73.0 60.4 50.5 45.3 39.7 35.1 31.6 27.5 25.1 23.2
Female 72.7 59.3 50.4 43.6 36.8 32.0 28.7 27.3 25.1 24.3
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 74.6 56.2 46.9 39.1 36.9 35.2 28.3 24.1 22.7 21.9
Male 72.6 54.2 41.1 35.5 34.9 32.3 26.1 20.2 20.7 21.3
Female 76.8 58.4 53.3 43.1 39.4 38.6 30.9 28.9 24.8 22.0
Non-Māori population, by sex
All 72.7 60.3 50.8 45.0 38.6 33.6 30.5 27.7 25.3 23.9
Male 73.0 61.0 51.3 46.2 40.2 35.4 32.1 28.2 25.5 23.3
Female 72.3 59.4 50.1 43.6 36.6 31.3 28.4 27.1 25.1 24.5
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised - - - - - - - - - -
Regional - - - - - - - - - -
Distant - - - - - - - - - -
Not stated - - - - - - - - - -
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 74.9 62.5 53.8 46.6 39.9 35.5 33.0 29.8 26.5 24.5
3 72.3 57.9 48.1 42.4 39.1 34.1 30.1 27.4 25.0 24.4
4 70.9 57.4 47.5 41.6 35.5 29.4 25.5 22.3 20.2 18.1
5 71.8 59.6 48.8 44.4 36.4 32.1 27.9 25.5 24.5 24.3
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Myeloma (C90)
New Zealand Cancer Registry 
New Zealand Mortality Collection
Key facts
•  Five-year and 10-year cumulative relative survival (CRS) for patients 
with myeloma were 38.4% and 23.7%, respectively.
•  Males and females had similar CRS. 
•  Māori CRS was generally slightly lower than non-Māori CRS.
•  Extent of disease information is not available for myeloma patients.
•  Survival was generally better for patients residing in less deprived areas.
Cumulative relative survival, New Zealand, 1994–2011
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Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 75.5 68.5 64.4 61.6 59.2 57.2 55.5 54.0 52.4 51.1
Male 76.5 69.1 64.6 62.0 59.6 57.7 56.1 54.2 52.7 51.2
Female 74.2 67.8 64.2 61.1 58.7 56.6 54.9 53.7 52.1 51.1
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 69.3 62.1 56.9 54.7 52.2 48.6 46.8 46.4 45.7 44.8
Male 70.6 62.2 56.2 53.6 52.1 48.8 47.3 46.5 45.5 44.7
Female 67.8 61.9 57.7 56.1 52.3 48.3 46.3 46.2 46.0 44.9
Non-Māori population, by sex
All 75.9 68.9 65.0 62.0 59.7 57.8 56.1 54.5 52.9 51.6
Male 76.9 69.6 65.2 62.6 60.2 58.3 56.8 54.7 53.2 51.6
Female 74.7 68.2 64.7 61.4 59.1 57.1 55.4 54.2 52.5 51.5
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised - - - - - - - - - -
Regional - - - - - - - - - -
Distant - - - - - - - - - -
Not stated 75.5 68.5 64.4 61.6 59.2 57.2 55.5 54.0 52.4 51.1
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 77.0 70.1 66.6 63.8 61.1 59.4 58.1 57.0 55.9 54.8
3 76.8 70.4 66.5 63.7 61.6 59.3 56.9 54.2 52.4 50.9
4 74.1 67.0 62.0 59.2 56.9 54.9 52.4 51.2 48.9 46.8
5 72.3 64.5 60.2 57.2 55.0 52.6 51.9 50.0 48.9 48.0
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Non-Hodgkin lymphoma (C82–C85, C96)
New Zealand Cancer Registry 
New Zealand Mortality Collection
Key facts
•  Five-year and 10-year cumulative relative survival (CRS) for patients 
with non-Hodgkin lymphoma were 59.2% and 51.1%, respectively.
•  Male and female CRS were comparable.
•  Māori had lower CRS than non-Māori.
•  Extent of disease information is not available for non-Hodgkin 
lymphoma patients.
•  Survival was better for patients residing in less deprived areas.
Cumulative relative survival, New Zealand, 1994–2011
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Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 34.1 20.1 15.1 12.8 11.8 11.3 11.0 10.9 10.8 10.9
Male 33.9 19.7 14.5 12.1 10.9 10.5 10.3 10.2 10.4 10.5
Female 34.5 20.8 16.3 14.3 13.4 12.7 12.5 12.1 11.4 11.5
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 26.6 13.8 8.2 7.1 5.9 5.4 5.0 5.2 5.4 5.6
Male 23.6 10.9 5.9 5.5 4.3 4.4 4.6 4.8 5.0 5.3
Female 34.2 21.2 14.2 11.4 9.9 8.5 6.9 7.1 7.3 7.6
Non-Māori population, by sex
All 34.8 20.6 15.7 13.3 12.3 11.7 11.5 11.3 11.2 11.3
Male 34.9 20.6 15.3 12.7 11.5 11.1 10.8 10.8 11.0 11.1
Female 34.5 20.8 16.4 14.5 13.6 13.0 12.8 12.5 11.7 11.8
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 69.9 56.3 51.4 43.5 39.9 39.2 39.7 40.3 39.3 38.0
Regional 51.6 30.7 21.7 16.2 14.7 14.0 13.3 13.2 12.2 12.1
Distant 12.8 5.8 4.9 4.6 4.6 4.5 4.7 4.9 5.1 5.4
Not stated 35.7 20.2 14.3 12.4 11.3 10.6 10.2 9.8 9.8 10.0
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 36.6 20.9 16.5 14.1 12.7 12.3 12.3 12.2 12.3 12.9
3 33.8 20.2 15.2 12.6 11.9 11.1 11.0 10.6 10.4 10.5
4 33.4 19.5 14.4 11.9 10.5 10.2 9.6 9.6 9.4 9.3
5 31.1 19.0 13.2 11.6 11.3 10.5 10.3 9.9 9.9 9.6
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Oesophagus (C15)
New Zealand Cancer Registry 
New Zealand Mortality Collection
Key facts
•  Five-year and 10-year cumulative relative survival (CRS) for patients 
with oesophageal cancer were low at 11.8% and 10.9%, respectively.
•  Males had slightly lower CRS than females.
•  Māori had lower CRS than non-Māori.
•  Extent of disease was unknown for about 60% of patients. Where this 
was stated, patients with regional or distant spread of disease had lower 
CRS than those with localised spread.
•  Survival was slightly higher for patients residing in less deprived areas.
Cumulative relative survival, New Zealand, 1994–2011
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Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 69.0 56.0 48.8 44.5 41.8 40.0 38.5 37.7 37.0 36.6
Male - - - - - - - - - -
Female 69.0 56.0 48.8 44.5 41.8 40.0 38.5 37.7 37.0 36.6
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 73.0 59.1 52.4 50.3 48.2 45.3 45.8 45.1 44.9 44.8
Male - - - - - - - - - -
Female 73.0 59.1 52.4 50.3 48.2 45.3 45.8 45.1 44.9 44.8
Non-Māori population, by sex
All 68.6 55.7 48.4 43.9 41.1 39.5 37.7 36.9 36.2 35.7
Male - - - - - - - - - -
Female 68.6 55.7 48.4 43.9 41.1 39.5 37.7 36.9 36.2 35.7
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 97.4 93.0 90.4 89.0 87.8 86.5 85.2 85.0 84.8 84.2
Regional 78.4 66.2 59.0 54.6 52.6 49.8 47.4 46.3 43.8 42.4
Distant 57.0 39.3 29.5 23.6 20.1 18.1 16.3 15.1 14.4 14.1
Not stated 57.7 51.9 48.9 46.9 44.0 43.8 43.2 43.6 42.4 42.3
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 71.7 58.9 52.0 47.0 44.4 42.2 39.9 39.0 37.9 37.4
3 68.8 54.6 46.5 42.3 37.7 36.2 34.5 34.2 34.1 34.1
4 67.3 53.5 45.4 41.2 39.3 37.5 36.8 35.3 34.4 34.1
5 66.1 54.4 48.4 45.2 43.1 41.7 40.6 40.3 40.1 39.1
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Ovary (C56)
New Zealand Cancer Registry 
New Zealand Mortality Collection
Key facts
•  Five-year and 10-year cumulative relative survival (CRS) for women with 
ovarian cancer were 41.8% and 36.6%, respectively.
•  Māori women had higher CRS than non-Māori women.
•  Patients with regional or distant spread of disease had substantially 
lower CRS than those with localised spread.
•  There was no apparent trend in survival by deprivation quintile.
Cumulative relative survival, New Zealand, 1994–2011
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Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 18.3 10.2 8.1 7.1 6.8 6.7 6.7 6.8 6.9 7.1
Male 18.9 10.6 8.4 7.4 7.2 7.0 7.1 7.2 7.5 7.7
Female 17.7 9.7 7.7 6.8 6.4 6.4 6.3 6.4 6.2 6.5
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 18.7 11.7 8.9 8.2 8.4 7.7 7.7 7.7 7.3 7.6
Male 18.7 12.7 9.3 8.8 9.1 8.0 8.4 8.1 7.7 8.1
Female 18.7 10.8 8.6 7.5 7.8 7.5 7.1 7.4 6.9 7.1
Non-Māori population, by sex
All 18.3 10.0 8.0 7.0 6.6 6.6 6.6 6.7 6.8 7.1
Male 18.9 10.4 8.4 7.3 7.0 6.9 7.0 7.1 7.5 7.7
Female 17.6 9.6 7.6 6.7 6.3 6.3 6.2 6.3 6.1 6.4
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 59.9 42.0 37.5 36.7 35.0 33.9 32.7 33.4 32.1 33.0
Regional 48.4 29.4 23.1 17.6 15.6 14.9 13.4 13.2 13.4 13.7
Distant 9.1 5.5 4.3 3.8 3.8 3.7 3.8 3.9 4.0 4.1
Not stated 20.2 9.5 7.4 6.9 6.7 6.8 7.0 7.2 7.1 7.7
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 20.5 11.4 9.1 8.3 7.9 7.5 7.4 7.2 7.3 7.5
3 18.0 8.7 6.6 5.4 5.1 5.2 5.2 5.5 5.7 5.9
4 17.1 9.3 7.3 6.3 5.9 5.8 5.8 6.0 6.1 6.5
5 15.4 9.6 7.7 6.9 6.6 6.7 6.8 6.9 6.6 6.8
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Pancreas (C25)
New Zealand Cancer Registry 
New Zealand Mortality Collection
Key facts
•  Five-year and 10-year cumulative relative survival (CRS) for patients 
with pancreatic cancer were 6.8% and 7.1%, respectively: the lowest CRS 
for cancers in this publication.
•  Males and females had comparable CRS.
•  Māori and non-Māori had comparable CRS.
•  Patients with regional or distant spread of disease had lower CRS than 
those with localised spread, although CRS was low regardless of extent of 
disease.
•  There was no apparent trend in survival by deprivation quintile.
Cumulative relative survival, New Zealand, 1994–2011
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Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 95.0 92.1 90.2 88.6 87.0 85.7 84.4 83.3 82.7 81.6
Male 95.0 92.1 90.2 88.6 87.0 85.7 84.4 83.3 82.7 81.6
Female - - - - - - - - - -
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 91.7 87.1 84.2 81.9 80.1 77.5 76.8 75.0 74.9 72.3
Male 91.7 87.1 84.2 81.9 80.1 77.5 76.8 75.0 74.9 72.3
Female - - - - - - - - - -
Non-Māori population, by sex
All 95.1 92.4 90.5 89.0 87.4 86.1 84.8 83.7 83.0 82.0
Male 95.1 92.4 90.5 89.0 87.4 86.1 84.8 83.7 83.0 82.0
Female - - - - - - - - - -
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 99.4 98.6 98.4 98.4 98.1 98.0 98.1 98.3 98.5 98.3
Regional 98.5 97.2 95.6 94.3 93.1 91.8 90.9 88.7 87.9 86.3
Distant 49.7 33.1 24.2 20.1 17.4 15.9 14.8 14.4 13.6 13.6
Not stated 97.5 95.3 93.5 91.8 89.9 88.3 86.7 85.3 84.5 83.1
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 96.2 94.2 93.0 92.0 90.9 89.7 88.8 88.2 87.8 87.0
3 95.4 92.7 90.6 89.2 87.7 86.9 85.3 83.8 83.2 82.0
4 93.7 90.2 88.1 85.8 83.9 82.3 80.6 79.2 78.1 76.3
5 93.3 89.3 86.5 84.0 81.5 79.3 78.2 76.5 75.8 74.8
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Prostate (C61)
New Zealand Cancer Registry 
New Zealand Mortality Collection
Key facts
•  Five-year and 10-year cumulative relative survival (CRS) for men with 
prostate cancer were high at 87.0% and 81.6%, respectively.
•  Māori men had lower CRS than non-Māori men.
•  Extent of disease was unknown for about 70% of patients. Where known, 
CRS was substantially lower in patients with distant spread of disease.
 
•  Survival was better for patients residing in less deprived areas.
Cumulative relative survival, New Zealand, 1994–2011
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Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 42.9 31.4 26.6 24.3 23.1 22.3 22.1 21.9 22.1 22.3
Male 43.5 31.3 26.6 24.4 22.9 22.1 21.9 21.7 22.0 22.3
Female 42.0 31.5 26.5 24.2 23.3 22.6 22.3 22.2 22.3 22.4
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 41.4 31.2 27.2 24.0 23.2 22.1 21.3 21.3 20.9 21.3
Male 40.0 30.3 26.5 23.3 21.7 20.9 19.5 19.8 19.7 20.3
Female 43.1 32.2 28.0 24.9 25.0 23.5 23.5 23.1 22.4 22.6
Non-Māori population, by sex
All 43.3 31.4 26.5 24.4 23.1 22.3 22.2 22.0 22.3 22.5
Male 44.1 31.5 26.6 24.6 23.2 22.3 22.3 22.0 22.4 22.6
Female 41.7 31.3 26.2 24.1 22.9 22.4 22.0 22.0 22.2 22.3
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 86.0 80.4 75.9 71.8 70.5 68.3 67.7 66.7 67.3 67.0
Regional 62.8 42.9 33.6 29.2 26.6 24.6 24.0 23.4 23.4 23.4
Distant 16.3 9.4 7.7 7.3 7.0 7.2 7.3 7.4 7.8 8.0
Not stated 37.9 26.2 21.8 20.1 19.0 18.8 18.6 18.9 19.0 19.7
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 45.3 33.7 28.4 26.1 24.7 23.8 23.7 23.8 23.7 24.2
3 41.6 29.3 24.4 22.8 22.0 21.0 21.1 20.8 21.0 20.9
4 42.0 29.3 24.6 22.1 20.6 20.2 19.9 19.2 20.0 20.3
5 40.8 30.6 26.2 23.6 22.5 21.5 20.8 20.8 20.8 20.6
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Stomach (C16)
New Zealand Cancer Registry 
New Zealand Mortality Collection
Key facts
•  Five-year and 10-year cumulative relative survival (CRS) for patients 
with stomach cancer were 23.1% and 22.3%, respectively.
•  Males and females had comparable CRS.
•  Māori and non-Māori patients had similar CRS.
•  Patients with regional or distant spread of disease had lower CRS than 
those with localised spread.
•  CRS was slightly better for patients residing in less deprived areas.
Cumulative relative survival, New Zealand, 1994–2011
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Survival for total population
Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 97.7 96.9 96.2 95.9 95.9 95.7 95.8 95.7 95.7 95.8
Male 97.7 96.9 96.2 95.9 95.9 95.7 95.8 95.7 95.7 95.8
Female - - - - - - - - - -
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 96.0 94.4 93.3 92.8 91.9 91.8 91.3 91.1 91.1 90.7
Male 96.0 94.4 93.3 92.8 91.9 91.8 91.3 91.1 91.1 90.7
Female - - - - - - - - - -
Non-Māori population, by sex
All 98.2 97.5 97.0 96.7 97.0 96.8 97.0 96.8 96.9 97.1
Male 98.2 97.5 97.0 96.7 97.0 96.8 97.0 96.8 96.9 97.1
Female - - - - - - - - - -
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 99.6 99.3 99.1 99.2 99.2 98.9 99.0 99.1 99.4 99.5
Regional 97.1 95.9 94.9 93.7 93.6 93.5 93.4 92.2 91.4 91.2
Distant 84.7 80.2 76.9 75.4 75.1 75.3 75.5 75.0 75.3 75.5
Not stated 99.0 98.0 97.0 96.0 96.3 96.6 97.0 96.6 95.5 95.9
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 98.4 98.1 98.2 98.1 98.3 98.2 98.4 98.6 98.5 98.9
3 98.1 97.2 95.9 95.6 95.9 95.1 94.9 93.7 94.0 94.0
4 97.3 95.7 94.9 94.6 94.9 94.9 95.2 95.2 95.5 95.5
5 96.7 95.8 94.8 94.2 93.5 93.4 93.3 93.3 93.1 92.8
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Testis (C62)
New Zealand Cancer Registry 
New Zealand Mortality Collection
Key facts
•  Five-year and 10-year cumulative relative survival (CRS) for men with 
testicular cancer were 95.9% and 95.8%, respectively, the highest of all 
cancers presented in this publication.
•  Māori men had lower survival than non-Māori men.
•  Disease was localised in the majority of testicular cancer patients. 
Patients with distant spread of disease had lower CRS than those with 
localised or regional spread.
•  CRS was slightly better for men residing in less deprived areas. The 
difference between CRS for patients in the least and most deprived 
quintiles increased in later years of follow-up.
Cumulative relative survival, New Zealand, 1994–2011
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Survival (%) 
Survival for total population
Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 93.9 93.0 92.1 91.9 91.4 90.7 90.2 89.8 89.5 89.1
Male 91.8 90.7 88.7 89.2 87.5 86.7 85.4 85.3 85.2 83.8
Female 94.7 93.9 93.2 92.8 92.8 92.0 91.8 91.4 91.0 90.9
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 94.7 94.1 92.9 91.9 90.7 88.6 88.5 87.1 86.7 85.0
Male 90.5 88.7 87.5 85.8 82.4 80.9 78.7 76.2 75.4 74.1
Female 96.0 95.7 94.5 93.7 93.1 90.9 91.3 90.1 89.8 88.1
Non-Māori population, by sex
All 93.8 92.9 91.9 91.9 91.5 91.0 90.5 90.3 90.0 89.8
Male 92.0 91.0 88.9 89.7 88.2 87.5 86.4 86.6 86.6 85.2
Female 94.4 93.5 93.0 92.7 92.7 92.2 91.9 91.6 91.2 91.4
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 99.1 98.9 98.7 99.2 99.1 98.8 98.9 98.6 98.8 98.7
Regional 94.6 93.4 91.1 91.1 90.5 89.2 87.9 87.8 86.9 85.7
Distant 57.6 54.3 50.1 44.5 40.2 36.0 34.6 32.2 31.5 29.5
Not stated 86.1 83.4 82.6 81.3 81.3 81.1 79.6 79.7 78.1 78.6
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 94.9 94.3 93.8 93.9 93.7 93.0 92.7 92.4 92.9 93.0
3 93.9 92.9 91.1 90.7 89.7 89.5 88.4 88.3 86.7 86.4
4 91.1 90.0 89.2 89.0 89.2 88.7 88.7 87.2 87.7 87.1
5 95.4 94.2 93.1 92.6 91.6 90.4 89.8 90.2 89.0 87.9
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Thyroid (C73)
New Zealand Cancer Registry 
New Zealand Mortality Collection
Key facts
•  Five-year and 10-year cumulative relative survival (CRS) for patients 
with thyroid cancer were 91.4% and 89.1%, respectively.
•  Males had slightly lower CRS than females.
•  Māori and non-Māori patients had comparable CRS until later years of 
follow-up, where survival for Māori was lower than for non-Māori.
•  Patients with localised and regional extent of disease had much better 
CRS than those with distant spread.
•  CRS was slightly better for patients residing in less deprived areas.
Cumulative relative survival, New Zealand, 1994–2011
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Survival (%) 
Survival for total population
Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 88.9 83.5 79.9 77.9 76.6 75.7 75.3 75.0 74.7 74.3
Male - - - - - - - - - -
Female 88.9 83.5 79.9 77.9 76.6 75.7 75.3 75.0 74.7 74.3
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 84.5 78.5 74.8 73.4 70.2 69.7 69.4 69.5 69.8 69.5
Male - - - - - - - - - -
Female 84.5 78.5 74.8 73.4 70.2 69.7 69.4 69.5 69.8 69.5
Non-Māori population, by sex
All 89.4 84.2 80.6 78.5 77.4 76.5 76.1 75.7 75.4 74.9
Male - - - - - - - - - -
Female 89.4 84.2 80.6 78.5 77.4 76.5 76.1 75.7 75.4 74.9
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 98.5 96.5 94.4 93.2 92.3 91.4 91.0 90.6 90.6 89.8
Regional 88.3 78.6 73.0 69.7 67.9 67.4 66.7 66.2 66.3 65.9
Distant 42.7 31.1 25.0 23.2 21.1 20.4 20.1 19.8 19.7 19.9
Not stated 75.8 65.0 59.0 55.2 52.8 51.6 51.5 51.9 50.3 50.5
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 90.7 86.0 82.4 80.8 79.4 78.8 78.6 78.9 78.3 78.5
3 90.1 84.4 82.2 80.0 79.2 78.7 78.7 78.4 79.0 77.3
4 88.3 81.6 78.0 75.7 74.2 73.5 72.5 71.7 71.4 71.9
5 86.3 81.6 77.0 74.8 73.3 71.7 71.1 70.5 70.2 68.8
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Uterus (C54–C55)
New Zealand Cancer Registry 
New Zealand Mortality Collection
Key facts
•  Five-year and 10-year cumulative relative survival (CRS) for women with 
uterine cancer were 76.6% and 74.3%, respectively.
•  Māori women had lower CRS than non-Māori women.
•  Localised disease had relatively high CRS; patients with regional or 
distant spread had progressively worse CRS.
•  Survival was better for patients residing in less deprived areas.
Cumulative relative survival, New Zealand, 1994–2011
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Years since diagnosis 
Survival (%) 
Survival for total population
Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 75.8 91.2 94.8 96.3 97.2 97.8 98.3 98.5 98.8 99.0
Male 74.7 90.9 94.8 96.3 97.2 97.6 98.2 98.5 99.0 98.9
Female 77.1 91.6 94.7 96.3 97.2 98.0 98.4 98.5 98.7 99.0
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 65.8 86.9 92.2 95.0 95.7 96.7 97.6 97.3 98.5 98.3
Male 59.6 84.8 91.2 94.7 96.0 96.6 97.9 97.7 99.2 98.8
Female 70.7 88.3 92.8 95.2 95.6 96.8 97.5 97.1 98.1 98.1
Non-Māori population, by sex
All 76.7 91.6 94.9 96.4 97.3 97.9 98.3 98.6 98.9 99.0
Male 75.7 91.2 95.0 96.4 97.2 97.7 98.3 98.5 99.0 98.9
Female 77.8 91.9 94.9 96.4 97.3 98.1 98.4 98.6 98.7 99.1
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 96.1 97.7 98.3 98.7 98.9 98.9 99.3 99.2 99.5 99.6
Regional 87.2 89.8 92.6 94.0 95.6 96.7 97.3 97.7 98.0 98.1
Distant 28.0 64.7 78.1 86.9 90.6 94.6 97.4 98.3 98.2 100.4
Not stated 74.6 89.3 93.7 95.6 96.3 97.2 97.5 97.9 98.4 98.4
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 79.7 92.5 95.7 96.9 97.6 98.2 98.7 99.0 99.0 99.3
3 76.2 91.2 94.8 96.3 97.2 97.9 98.2 98.1 98.9 99.0
4 73.7 90.4 94.2 96.0 96.9 97.6 97.8 98.1 98.7 98.6
5 71.0 89.6 93.5 95.5 96.4 97.2 98.0 98.1 98.5 98.6
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Note: Relative survival rates that exceed 100% indicates that cancer patients have better observed survival than is expected for people in the general population.
New Zealand Cancer Registry 
New Zealand Mortality Collection
Years since diagnosis
Years since diagnosis
Years since diagnosis
Years since diagnosis
Key facts
Interval-specific relative survival, New Zealand, 1994–2011
•  Interval-specific relative survival (ISRS) increased with each additional year 
survived, from 75.8% in the first year of follow-up to 99.0% in the 10th year of follow-
up.
•  If adult cancer patients survived the first year after diagnosis, their chances of 
survival were more than 90% for the subsequent years.
•  Male adults had slightly lower ISRS than female adults in the first two years of 
follow-up. 
•  Māori adults had lower ISRS than non-Māori adults, particularly in the first two 
years of follow-up.
•  In patients with distant spread of disease, ISRS improved substantially if the first 
few years of follow-up were survived.
•  Survival was slightly lower for patients residing in more deprived areas. ISRS 
increased markedly in the second year of follow-up for all deprivation quintiles.
All adult cancers (C00–C96, D45–D47)
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Survival (%) 
Survival for total population
Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 80.0 89.7 94.3 96.1 96.8 97.6 97.9 98.4 98.9 99.7
Male 82.4 90.1 94.4 95.9 96.6 97.7 97.8 97.7 98.7 99.4
Female 73.3 88.6 93.8 96.7 97.2 97.2 98.0 100.5 99.4 100.4
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 72.7 87.8 96.2 95.6 96.2 101.0 98.9 99.0 95.3 101.8
Male 78.2 87.9 95.3 96.6 95.4 100.1 101.2 99.0 92.8 103.0
Female 62.6 87.4 98.2 93.2 98.3 103.4 93.0 98.8 103.1 98.4
Non-Māori population, by sex
All 80.3 89.8 94.2 96.1 96.8 97.5 97.8 98.4 99.0 99.6
Male 82.6 90.2 94.4 95.9 96.7 97.6 97.7 97.6 98.9 99.3
Female 73.9 88.6 93.6 96.8 97.1 97.0 98.1 100.6 99.2 100.5
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 92.3 93.0 95.1 97.7 98.5 98.5 99.1 97.8 97.4 101.2
Regional 66.7 72.5 84.5 88.6 96.8 91.7 98.5 88.8 101.0 98.6
Distant 17.8 42.3 84.2 92.5 83.8 89.7 80.0 93.2 104.3 105.3
Not stated 84.5 91.4 94.9 96.3 96.5 97.7 97.7 98.9 99.0 99.4
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 82.1 90.4 94.3 96.9 96.8 97.7 97.3 98.9 99.4 100.1
3 81.3 89.8 95.9 95.7 97.1 97.9 98.1 98.1 98.8 100.2
4 78.1 88.9 93.6 95.6 96.6 97.4 98.3 98.0 99.2 99.0
5 76.5 89.0 92.8 95.3 96.1 96.5 97.8 97.9 96.8 98.6
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Note: Relative survival rates that exceed 100% indicates that cancer patients have better observed survival than is expected for people in the general population.
New Zealand Cancer Registry 
New Zealand Mortality Collection
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Key facts
Interval-specific relative survival, New Zealand, 1994–2011
•  Interval-specific relative survival (ISRS) increased with each additional year 
survived, from 80% in the first year of follow-up to 99.7% in the 10th year of follow-
up.
•  If bladder cancer patients survived two years after diagnosis, their chances of 
survival were more than 90% for subsequent years.
•  Female adults had slightly lower ISRS than male adults in the first two years of 
follow-up. 
•  ISRS was similar for Māori and non-Māori patients.
•  Extent of disease information was unknown for 75.7% of bladder cancer patients, 
precluding meaningful analysis.
•  There was no apparent trend in ISRS by deprivation quintile.
Bladder (C67)
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Survival (%) 
Survival for total population
Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 39.6 66.4 85.8 90.4 92.5 93.1 93.8 96.9 96.5 96.2
Male 40.5 64.2 85.6 89.3 92.1 92.2 93.2 98.3 96.7 96.7
Female 38.4 69.7 86.1 92.0 93.1 94.3 94.6 95.1 96.2 95.5
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 41.8 64.8 82.6 95.2 98.6 92.2 95.6 92.2 87.6 92.5
Male 41.4 65.2 78.4 93.8 97.0 84.6 95.5 95.1 94.4 93.5
Female 42.5 64.4 87.9 96.7 100.4 100.4 95.7 89.5 80.3 91.3
Non-Māori population, by sex
All 39.5 66.5 86.0 90.0 92.0 93.2 93.7 97.4 97.3 96.5
Male 40.5 64.1 86.1 89.0 91.8 92.8 93.1 98.5 96.9 96.9
Female 38.1 70.1 85.9 91.6 92.4 93.7 94.5 95.7 97.9 95.8
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 40.6 65.8 85.3 90.0 92.4 93.1 93.3 96.5 95.6 95.8
Regional 18.4 50.1 100.0 100.0 100.1 100.0 100.1 100.1 100.1 100.1
Distant 27.1 77.9 71.6 80.2 75.2 66.9 100.5 101.0 101.2 101.3
Not stated 30.7 75.3 93.0 95.4 95.0 94.7 98.4 100.6 103.1 98.4
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 42.9 63.9 81.9 91.1 92.9 95.4 95.2 98.4 97.5 95.1
3 35.5 65.6 82.6 94.2 94.7 93.0 91.8 95.4 99.3 94.4
4 37.8 65.0 89.0 88.8 89.3 92.5 96.6 98.2 93.5 97.6
5 39.1 73.1 91.5 87.9 92.5 90.7 89.5 93.5 95.0 97.2
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Note: Relative survival rates that exceed 100% indicates that cancer patients have better observed survival than is expected for people in the general population.
New Zealand Cancer Registry 
New Zealand Mortality Collection
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Key facts
Interval-specific relative survival, New Zealand, 1994–2011
•  Interval-specific relative survival (ISRS) increased with each additional year 
survived, from 39.6% in the first year of follow-up to 96.2% in the 10th year of follow-
up.
•  ISRS showed that the risk of death was greatest in the first few years after diagnosis.
•  Females and males had comparable ISRS. 
•  ISRS for Māori and non-Māori improved comparably in the first few years after 
diagnosis, after which there was some variation.
•  Brain cancer was localised in 99% of patients where extent of disease was stated and 
ISRS increased most in the first three years after diagnosis. Survival was varied for 
patients with regional and distant spread due to extremely low patient numbers.
•  There was no apparent trend in ISRS by deprivation quintile.
Brain (C71)
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Years since diagnosis 
Survival (%) 
Survival for total population
Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 96.1 96.2 96.4 96.9 97.2 98.0 98.3 98.3 98.3 98.5
Male - - - - - - - - - -
Female 96.1 96.2 96.4 96.9 97.2 98.0 98.3 98.3 98.3 98.5
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 95.3 95.3 95.2 96.0 95.6 96.6 97.1 96.1 97.3 96.5
Male - - - - - - - - - -
Female 95.3 95.3 95.2 96.0 95.6 96.6 97.1 96.1 97.3 96.5
Non-Māori population, by sex
All 96.2 96.3 96.5 97.0 97.4 98.2 98.5 98.5 98.4 98.7
Male - - - - - - - - - -
Female 96.2 96.3 96.5 97.0 97.4 98.2 98.5 98.5 98.4 98.7
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 100.3 99.3 98.9 99.1 99.2 99.3 99.5 99.1 99.1 99.4
Regional 97.7 94.6 94.9 95.1 95.2 96.4 96.7 97.0 97.1 97.0
Distant 51.8 71.7 73.3 78.0 82.8 89.1 94.6 95.1 91.2 101.5
Not stated 92.2 92.8 93.4 94.8 95.4 97.6 97.5 98.4 98.1 98.0
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 96.9 96.8 97.2 97.1 97.6 98.2 98.9 98.8 98.4 98.9
3 96.2 96.0 96.5 96.6 97.2 97.8 98.2 97.8 98.3 98.5
4 95.7 96.0 95.8 97.1 96.7 98.2 97.8 98.3 98.3 98.4
5 95.3 95.3 95.2 96.8 96.9 97.7 97.9 98.0 97.7 97.6
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Note: Relative survival rates that exceed 100% indicates that cancer patients have better observed survival than is expected for people in the general population.
New Zealand Cancer Registry 
New Zealand Mortality Collection
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Key facts
Interval-specific relative survival, New Zealand, 1994–2011
•  Interval-specific relative survival (ISRS) was relatively high (96.1% one year after 
diagnosis) and remained consistently high up to 10 years after diagnosis.
•  ISRS showed that the risk of death was relatively similar regardless of additional 
years survived.
•  Māori women had slightly lower ISRS than non-Māori women.
•  ISRS was consistently high for women with localised or regional disease. ISRS for 
women with distant spread of disease was half that of localised or regional disease in 
the first year of follow-up. 
•  There was no apparent trend in ISRS by deprivation quintile.
Breast – female (C50)
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Survival (%) 
Survival for total population
Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 87.4 91.0 95.5 96.5 97.9 98.8 98.7 99.3 98.8 99.6
Male - - - - - - - - - -
Female 87.4 91.0 95.5 96.5 97.9 98.8 98.7 99.3 98.8 99.6
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 83.9 89.4 95.0 95.4 96.3 98.5 97.9 99.3 100.0 100.9
Male - - - - - - - - - -
Female 83.9 89.4 95.0 95.4 96.3 98.5 97.9 99.3 100.0 100.9
Non-Māori population, by sex
All 88.3 91.4 95.6 96.7 98.2 98.8 98.9 99.3 98.6 99.3
Male - - - - - - - - - -
Female 88.3 91.4 95.6 96.7 98.2 98.8 98.9 99.3 98.6 99.3
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 100.0 99.4 99.4 99.7 99.8 99.6 99.4 100.0 99.9 100.1
Regional 90.4 89.5 94.6 91.1 96.8 96.8 97.4 97.8 97.0 98.1
Distant 35.8 62.0 78.8 87.1 85.5 88.3 100.6 94.3 101.0 101.1
Not stated 83.0 81.8 89.9 92.7 94.6 98.2 97.1 98.3 96.3 98.5
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 90.5 93.2 97.0 98.4 97.8 99.3 98.7 99.5 98.7 99.7
3 87.5 89.4 96.4 96.4 98.2 99.1 98.6 98.7 99.2 100.0
4 87.0 89.9 94.2 96.1 98.6 99.0 99.3 99.5 98.5 98.9
5 84.6 90.6 94.2 94.5 97.0 97.8 98.2 99.2 98.9 99.9
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Note: Relative survival rates that exceed 100% indicates that cancer patients have better observed survival than is expected for people in the general population.
New Zealand Cancer Registry 
New Zealand Mortality Collection
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Key facts
Interval-specific relative survival, New Zealand, 1994–2011
•  Interval-specific relative survival (ISRS) was relatively high one year after diagnosis 
and remained consistently high up to 10 years after diagnosis.
•  Māori women had slightly lower ISRS than non-Māori women in the first two years 
of follow-up, after which ISRS was comparable.
•  Disease was localised in nearly 70% of cases where extent of disease was known; 
ISRS for these women indicates similar survival prospects as the general population.  
•  In the first few years after diagnosis survival was better for women residing in less 
deprived areas, after which ISRS was comparable for women in all deprivation 
quintiles.
•  Cervical screening may affect survival. Screening finds cervical tumours at the pre-
cancerous stage (not included in this data), potentially resulting in a larger proportion 
of registered cervical cancers at an aggressive or advanced stage, increasing the 
likelihood of death.
Cervix (C53)
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Survival (%) 
Survival for total population
Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 89.4 94.0 96.1 98.2 98.8 99.0 99.4 99.3 99.9 99.9
Male 89.5 93.8 96.5 98.7 99.0 98.8 99.3 99.1 99.9 99.9
Female 89.3 94.3 95.7 97.6 98.5 99.3 99.5 99.5 100.0 100.0
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 85.7 92.7 94.9 97.7 99.1 99.0 99.7 98.4 100.0 100.1
Male 86.1 90.5 95.8 98.5 100.0 98.1 99.3 97.7 100.1 100.1
Female 85.3 95.4 93.9 96.9 98.0 100.0 100.0 99.1 100.0 100.0
Non-Māori population, by sex
All 90.4 94.4 96.4 98.3 98.7 99.0 99.4 99.5 99.9 99.9
Male 90.5 94.7 96.6 98.8 98.7 98.9 99.4 99.5 99.8 99.8
Female 90.4 94.0 96.2 97.8 98.6 99.1 99.4 99.6 100.0 100.0
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 87.1 94.2 96.2 98.9 99.3 98.6 99.3 99.5 100.0 100.0
Regional 91.8 92.6 94.4 97.9 98.9 100.0 100.0 100.0 100.0 100.0
Distant 72.1 82.7 89.7 93.8 96.5 97.4 100.0 100.0 100.0 100.0
Not stated 92.7 95.4 96.9 98.3 98.7 99.2 99.4 99.1 99.9 99.9
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 91.7 94.5 95.9 98.4 99.4 99.0 99.3 99.8 100.0 100.0
3 90.3 92.9 97.6 98.3 98.8 99.0 99.3 98.8 100.0 99.5
4 87.8 94.6 96.0 97.3 97.4 98.6 99.6 99.6 100.0 100.0
5 87.2 93.6 95.3 98.4 99.1 99.2 99.7 98.8 99.7 100.0
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Note: Relative survival rates that exceed 100% indicates that cancer patients have better observed survival than is expected for people in the general population.
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Key facts
Interval-specific relative survival, New Zealand, 1994–2011
•  Interval-specific relative survival (ISRS) increased with each additional year 
survived, from 89.4% in the first year of follow-up to 99.9% in the 10th year of follow-
up.
•  Females and males had comparable ISRS.
•  ISRS was slightly lower for Māori children than for non-Māori children in the first 
few years after diagnosis, after which ISRS was comparable.
•  ISRS was better for children with localised or regional cancer, although extent of 
disease was only stated in 40% of patients so comparisons should be made with 
caution.
•  In the first two years of follow-up survival was slightly better for children residing in 
less deprived areas.
Childhood cancers (C00–C96, D45–D47, ages 0–14)
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Survival (%) 
Survival for total population
Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 79.0 89.5 93.0 95.1 96.7 97.7 98.4 98.6 99.0 99.4
Male 79.3 89.4 92.5 94.3 96.1 97.2 98.4 98.6 98.9 99.5
Female 78.7 89.6 93.5 95.8 97.2 98.3 98.5 98.6 99.2 99.4
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 73.7 86.9 87.1 92.8 94.0 97.8 97.3 99.2 99.1 100.4
Male 71.1 85.5 86.5 91.4 93.0 96.1 96.3 99.8 100.7 101.0
Female 76.7 88.4 87.7 94.2 94.9 99.4 98.3 98.7 97.5 99.8
Non-Māori population, by sex
All 79.2 89.6 93.2 95.1 96.7 97.7 98.5 98.6 99.0 99.4
Male 79.7 89.5 92.7 94.4 96.2 97.2 98.4 98.6 98.9 99.4
Female 78.8 89.7 93.8 95.9 97.2 98.3 98.5 98.6 99.2 99.4
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 96.7 98.7 98.3 98.5 98.6 99.1 99.0 98.9 99.3 99.5
Regional 88.8 90.2 92.1 93.7 95.8 96.9 98.0 98.2 98.7 99.1
Distant 37.2 56.6 71.5 83.1 88.6 93.2 97.2 98.5 99.0 100.6
Not stated 70.3 85.1 89.8 93.0 95.4 97.6 98.4 99.0 99.5 100.0
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 81.3 90.5 93.7 96.0 97.3 97.7 98.8 99.2 99.0 99.9
3 79.1 89.6 93.1 95.1 96.3 98.3 98.1 98.4 99.1 99.6
4 77.6 89.1 92.4 94.3 96.3 97.3 98.0 97.9 99.4 99.0
5 75.9 87.8 92.0 93.9 95.9 97.5 98.4 98.4 98.5 98.6
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Note: Relative survival rates that exceed 100% indicates that cancer patients have better observed survival than is expected for people in the general population.
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Key facts
Interval-specific relative survival, New Zealand, 1994–2011
•  Interval-specific relative survival (ISRS) increased with each additional year 
survived, from 79.0% in the first year of follow-up to 99.4% in the 10th year of follow-
up.
•  If colorectal cancer patients survived two years after diagnosis, their chances of 
survival were more than 90% for the subsequent years.
•  Males and females had comparable ISRS.
•  Māori adults had slightly lower ISRS than non-Māori adults in the five years after 
diagnosis. 
•  In patients with distant spread of disease, ISRS improved substantially in the first 
few years of follow-up.
•  In the first five years of follow-up survival was slightly better for patients residing in 
less deprived areas.
Colorectum and anus (C18–C21)
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Years since diagnosis 
Survival (%) 
Survival for total population
Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 82.8 88.9 94.1 95.7 96.5 96.7 97.8 97.0 97.3 97.5
Male 82.8 88.0 93.8 95.2 96.4 96.3 97.9 97.0 96.8 97.5
Female 82.7 91.0 94.9 96.7 96.7 97.6 97.6 96.9 98.4 97.4
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 81.6 85.2 92.0 93.3 93.6 97.4 95.0 94.8 93.2 99.7
Male 79.0 81.9 91.6 91.5 93.4 95.8 93.8 96.7 91.0 101.4
Female 88.5 92.9 92.7 96.9 94.0 100.5 97.2 91.2 97.5 96.6
Non-Māori population, by sex
All 82.9 89.2 94.3 95.9 96.8 96.6 98.1 97.1 97.6 97.4
Male 83.1 88.5 94.0 95.5 96.7 96.3 98.3 97.0 97.2 97.3
Female 82.2 90.8 95.1 96.7 97.0 97.4 97.6 97.5 98.5 97.5
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 96.6 94.7 96.7 98.2 97.6 98.1 99.1 96.6 98.1 99.1
Regional 80.6 84.4 90.8 93.3 95.2 96.5 96.8 98.1 96.3 97.3
Distant 57.4 79.6 91.2 92.9 94.1 97.7 98.5 99.4 93.3 98.7
Not stated 79.8 88.7 94.7 95.4 96.7 95.6 97.4 96.5 97.5 96.2
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 85.2 91.3 94.9 95.9 95.5 97.7 99.4 98.0 97.2 98.9
3 80.7 89.7 93.5 96.3 97.2 97.0 97.7 95.8 95.9 96.9
4 82.2 86.2 93.6 96.3 98.1 96.9 96.3 97.0 99.4 96.2
5 81.6 87.5 94.1 94.1 95.4 94.6 97.2 96.4 97.0 97.5
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Note: Relative survival rates that exceed 100% indicates that cancer patients have better observed survival than is expected for people in the general population.
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Key facts
Interval-specific relative survival, New Zealand, 1994–2011
•  Interval-specific relative survival (ISRS) increased with each additional year 
survived, from 82.8% in the first year of follow-up to 97.5% in the 10th year of follow-
up.
•  If patients survived the two years after diagnosis their chances of survival were more 
than 90.0% for the subsequent years.
•  Males and females had comparable ISRS.
•  Māori patients generally had slightly lower ISRS than non-Māori patients.
•  57.4% of patients with distant metastases who survived their first year after 
diagnosis were expected to survive their second, compared to 96.6% of patients with 
localised head, neck and laryngeal cancer.
•  There was no apparent trend in ISRS by deprivation quintile.
Head, neck and larynx (C00–C14, C32)
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Survival (%) 
Survival for total population
Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 91.7 96.5 97.7 97.3 98.3 98.5 98.7 98.2 98.9 98.6
Male 91.6 97.2 97.8 97.6 97.8 98.4 98.0 97.4 98.1 98.0
Female 91.8 95.5 97.6 96.8 99.1 98.7 99.5 99.1 99.7 99.3
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 95.7 95.4 97.6 97.2 98.0 95.1 99.0 97.1 100.6 98.1
Male 95.5 97.1 96.8 96.4 95.8 92.4 97.4 93.2 100.8 95.4
Female 95.9 93.8 98.4 98.1 100.4 97.7 100.5 100.5 100.5 100.5
Non-Māori population, by sex
All 91.3 96.6 97.7 97.3 98.4 98.9 98.6 98.3 98.7 98.6
Male 91.2 97.2 97.9 97.7 97.9 98.9 98.1 97.7 98.0 98.2
Female 91.4 95.7 97.5 96.7 99.0 98.8 99.4 98.9 99.7 99.2
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised - - - - - - - - - -
Regional - - - - - - - - - -
Distant - - - - - - - - - -
Not stated 91.7 96.5 97.7 97.3 98.3 98.5 98.7 98.2 98.9 98.6
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 92.8 96.4 98.5 98.8 98.6 99.3 98.8 97.9 99.3 98.2
3 90.7 95.4 96.9 95.7 96.9 98.1 98.4 98.1 99.7 99.6
4 91.3 97.9 98.1 97.0 100.2 97.8 98.7 97.8 98.3 97.9
5 90.7 96.2 97.1 96.4 97.4 98.1 98.4 98.9 97.7 98.8
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Note: Relative survival rates that exceed 100% indicates that cancer patients have better observed survival than is expected for people in the general population.
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Key facts
Interval-specific relative survival, New Zealand, 1994–2011
•  Interval-specific relative survival (ISRS) increased with each additional year 
survived, from 91.7% in the first year of follow-up to 98.6% in the 10th year of follow-
up.
•  If patients survived the first year after diagnosis their chances of survival were more 
than 95% for the subsequent years.
•  Males and females had comparable ISRS. 
•  Māori and non-Māori had similar ISRS, however the number of Māori patients was 
low so comparison should be made with caution.
•  Extent of disease information is not available for Hodgkin lymphoma patients.
•  There was no apparent trend in ISRS by deprivation quintile.
Hodgkin lymphoma (C81)
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5 6 7 8 9 10
Years since diagnosis 
Male
Female
Survival (%) 
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5 6 7 8 9 10
Years since diagnosis 
Māori
Non-Māori
Survival (%) 
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5 6 7 8 9 10
Years since diagnosis 
Localised
Regional
Distant
Survival (%) 
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5 6 7 8 9 10
Years since diagnosis 
1−2 
3
4
5
Survival (%) 
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5 6 7 8 9 10
Years since diagnosis 
Survival (%) 
Survival for total population
Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 74.1 90.5 95.0 96.0 96.3 97.2 98.0 97.9 98.1 98.4
Male 74.3 90.0 95.0 95.8 96.7 97.1 98.0 97.5 98.3 98.3
Female 73.6 91.2 95.0 96.2 95.6 97.4 98.0 98.4 97.9 98.6
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 70.6 88.9 92.9 92.0 95.5 95.4 99.3 95.9 97.8 100.5
Male 69.5 88.1 93.1 91.0 98.1 95.9 101.9 92.3 98.1 99.2
Female 72.8 90.4 92.5 93.6 91.6 94.6 94.8 102.2 97.5 102.4
Non-Māori population, by sex
All 74.4 90.6 95.2 96.3 96.4 97.4 97.9 98.0 98.1 98.3
Male 74.7 90.2 95.1 96.2 96.6 97.2 97.8 97.9 98.3 98.2
Female 73.7 91.3 95.2 96.5 95.9 97.6 98.2 98.2 97.9 98.4
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 97.7 96.9 97.7 98.0 97.9 97.7 99.7 98.5 98.5 98.8
Regional 85.2 87.5 92.5 93.2 96.6 95.7 94.4 97.3 97.5 96.1
Distant 24.8 56.0 79.2 83.3 82.2 98.2 96.4 98.8 94.3 102.6
Not stated 67.7 87.0 92.0 93.6 91.7 96.3 93.4 94.6 97.7 98.0
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 76.6 90.5 95.9 97.1 97.5 97.3 98.4 98.8 99.2 98.0
3 74.2 89.8 95.3 96.0 95.8 97.5 98.2 97.0 96.6 99.5
4 72.6 90.6 93.8 96.5 96.3 96.3 97.5 96.8 98.6 96.9
5 71.0 90.8 94.1 93.2 94.4 97.7 97.5 98.4 96.8 99.6
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Note: Relative survival rates that exceed 100% indicates that cancer patients have better observed survival than is expected for people in the general population.
New Zealand Cancer Registry 
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Key facts
Interval-specific relative survival, New Zealand, 1994–2011
•  Interval-specific relative survival (ISRS) increased with each additional year 
survived, from 74.1% in the first year of follow-up to 98.4% in the 10th year of follow-
up.
•  If patients survived the first year after diagnosis their chances of survival were more 
than 90% for the subsequent years.
•  Males and females had comparable ISRS.
•  ISRS was generally slightly lower for Māori compared to non-Māori patients.
•  Survival was substantially lower for patients with distant spread of disease in the 
first 5 years after diagnosis.
•  Survival was slightly better for patients residing in less deprived areas in the first 
two years after diagnosis. ISRS increased to 90% for all deprivation quintiles in the 
second year of follow-up.
Kidney (C64–C66, C68)
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Years since diagnosis 
Survival (%) 
Survival for total population
Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 68.7 90.2 92.8 93.9 95.1 95.8 96.3 96.6 97.2 97.3
Male 69.6 90.1 92.5 93.7 94.4 95.2 96.6 96.6 97.3 96.7
Female 67.5 90.4 93.3 94.3 96.1 96.6 95.9 96.5 97.0 98.1
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 68.9 87.6 91.2 92.5 93.3 97.3 97.6 96.6 98.1 101.9
Male 69.2 87.6 91.4 90.8 92.3 99.2 99.8 96.4 97.5 102.0
Female 68.5 87.6 90.9 94.8 94.5 95.1 95.0 96.8 98.7 101.8
Non-Māori population, by sex
All 68.7 90.5 92.9 94.1 95.3 95.7 96.2 96.6 97.1 97.0
Male 69.6 90.3 92.6 93.9 94.6 94.9 96.4 96.6 97.3 96.3
Female 67.4 90.7 93.5 94.3 96.2 96.7 96.0 96.5 96.9 97.8
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised - - - - - - - - - -
Regional - - - - - - - - - -
Distant - - - - - - - - - -
Not stated - - - - - - - - - -
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 71.7 90.3 93.1 95.0 95.3 96.4 97.3 97.2 97.6 98.4
3 68.2 90.4 92.0 93.4 95.2 96.1 95.7 98.0 97.3 97.1
4 66.7 90.7 94.5 92.9 95.1 94.9 97.3 95.4 95.7 96.2
5 65.9 88.9 91.2 93.6 94.8 95.3 93.8 94.9 97.2 96.6
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Note: Relative survival rates that exceed 100% indicates that cancer patients have better observed survival than is expected for people in the general population.
New Zealand Cancer Registry 
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Key facts
Interval-specific relative survival, New Zealand, 1994–2011
•  Interval-specific relative survival (ISRS) increased with each additional year 
survived, from 68.7% in the first year of follow-up to 97.3% in the 10th year of follow-
up.
•  If patients survived the first year after diagnosis, their chances of survival were more 
than 90.0% for the subsequent years.
•  Males and females had comparable ISRS. 
•  Māori and non-Māori had similar ISRS, however the number of Māori patients was 
low so comparison should be made with caution.
•  Extent of disease information is not available for leukaemia patients.
•  There was no apparent trend in ISRS by deprivation quintile.
Leukaemia (C91–C95)
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Survival for total population
Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 31.6 70.4 78.9 90.3 93.1 96.5 96.0 98.6 100.7 101.3
Male 33.6 71.0 76.9 89.8 91.6 99.0 96.1 100.7 101.5 102.7
Female 27.3 68.6 84.5 91.7 96.3 91.5 95.8 94.5 98.8 97.9
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 27.5 70.3 78.4 95.4 90.5 90.0 93.3 93.1 98.7 98.0
Male 26.8 68.0 75.3 96.6 89.8 94.8 93.0 93.9 102.9 102.8
Female 30.1 78.1 87.2 92.8 91.9 79.8 94.1 91.2 87.8 85.6
Non-Māori population, by sex
All 32.7 70.4 79.0 89.2 93.7 98.2 96.6 99.8 101.1 102.0
Male 35.7 71.7 77.2 88.3 92.1 100.2 96.9 102.2 101.2 102.7
Female 26.8 66.9 84.0 91.4 97.4 94.3 96.1 95.1 100.7 100.2
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 79.9 88.7 86.4 96.0 93.4 95.1 95.3 93.3 99.7 102.4
Regional 53.6 59.3 74.7 88.7 93.1 90.4 102.4 103.3 103.6 104.1
Distant 12.8 53.5 81.6 87.2 95.3 99.0 94.3 104.1 98.3 106.1
Not stated 30.5 67.2 75.6 88.0 92.6 97.3 96.4 100.5 101.4 100.0
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 32.4 70.4 79.5 88.8 90.7 92.3 98.8 98.0 103.1 103.2
3 32.8 65.2 82.5 88.6 92.6 100.2 95.6 94.1 95.4 102.4
4 29.5 73.8 74.8 92.3 92.9 97.1 90.2 102.0 98.6 94.3
5 31.4 69.9 77.9 90.4 94.6 97.9 97.5 99.4 103.0 103.3
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Note: Relative survival rates that exceed 100% indicates that cancer patients have better observed survival than is expected for people in the general population.
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Key facts
Interval-specific relative survival, New Zealand, 1994–2011
•  Interval-specific relative survival (ISRS) increased with each additional year 
survived, from 31.6% in the first year of follow-up to 101.3% in the 10th year of follow-
up.
•  If patients survived the first year after diagnosis, their chances of survival increased 
to approximately 70% and continued to increase in subsequent years.
•  Males and females had comparable ISRS.
•  Māori and non-Māori had similar ISRS for the first few years after diagnosis, after 
which Māori ISRS was slightly lower than non-Māori.
•  ISRS was markedly lower in patients with distant spread in the first three years after 
diagnosis.
•  There was no apparent trend in ISRS by deprivation quintile.
Liver (C22)
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5 6 7 8 9 10
Years since diagnosis 
Male
Female
Survival (%) 
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5 6 7 8 9 10
Years since diagnosis 
Māori
Non-Māori
Survival (%) 
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5 6 7 8 9 10
Years since diagnosis 
Localised
Regional
Distant
Survival (%) 
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5 6 7 8 9 10
Years since diagnosis 
1−2 
3
4
5
Survival (%) 
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5 6 7 8 9 10
Years since diagnosis 
Survival (%) 
Survival for total population
Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 31.8 59.9 76.6 85.7 91.8 93.5 95.9 96.6 99.3 99.0
Male 29.8 58.0 76.9 85.9 92.9 92.9 96.6 98.0 100.8 99.0
Female 34.7 62.0 76.4 85.4 90.7 94.3 95.2 95.0 97.5 99.0
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 29.7 51.7 69.6 81.4 90.1 92.0 94.3 95.8 98.0 99.3
Male 26.3 49.8 68.4 82.3 91.1 95.1 93.4 97.4 102.2 96.3
Female 32.8 52.9 70.4 80.8 89.4 89.7 95.1 94.6 94.7 101.8
Non-Māori population, by sex
All 32.3 61.4 77.7 86.2 92.0 93.7 96.1 96.7 99.4 98.9
Male 30.3 59.1 77.9 86.3 93.0 92.7 96.8 98.1 100.6 99.2
Female 35.2 64.2 77.6 86.1 90.9 95.0 95.2 95.1 97.9 98.6
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 85.3 89.2 92.5 93.3 96.2 94.3 96.4 95.2 99.0 97.8
Regional 53.1 66.5 79.1 83.9 88.2 95.4 93.5 93.2 96.0 96.0
Distant 12.5 48.0 73.1 88.6 94.4 95.8 101.2 101.8 102.1 102.2
Not stated 37.4 51.9 67.9 79.8 88.8 91.3 94.8 97.4 99.7 99.8
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 33.8 63.1 78.4 87.3 92.5 95.3 96.9 95.8 99.2 99.8
3 32.3 59.0 75.0 84.9 92.3 90.9 95.4 94.3 98.2 99.4
4 30.7 58.3 76.9 84.7 92.1 93.7 94.8 96.6 100.0 96.8
5 30.2 57.9 74.7 84.1 89.4 92.6 95.6 98.8 98.8 99.2
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Note: Relative survival rates that exceed 100% indicates that cancer patients have better observed survival than is expected for people in the general population.
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Key facts
Interval-specific relative survival, New Zealand, 1994–2011
•  Interval-specific relative survival (ISRS) increased with each additional year 
survived, from 31.8% in the first year of follow-up to 99.0% in the 10th year of follow-
up.
•  ISRS improved substantially in the first five years after diagnosis.
•  Males and females had comparable ISRS. 
•  Māori had slightly lower ISRS than non-Māori in the first five years after diagnosis, 
after which survival converged.
•  12.5% of patients with distant spread who survived their first year after diagnosis 
were expected to survive their second, compared to 53.1% and 85.3% of patients with 
regional or localised lung cancer, respectively. 
•  There was no apparent trend in ISRS by deprivation quintile.
Lung (C33–C34)
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Survival (%) 
Survival for total population
Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 96.9 97.4 97.9 98.3 98.8 98.8 99.2 99.5 99.6 99.8
Male 95.8 96.4 97.4 97.7 98.4 98.3 98.7 99.5 99.8 99.7
Female 98.0 98.4 98.4 98.9 99.1 99.3 99.6 99.4 99.5 99.8
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 93.2 94.9 97.0 98.1 99.2 99.6 99.5 100.7 101.2 98.5
Male 89.5 92.5 93.5 96.4 97.8 99.3 97.3 100.1 101.6 99.0
Female 95.7 96.4 99.0 99.0 99.8 99.7 100.4 101.0 100.9 98.3
Non-Māori population, by sex
All 96.9 97.4 97.9 98.3 98.8 98.8 99.2 99.5 99.6 99.8
Male 95.9 96.5 97.5 97.7 98.4 98.3 98.7 99.5 99.7 99.7
Female 98.1 98.4 98.4 98.9 99.1 99.3 99.6 99.4 99.5 99.8
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 99.9 98.8 98.7 98.8 99.1 98.9 99.3 99.5 99.7 99.8
Regional 89.1 84.8 88.9 89.2 93.8 95.8 96.5 98.6 97.3 98.8
Distant 54.3 76.7 85.2 92.2 92.3 96.3 100.0 99.7 98.9 98.1
Not stated 94.9 96.1 96.5 99.2 99.0 99.7 98.0 98.7 99.5 99.6
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 97.5 98.0 98.4 98.4 98.9 99.2 99.6 99.9 99.7 99.7
3 96.9 97.4 97.8 98.4 98.7 98.7 99.6 99.2 99.7 99.8
4 96.6 96.9 97.4 98.3 98.6 98.5 98.6 99.0 99.4 100.4
5 95.5 96.3 97.1 97.6 98.6 98.5 98.5 99.2 99.7 99.2
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Note: Relative survival rates that exceed 100% indicates that cancer patients have better observed survival than is expected for people in the general population.
New Zealand Cancer Registry 
New Zealand Mortality Collection
Years since diagnosis
Years since diagnosis
Years since diagnosis
Years since diagnosis
Key facts
Interval-specific relative survival, New Zealand, 1994–2011
•  Interval-specific relative survival (ISRS) was 96.9% in the first year of follow-up and 
increased slightly with each additional year survived.
•  Males had slightly lower ISRS in the first couple of years of follow-up, after which 
ISRS was comparable in males and females.
•  Māori had slightly lower ISRS than non-Māori in the first three years of follow-up, 
after which ISRS was comparable in Māori and non-Māori.
•  Patients with distant spread of melanoma had substantially lower survival in the 
first few years of follow-up compared to those with localised disease.
•  There was no apparent trend in ISRS by deprivation quintile.
Melanoma (C43)
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Survival for total population
Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 72.9 82.3 84.2 88.3 86.3 87.7 89.9 90.5 91.7 94.4
Male 73.0 82.8 83.5 89.8 87.7 88.3 90.0 87.1 91.4 92.5
Female 72.7 81.6 85.0 86.4 84.5 86.8 89.8 95.1 92.0 96.8
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 74.6 75.3 83.5 83.4 94.5 95.4 80.4 85.2 94.2 96.6
Male 72.6 74.7 75.8 86.5 98.2 92.5 80.7 77.5 102.5 102.7
Female 76.8 76.0 91.4 80.8 91.4 97.9 80.0 93.5 85.8 88.8
Non-Māori population, by sex
All 72.7 82.9 84.2 88.7 85.6 87.0 90.8 90.9 91.4 94.2
Male 73.0 83.5 84.1 90.0 87.0 88.0 90.7 87.8 90.5 91.5
Female 72.3 82.2 84.3 87.0 83.8 85.5 91.0 95.2 92.6 97.5
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised - - - - - - - - - -
Regional - - - - - - - - - -
Distant - - - - - - - - - -
Not stated - - - - - - - - - -
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 74.9 83.5 86.1 86.6 85.5 89.2 92.9 90.2 89.0 92.5
3 72.3 80.0 83.1 88.3 92.2 87.1 88.2 90.9 91.5 97.5
4 70.9 81.0 82.8 87.6 85.3 82.8 86.7 87.7 90.5 89.3
5 71.8 83.0 81.9 90.9 81.9 88.4 86.9 91.3 96.1 99.1
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Note: Relative survival rates that exceed 100% indicates that cancer patients have better observed survival than is expected for people in the general population.
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Key facts
Interval-specific relative survival, New Zealand, 1994–2011
•  Interval-specific relative survival (ISRS)  increased with each additional year 
survived, from 72.9% in the first year of follow-up to 94.4% in the 10th year of follow-
up. 
•  Males and females had comparable ISRS.
•  Non-Māori ISRS increased steadily with each year survived after diagnosis, however 
Māori ISRS was more variable, probably due to low patient numbers.
•  Extent of disease information is not available for myeloma patients.
•  There was no apparent trend in ISRS by deprivation quintile; ISRS increased from 
approximately 70% in the first year after diagnosis to 90% in the 10th year for patients 
residing in all deprivation quintiles.
Myeloma (C90)
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Survival (%) 
Survival for total population
Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 75.5 90.7 94.1 95.5 96.2 96.6 97.2 97.2 97.2 97.5
Male 76.5 90.3 93.5 95.9 96.2 96.8 97.3 96.5 97.3 97.0
Female 74.2 91.3 94.8 95.1 96.1 96.4 97.0 97.9 97.0 98.1
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 69.3 89.5 91.7 96.2 95.3 93.2 96.4 99.0 98.5 98.0
Male 70.6 88.1 90.4 95.3 97.2 93.8 96.9 98.3 97.7 98.3
Female 67.8 91.3 93.2 97.2 93.2 92.4 95.8 99.9 99.4 97.6
Non-Māori population, by sex
All 75.9 90.8 94.2 95.5 96.2 96.8 97.2 97.1 97.1 97.5
Male 76.9 90.4 93.7 96.0 96.2 96.9 97.3 96.4 97.3 96.9
Female 74.7 91.3 94.9 95.0 96.3 96.6 97.1 97.8 96.8 98.1
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised - - - - - - - - - -
Regional - - - - - - - - - -
Distant - - - - - - - - - -
Not stated 75.5 90.7 94.1 95.5 96.2 96.6 97.2 97.2 97.2 97.5
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 77.0 91.0 95.0 95.7 95.8 97.2 97.9 98.0 98.2 98.1
3 76.8 91.6 94.5 95.8 96.7 96.2 96.0 95.2 96.7 97.2
4 74.1 90.4 92.6 95.4 96.2 96.4 95.5 97.8 95.5 95.7
5 72.3 89.2 93.4 95.0 96.2 95.7 98.6 96.4 97.7 98.2
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Note: Relative survival rates that exceed 100% indicates that cancer patients have better observed survival than is expected for people in the general population.
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Key facts
Interval-specific relative survival, New Zealand, 1994–2011
•  Interval-specific relative survival (ISRS) increased with each additional year 
survived, from 75.5% in the first year of follow-up to 90.7% in the second year, after 
which chances of survival increased gradually.
•  Males and females had comparable ISRS.
•  75.9% of non-Māori patients who survive their first year are expected to survive 
their second, compared to 69.3% of Māori patients. ISRS increased in both ethnic 
groups to approximately 90% in the second year of follow-up.
•  Extent of disease information is not available for non-Hodgkin lymphoma patients.
•  In the first three years after diagnosis ISRS is slightly better for patients who reside 
in less deprived areas, after which ISRS is similar across deprivation quintiles.
Non-Hodgkin lymphoma (C82–C85, C96)
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5 6 7 8 9 10
Years since diagnosis 
Male
Female
Survival (%) 
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5 6 7 8 9 10
Years since diagnosis 
Māori
Non-Māori
Survival (%) 
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5 6 7 8 9 10
Years since diagnosis 
Localised
Regional
Distant
Survival (%) 
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5 6 7 8 9 10
Years since diagnosis 
1−2 
3
4
5
Survival (%) 
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5 6 7 8 9 10
Years since diagnosis 
Survival (%) 
Survival for total population
Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 34.1 58.9 75.1 85.0 91.8 95.6 97.9 98.7 99.0 100.9
Male 33.9 58.2 73.4 83.3 90.5 96.1 97.9 99.6 101.9 101.1
Female 34.5 60.3 78.2 87.9 93.9 94.8 97.9 97.3 94.4 100.6
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 26.6 51.8 59.6 87.2 82.0 92.9 91.5 103.4 104.0 104.3
Male 23.6 46.1 54.3 93.4 77.2 103.1 104.0 104.3 104.6 105.8
Female 34.2 62.0 66.8 80.4 87.3 85.3 81.7 102.6 103.0 103.3
Non-Māori population, by sex
All 34.8 59.4 75.9 84.9 92.2 95.7 98.1 98.5 98.8 100.8
Male 34.9 58.9 74.4 83.0 90.9 95.9 97.8 99.4 101.8 101.0
Female 34.5 60.2 78.9 88.3 94.2 95.3 98.7 97.1 94.0 100.5
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 69.9 80.5 91.4 84.5 91.8 98.4 101.3 101.4 97.5 96.7
Regional 51.6 59.4 70.9 74.3 90.7 95.7 94.5 99.8 92.5 98.8
Distant 12.8 45.6 83.6 93.9 99.5 99.7 103.6 104.1 104.7 105.4
Not stated 35.7 56.5 70.8 87.0 90.9 93.7 96.2 95.8 100.3 102.4
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 36.6 57.2 78.9 85.6 89.4 97.0 99.8 99.6 100.9 104.9
3 33.8 59.6 75.3 83.0 94.8 93.0 98.7 96.4 98.4 101.3
4 33.4 58.3 73.7 82.9 88.3 96.8 94.7 100.1 97.7 98.4
5 31.1 61.1 69.4 87.5 97.4 93.7 97.5 96.8 99.8 97.1
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Note: Relative survival rates that exceed 100% indicates that cancer patients have better observed survival than is expected for people in the general population.
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Key facts
Interval-specific relative survival, New Zealand, 1994–2011
•  Interval-specific relative survival (ISRS)  increased with each additional year 
survived, from 34.1% in the first year of follow-up to 91.8% in the fifth year, after 
which chances of survival continued to increase.
•  Males and females had comparable ISRS.
•  Non-Māori ISRS increased steadily with each year survived after diagnosis; Māori 
ISRS was more variable, probably due to low patient numbers.
•  Extent of disease information was unknown in 60% of cases. 12.8% of patients with 
distant metastasis who survived their first year after diagnosis were expected to 
survive their second, compared to 69.9% of patients with localised oesophageal cancer. 
ISRS improved for patients with all extents of disease to at least 90% by the fifth year 
of follow-up.
•  There was no apparent trend in ISRS by deprivation quintile.
Oesophagus (C15)
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Survival (%) 
Survival for total population
Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 69.0 81.2 87.1 91.2 93.9 95.9 96.1 98.0 98.3 98.8
Male - - - - - - - - - -
Female 69.0 81.2 87.1 91.2 93.9 95.9 96.1 98.0 98.3 98.8
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 73.0 81.0 88.6 96.0 95.9 94.0 101.1 98.4 99.7 99.7
Male - - - - - - - - - -
Female 73.0 81.0 88.6 96.0 95.9 94.0 101.1 98.4 99.7 99.7
Non-Māori population, by sex
All 68.6 81.2 86.9 90.7 93.6 96.1 95.5 97.9 98.1 98.7
Male - - - - - - - - - -
Female 68.6 81.2 86.9 90.7 93.6 96.1 95.5 97.9 98.1 98.7
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 97.4 95.5 97.1 98.5 98.6 98.6 98.4 99.8 99.8 99.3
Regional 78.4 84.4 89.2 92.5 96.3 94.7 95.3 97.5 94.8 96.7
Distant 57.0 68.9 75.1 80.1 85.1 89.9 90.3 92.3 95.9 97.7
Not stated 57.7 89.9 94.3 96.0 93.7 99.4 98.6 101.1 97.3 99.7
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 71.7 82.1 88.4 90.4 94.3 95.1 94.5 98.0 97.2 98.6
3 68.8 79.4 85.2 90.9 89.2 96.1 95.2 99.3 99.6 100.0
4 67.3 79.6 84.8 90.7 95.5 95.6 97.9 95.9 97.4 99.3
5 66.1 82.4 89.0 93.3 95.3 96.9 97.4 99.1 99.5 97.6
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Note: Relative survival rates that exceed 100% indicates that cancer patients have better observed survival than is expected for people in the general population.
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Key facts
Interval-specific relative survival, New Zealand, 1994–2011
•  Interval-specific relative survival (ISRS)  increased with each additional year 
survived, from 69.0% in the first year of follow-up to 98.8% in the 10th year.
•  Survival for Māori and non-Māori women was comparable over 10 years of follow-
up.
•  57.0% of women with distant spread who survived their first year after diagnosis 
were expected to survive their second, compared to 97.4% of women with localised 
ovarian cancer. ISRS improved for women with each extent of disease to 
approximately 96.7% in the 10th year.
•  There was no apparent trend in ISRS by deprivation quintile.
Ovary (C56)
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Survival (%) 
Survival for total population
Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 18.3 55.5 79.6 88.2 95.2 99.3 99.5 101.3 100.9 104.0
Male 18.9 56.1 79.8 88.2 96.2 98.1 100.8 101.7 103.9 103.3
Female 17.7 55.0 79.4 88.2 94.0 100.6 98.1 100.8 97.4 104.8
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 18.7 62.8 76.1 91.5 103.3 91.4 100.2 100.2 93.9 104.1
Male 18.7 68.0 73.5 94.5 103.5 87.8 104.1 97.2 94.9 104.7
Female 18.7 58.0 79.1 87.9 103.1 96.2 95.7 104.1 92.6 103.5
Non-Māori population, by sex
All 18.3 54.7 80.0 87.8 94.1 100.4 99.4 101.5 101.8 104.0
Male 18.9 54.9 80.6 87.4 95.2 99.7 100.3 102.4 105.1 103.1
Female 17.6 54.6 79.4 88.3 92.9 101.2 98.4 100.4 98.0 105.0
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 59.9 70.1 89.3 97.8 95.4 97.0 96.5 102.2 96.0 102.9
Regional 48.4 60.7 78.5 76.4 88.4 95.9 89.6 98.2 102.1 102.3
Distant 9.1 60.3 78.3 88.0 99.3 99.5 102.3 101.0 104.7 101.0
Not stated 20.2 47.0 78.3 93.3 96.1 101.8 103.1 102.4 99.8 107.1
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 20.5 55.5 79.8 91.0 95.3 95.6 97.9 97.5 101.4 102.8
3 18.0 48.1 76.3 81.5 94.5 102.6 99.8 105.9 103.3 103.4
4 17.1 54.3 78.3 86.8 92.9 99.5 99.4 103.8 101.8 105.4
5 15.4 62.1 80.7 88.8 96.1 102.3 100.9 101.2 95.2 104.3
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Note: Relative survival rates that exceed 100% indicates that cancer patients have better observed survival than is expected for people in the general population.
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Key facts
Interval-specific relative survival, New Zealand, 1994–2011
•  Interval-specific relative survival (ISRS) increased with each additional year 
survived from 18.3% in the first year of follow-up to 104.0% in the 10th year.
•  Males and females had comparable ISRS.
•  Māori and non-Māori ISRS were relatively comparable for 10 years of follow-up; 
Māori ISRS was more varied, probably due to low patient numbers.
•  9.1% of patients with distant spread who survived their first year after diagnosis 
were expected to survive their second, compared to 59.9% of patients with localised 
pancreatic cancer. ISRS improved for patients with all extents of disease to 
approximately 100% by the eighth year of follow-up. 
•  There was no apparent trend in ISRS by deprivation quintile.
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Years since diagnosis 
Survival (%) 
Survival for total population
Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 95.0 97.0 97.9 98.2 98.2 98.5 98.5 98.7 99.2 98.7
Male 95.0 97.0 97.9 98.2 98.2 98.5 98.5 98.7 99.2 98.7
Female - - - - - - - - - -
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 91.7 95.0 96.6 97.3 97.9 96.7 99.2 97.7 99.8 96.6
Male 91.7 95.0 96.6 97.3 97.9 96.7 99.2 97.7 99.8 96.6
Female - - - - - - - - - -
Non-Māori population, by sex
All 95.1 97.1 98.0 98.3 98.2 98.5 98.5 98.7 99.2 98.8
Male 95.1 97.1 98.0 98.3 98.2 98.5 98.5 98.7 99.2 98.8
Female - - - - - - - - - -
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 99.4 99.2 99.8 99.9 99.7 99.9 100.1 100.2 100.2 99.8
Regional 98.5 98.7 98.4 98.6 98.7 98.6 99.0 97.5 99.1 98.2
Distant 49.7 66.7 73.0 83.0 86.8 91.1 92.9 97.3 94.5 100.1
Not stated 97.5 97.7 98.2 98.1 98.0 98.2 98.2 98.3 99.0 98.4
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 96.2 97.9 98.7 98.9 98.8 98.8 99.0 99.3 99.6 99.1
3 95.4 97.1 97.7 98.5 98.4 99.0 98.2 98.2 99.3 98.5
4 93.7 96.3 97.6 97.5 97.7 98.1 98.0 98.2 98.6 97.8
5 93.3 95.7 96.8 97.2 97.0 97.3 98.6 97.8 99.0 98.7
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Note: Relative survival rates that exceed 100% indicates that cancer patients have better observed survival than is expected for people in the general population.
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Key facts
Interval-specific relative survival, New Zealand, 1994–2011
•  Interval-specific relative survival (ISRS) was high for all 10 years of follow-up, and 
increased from 95.0% in the first year of follow-up to 98.7% in the 10th year.
•  ISRS was generally slightly lower for Māori men compared to non-Māori men.
•  Extent of disease was unknown in nearly 75% of prostate cancer cases. Where stated, 
49.7% of patients with distant spread who survived their first year after diagnosis were 
expected to survive their second, compared to approximately 99% of patients with 
localised or regional spread of prostate cancer.
•  There was no apparent trend in ISRS by deprivation quintile.
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Survival (%) 
Survival for total population
Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 42.9 73.0 84.8 91.5 95.0 96.5 99.0 99.2 101.0 101.0
Male 43.5 71.9 85.1 91.6 94.1 96.3 99.2 99.1 101.5 101.2
Female 42.0 75.0 84.2 91.3 96.4 96.9 98.6 99.5 100.3 100.7
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 41.4 75.3 87.2 88.3 96.6 95.2 96.5 100.0 98.4 101.9
Male 40.0 75.7 87.4 87.9 93.1 96.3 93.5 101.7 99.3 103.1
Female 43.1 74.9 86.9 88.7 100.6 94.1 100.0 98.0 97.3 100.6
Non-Māori population, by sex
All 43.3 72.6 84.3 92.1 94.7 96.8 99.4 99.1 101.5 100.8
Male 44.1 71.3 84.7 92.2 94.3 96.2 100.1 98.7 101.8 100.9
Female 41.7 75.0 83.6 92.0 95.4 97.6 98.3 99.8 101.0 100.7
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 86.0 93.5 94.5 94.5 98.3 96.9 99.2 98.5 100.8 99.6
Regional 62.8 68.4 78.3 86.8 91.1 92.5 97.5 97.3 100.4 99.9
Distant 16.3 57.5 81.7 94.6 96.6 102.1 102.5 101.5 104.3 102.4
Not stated 37.9 69.1 83.3 92.2 94.6 98.7 99.1 101.5 100.7 103.5
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 45.3 74.3 84.4 91.9 94.6 96.1 99.9 100.2 99.5 102.5
3 41.6 70.4 83.3 93.4 96.4 95.7 100.1 98.7 100.9 99.7
4 42.0 69.7 84.0 89.7 93.3 97.9 98.9 96.5 103.8 101.6
5 40.8 74.9 85.7 90.3 95.1 95.5 96.7 100.0 100.2 99.1
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Note: Relative survival rates that exceed 100% indicates that cancer patients have better observed survival than is expected for people in the general population.
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Key facts
Interval-specific relative survival, New Zealand, 1994–2011
•  Interval-specific relative survival (ISRS) increased with each additional year 
survived, from 42.9% in the first year of follow-up to 101.0% in the 10th year of follow-
up.
•  ISRS improved substantially in the first five years after diagnosis.
•  Males and females had comparable ISRS.
•  Māori and non-Māori patients had comparable ISRS.
•  16.3% of patients with distant spread of disease who survived their first year after 
diagnosis were expected to survive their second, compared to 86.0% of patients with 
localised stomach cancer. ISRS improved for patients with all extents of disease to at 
least 90% by the fifth year of follow-up.
•  There was no apparent trend in ISRS by deprivation quintile.
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Years since diagnosis 
Survival (%) 
Survival for total population
Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 97.7 99.1 99.3 99.7 100.0 99.8 100.1 99.9 100.0 100.1
Male 97.7 99.1 99.3 99.7 100.0 99.8 100.1 99.9 100.0 100.1
Female - - - - - - - - - -
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 96.0 98.3 98.9 99.4 99.1 99.8 99.5 99.7 100.0 99.6
Male 96.0 98.3 98.9 99.4 99.1 99.8 99.5 99.7 100.0 99.6
Female - - - - - - - - - -
Non-Māori population, by sex
All 98.2 99.3 99.4 99.7 100.2 99.8 100.2 99.9 100.0 100.2
Male 98.2 99.3 99.4 99.7 100.2 99.8 100.2 99.9 100.0 100.2
Female - - - - - - - - - -
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 99.6 99.7 99.8 100.1 100.1 99.7 100.0 100.1 100.3 100.1
Regional 97.1 98.7 98.9 98.8 99.9 99.9 99.9 98.7 99.2 99.8
Distant 84.7 94.8 95.8 98.0 99.6 100.3 100.3 99.4 100.3 100.3
Not stated 99.0 99.0 99.0 98.9 100.3 100.4 100.4 99.6 98.8 100.4
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 98.4 99.7 100.1 99.9 100.2 99.9 100.2 100.2 99.8 100.5
3 98.1 99.1 98.6 99.7 100.3 99.2 99.8 98.7 100.4 100.0
4 97.3 98.4 99.2 99.7 100.3 100.0 100.3 100.0 100.3 100.0
5 96.7 99.0 99.0 99.3 99.3 99.9 99.8 100.1 99.8 99.7
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Note: Relative survival rates that exceed 100% indicates that cancer patients have better observed survival than is expected for people in the general population.
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Key facts
Interval-specific relative survival, New Zealand, 1994–2011
•  Interval-specific relative survival (ISRS) remained high for all 10 years of follow-up, 
increasing from 97.7% in the first year of follow-up to 100.1% in the 10th year.
•  Māori and non-Māori testicular cancer patients had similar ISRS; 96% of Māori and 
98.2% of non-Māori patients who survive their first year are expected to survive the 
second year of follow-up. 
•  84.7% of patients with distant metastasis who survived their first year after 
diagnosis were expected to survive their second, compared to approximately 98.0% of 
patients with localised or regional spread of testicular cancer; by the fifth year of 
follow-up ISRS was comparable between patients with all extents of disease.
•  There was no apparent trend in ISRS by deprivation quintile.
Testis (C62)
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5 6 7 8 9 10
Years since diagnosis 
Male
Female
Survival (%) 
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5 6 7 8 9 10
Years since diagnosis 
Māori
Non-Māori
Survival (%) 
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5 6 7 8 9 10
Years since diagnosis 
Localised
Regional
Distant
Survival (%) 
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5 6 7 8 9 10
Years since diagnosis 
1−2 
3
4
5
Survival (%) 
0
10
20
30
40
50
60
70
80
90
100
0 1 2 3 4 5 6 7 8 9 10
Years since diagnosis 
Survival (%) 
Survival for total population
Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 93.9 99.0 98.9 99.8 99.5 99.2 99.5 99.6 99.6 99.5
Male 91.8 98.8 97.8 100.5 98.1 99.1 98.6 99.9 99.8 98.4
Female 94.7 99.1 99.3 99.6 99.9 99.2 99.8 99.6 99.6 99.9
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 94.7 99.3 98.7 99.0 98.7 97.7 99.9 98.4 99.6 98.1
Male 90.5 98.0 98.6 98.1 96.0 98.2 97.4 96.8 98.9 98.2
Female 96.0 99.7 98.7 99.2 99.4 97.5 100.4 98.8 99.7 98.1
Non-Māori population, by sex
All 93.8 99.0 99.0 100.0 99.6 99.4 99.4 99.8 99.6 99.7
Male 92.0 98.9 97.7 100.8 98.4 99.2 98.7 100.3 100.0 98.4
Female 94.4 99.0 99.4 99.7 100.0 99.5 99.6 99.7 99.5 100.2
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 99.1 99.8 99.9 100.5 99.9 99.7 100.1 99.7 100.2 99.9
Regional 94.6 98.8 97.5 100.1 99.3 98.6 98.5 99.9 98.9 98.6
Distant 57.6 94.2 92.3 88.9 90.2 89.6 96.2 92.9 97.9 93.8
Not stated 86.1 96.9 99.1 98.4 99.9 99.8 98.2 100.1 98.0 100.6
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 94.9 99.4 99.5 100.1 99.8 99.2 99.7 99.6 100.6 100.1
3 93.9 98.9 98.0 99.6 98.9 99.8 98.8 99.9 98.2 99.7
4 91.1 98.8 99.1 99.9 100.2 99.4 100.0 98.4 100.6 99.2
5 95.4 98.7 98.9 99.5 98.9 98.7 99.3 100.4 98.7 98.7
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Note: Relative survival rates that exceed 100% indicates that cancer patients have better observed survival than is expected for people in the general population.
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Key facts
Interval-specific relative survival, New Zealand, 1994–2011
•  Interval-specific relative survival (ISRS) was high for thyroid cancer; 93.9% who 
survived their first year were expected to survive their second.
•  Males and females had comparable ISRS.
•  Māori and non-Māori patients had comparable ISRS.
•  57.6% of patients with distant spread of disease who survived their first year after 
diagnosis were expected to survive their second, compared to 94.6% and 99.1% of 
patients with regional or localised thyroid cancer, respectively.
•  There was no apparent trend in ISRS by deprivation quintile.
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Survival (%) 
Survival for total population
Survival, by sex
1 2 3 4 5 6 7 8 9 10
Total population, by sex
All 88.9 94.0 95.7 97.5 98.3 98.9 99.4 99.6 99.7 99.4
Male - - - - - - - - - -
Female 88.9 94.0 95.7 97.5 98.3 98.9 99.4 99.6 99.7 99.4
Survival, by ethnic group
1 2 3 4 5 6 7 8 9 10
Māori population, by sex
All 84.5 92.9 95.2 98.2 95.7 99.2 99.6 100.1 100.4 99.6
Male - - - - - - - - - -
Female 84.5 92.9 95.2 98.2 95.7 99.2 99.6 100.1 100.4 99.6
Non-Māori population, by sex
All 89.4 94.1 95.8 97.4 98.6 98.8 99.4 99.5 99.6 99.4
Male - - - - - - - - - -
Female 89.4 94.1 95.8 97.4 98.6 98.8 99.4 99.5 99.6 99.4
Survival, by extent of disease
1 2 3 4 5 6 7 8 9 10
Total population, by extent of disease
Localised 98.5 98.0 97.8 98.7 99.1 99.0 99.5 99.6 100.0 99.1
Regional 88.3 89.0 92.9 95.4 97.4 99.3 98.9 99.2 100.2 99.4
Distant 42.7 72.9 80.1 93.1 90.7 96.9 98.5 98.3 99.5 101.2
Not stated 75.8 85.8 90.7 93.5 95.7 97.6 100.0 100.8 96.8 100.5
Survival, by deprivation quintile
1 2 3 4 5 6 7 8 9 10
Total population, by deprivation quintile
1−2 90.7 94.9 95.8 98.1 98.3 99.2 99.7 100.4 99.2 100.2
3 90.1 93.7 97.4 97.3 99.0 99.4 100.0 99.7 100.7 97.8
4 88.3 92.4 95.6 97.1 98.0 99.0 98.7 98.9 99.5 100.7
5 86.3 94.6 94.4 97.1 98.0 97.9 99.2 99.1 99.5 98.1
Note: Quintile 1−2 is the least deprived and quintile 5 is the most deprived.
Source: 
Note: Relative survival rates that exceed 100% indicates that cancer patients have better observed survival than is expected for people in the general population.
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Key facts
Interval-specific relative survival, New Zealand, 1994–2011
•  Interval-specific relative survival (ISRS) was high for uterine cancer; 88.9% who 
survived their first year were expected to survive their second.
•  Māori and non-Māori women had comparable ISRS.
•  42.7% of women with distant spread of disease who survived their first year after 
diagnosis were expected to survive their second, compared to 88.3% and 98.5% of 
patients with regional or localised uterine cancer, respectively.
•  There was no apparent trend in ISRS by deprivation quintile.
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